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Summary 
The development of large-scale catalogs of genetic variation has stimulated 
interest in finding targets of positive selection, leading to the development of a plethora 
of genome-wide scans for positive selection. The identification of these genes can 
prime insights into how individuals are predisposed to disease, and may inform the 
development of improved therapeutic and disease-prevention strategies. Some gene 
ontology categories are enriched for signals of positive selection, among which are 
genes involved in immunity and host-pathogen interactions and reproduction. In this 
regard, a genome-wide scan for positive selection has pinpointed several Whey-Acidic-
Protein (WAP) four-disulfide core domain (WFDC) genes to be under positive selection 
in human populations.  
WFDC genes encode 17 serine protease inhibitors, which in most cases are not 
functionally characterized, but well-studied WFDC genes have biological functions 
associated with innate immune response and reproduction in mammals. Additionally, 
neighboring genes encode seminal proteins Semenogelin 1 and 2 (SEMG1 and 
SEMG2), the main components of the semen coagulum. WFDC and SEMG genes 
have demonstrated a strikingly high rate of amino acid replacement (dN/dS), indicative 
of responses to adaptive pressures during vertebrate evolution. In addition, SEMG2 
evolution was previously shown to be correlated with promiscuity rates in primates.  
The complex and rapid evolution of WFDC and SEMG in primates motivated 
the characterization of their genetic variation and the extent to which natural selection 
has shaped their evolution in human populations. The evolution of WFDC and SEMG 
genes in chimpanzees was also pursued in an effort to contrast selective pressures in 
two closely related species. The main goal was to identify which WFDC and SEMG 
genes are evolving under stronger selective pressures and should be further assessed 
for their biological function.  
The study was designed in two stages: the first was based on a genome-wide 
scan for positive selection and the second enclosed a high-throughput comprehensive 
sequencing study of the WFDC locus. A signature of short-term balancing selection in 
WFDC8 in Europeans was identified, characterized by an intermediate-frequency long 
haplotype linked to the proposed candidate variant -44A. In addition, a signal of recent 
positive selection (incomplete selective sweep) in Africans was pinpointed as the result 
of a high frequency haplotype defined by the Ser73+98A configuration. In the second 
stage, a follow-up approach was taken to perform a systematic high-throughput Sanger 
sequencing effort across the entire WFDC locus in the three major HapMap human 
populations, and in three chimpanzee subspecies (P. t. troglodytes, P. t. ellioti and P. t. 
verus). The comprehensive analysis of the human genetic variation allowed 
confirmation of the previously identified signals, and endorsed the identification of a 
signature of selection on standing variation centered in SEMG1 in Asians. The 
candidate variant was hypothesized to be Thr56Ser, which may alter the proteolytic 
profile of SEMG1 and antimicrobial activities of semen. The heterogeneous signals of 
non-neutral evolution of WFDC and SEMGs in human populations led to propose that 
they are primary targets of selection, likely due to immune response to pathogens and 
reproductive pressures.  
Conversely, when genetic variation in chimpanzee subspecies was analyzed 
the signals of selection pointed toward purifying selection acting in WFDC6 and EPPIN, 
genes involved in antimicrobial defense in the reproductive tract. Multispecies studies 
coupled with analyses of summary statistics suggested WFDC6 is evolving to be 
functionally divergent from EPPIN and to target different proteases and to increase the 
response against pathogens. Due to the function of these genes and the promiscuous 
mating patterns of chimpanzees, it is hypothesized that the selective pressures shaping 
the genetic diversity in chimpanzees are driven by increased protection from sexually 
transmitted diseases.  
Overall, it was confirmed that the WFDC genes are evolving under different 
pressures in humans and chimpanzees, with selection targeting different genes in the 
two species. The time scale of the selective pressures was found to be more recent in 
humans.  
Three genes were prioritized for future functional characterization: WFDC8, 
SPINT4 and SEMG1. For WFDC8, preliminary in vitro and in vivo studies were 
inconclusive in clarifying the functional impact of the candidate variant -44A in gene 
expression/regulation. Specifically, the effect of this variant in the expression of 
WFDC8 appears to be dependent on the tissue background, where -44A enhances 
expression in ovaries (in vivo) and HeLa cell lines (in vitro); and decreases expression 
in Caco-2 cell lines (in vitro). Further assessment of WFDC8 functionality as an 
antimicrobial and protease inhibitor protein can elucidate not only the consequences of 
the short-term balancing selection event but also the role WFDC8 plays in innate 
immunity in the reproductive tract. The deep characterization of other genes in the 
WFDC locus will increase the knowledge on the biological dynamics of rapidly evolving 
genomic regions in primates. 
 
  
Sumário 
O desenvolvimento de novos catálogos de variação genética tem vindo a 
estimular o interesse em encontrar alvos de seleção positiva, levando ao 
desenvolvimento de uma panóplia de scans genómicos para deteção de seleção 
positiva. A identificação de genes envolvidos na seleção positiva poderá ajudar a 
compreender a predisposição de indivíduos a certas doenças e bem como orientar no 
desenvolvimento de estratégias de terapia e prevenção de doenças. Algumas 
categorias génicas são mais enriquecidas em sinais de seleção entre as quais genes 
envolvidos em imunidade, interações hospedeiro-patogénio e reprodução. Neste 
contexto, um scan genómico para a deteção de seleção positiva identificou uma 
vantagem seletiva em vários genes de Whey-Acidic-Protein (WAP) four-disulfide core 
domain (WFDC) em populações humanas. 
Os genes WFDC codificam 17 inibidores de protease de serina que na sua 
maioria, não estão ainda caracterizados funcionalmente, apesar de os genes WFDC 
com função biológica conhecida estarem associados com a resposta imune inata e a 
reprodução em mamíferos. Os genes vizinhos aos WFDC codificam as proteínas 
Semenogelinas 1 e 2 (SEMG1 e SEMG2), que são as principais proteínas do coágulo 
seminal. Os genes WFDC e SEMGs demonstraram um elevado rácio de substituições 
amino acídicas (dN/dS) indicando uma resposta a pressões adaptativas durante a 
evolução de vertebrados. Por exemplo, a evolução acelerada da SEMG2 foi 
previamente correlacionada com os níveis de promiscuidade em primatas. 
A complexa e rápida evolução dos WFDC e SEMG em primatas encorajou a 
caracterização da variação genética destes genes, assim como o estudo da seleção 
natural que tem vindo a influenciar a sua evolução em populações humanas. A 
evolução dos genes WFDC e SEMG em chimpanzés foi também analisada de forma a 
contrastar as pressões seletivas em duas espécies próximas. O principal objetivo foi 
identificar quais genes WFDC e SEMG estão a evoluir sobre fortes pressões seletivas 
e deverão ser caracterizados biologicamente. 
Num estudo desenhado em duas fases, a primeira foi baseada num estudo 
genómico de deteção de seleção positiva e a segunda baseada num estudo 
sistemático de todos os genes WFDC. A primeira fase permitu identificar uma 
assinatura de seleção balanceadora recente no gene WFDC8 em Europeus, 
caracterizada por um longo haplótipo de frequência intermédia associado ao variante 
candidato -44A. Este mesmo estudo identificou ainda um sinal em Africanos de 
seleção positiva recente (incomplete selective sweep) associado a uma configuração 
haplotipica de elevada frequência definida pelas variantes Ser73+98A. A segunda 
parte do estudo envolveu a sequenciação Sanger de todo a região WFDC em três 
populações humanas do HapMap e em três subespécies de chimpanzés (P. t. 
troglodytes, P. t. ellioti e P. t. verus). Este estudo extensivo da variação genética 
humana permitiu a confirmação dos dois sinais identificados previamente, e 
proporcionou a identificação de um sinal de seleção sobre variação pré-existente, 
centrada no gene SEMG1 em Asiáticos. O variante candidato proposto, Thr56Ser, 
poderá alterar o perfil proteolítico da SEMG1 e as atividades antimicrobianas do 
sémen. Baseado na heterogeneidade de sinais de evolução não-neutra dos genes de 
WFDC e SEMGs em populações humanas, os resultados deste trabalho sugerem que 
estes genes são alvos primários de seleção positiva, provavelmente devido a pressões 
ligadas à resposta imune a patogénios e a reprodução. 
Por outro lado, quando a variação genética das subespécies de chimpanzés foi 
analisada, os sinais de seleção apontaram para um sinal de seleção purificante 
centrado nos genes WFDC6 e EPPIN, cujas proteínas estão envolvidas na defesa 
antimicrobiana do aparelho reprodutor. Estudos comparativos de várias espécies 
combinados com estatísticas sumárias sugeriram que o gene WFDC6 está a evoluir de 
forma a se tornar funcionalmente divergente da EPPIN para interagir com diferentes 
proteases e para aumentar a resposta contra os patogénios. Devido à função destes 
genes e à natureza promiscua dos chimpanzés, propôs-se que as pressões seletivas 
que estão a moldar a diversidade genética em chimpanzés são desencadeadas pelo 
aumento da proteção contra doenças sexualmente transmissíveis.  
Em resumo, confirmou-se que os genes WFDC estão a evoluir sobre pressões 
seletivas divergentes em humanos e chimpanzés, com eventos de seleção natural a 
ocorrer em genes diferentes nas duas espécies. Os resultados apresentados neste 
trabalho indicam ainda que as pressões seletivas em humanos parecem ser bastante 
mais recentes que em chimpanzés. 
Três genes foram determinados como prioritários para uma caraterização 
funcional futura: WFDC8, SPINT4 e SEMG1. No caso do gene WFDC8, os resultados 
preliminares in vitro e in vivo foram inconclusivos na clarificação do impacto funcional 
do variante candidato -44A na regulação/expressão do gene. O efeito desta variante 
na expressão de WFDC8 parece depender do tecido estudado, uma vez que o 
variante -44A aumenta a expressão do WFDC8 em ovários (in vivo) e na linha celular 
de HeLa (in vitro), mas diminui a expressão na linha celular Caco-2 (in vitro). Mais 
estudos do WFDC8 deverão ser efetuados para determinar a sua atividade 
antimicrobiana e de inibição proteolítica de forma a elucidar as repercussões da 
seleção balanceadora recente e o papel do WFDC8 na imunidade inata do aparelho 
reprodutivo. A caracterização exaustiva dos outros genes sobre seleção positiva no 
locus WFDC irá potenciar o conhecimento na dinâmica biológica de regiões que 
evoluem de forma acelerada em primatas. 
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Figure 1: Schematic representation of the 20q13 WFDC locus. Diagram showing the 
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Figure 2: Three dimensional structure of the WAP domain from elafin (PDB reference: 
2REL). β-sheets are represented in arrows and loops are represented by lines. 
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1.1 Natural Selection in Humans  
 
Natural selection, described by Darwin in 1872, is the principle in which 
beneficial traits make their carriers survive longer and reproduce more, tending to 
become more frequent in populations over time (Darwin 1859; Jobling, Hurles and 
Tyler-Smith 2004; Hartl and Clark 2007). Selection can occur at any stage of the 
development of an individual, from the zygote to the reproductive age at the moment of 
generating progeny, going through fertility and gamete selection, and fecundity and 
mate choice. Altogether, these factors contribute to the fitness of an individual in a 
particular environment where the important factor is the relative fitness of a phenotype 
compared to the other phenotypes competing for the same resources (Jobling, Hurles 
and Tyler-Smith 2004; Orr 2009).  
 
Even though relative fitness is expressed as a function of phenotypic variation 
(such as height, weight, resistance to diseases, etc.), natural selection can only occur 
in a population if mutation has generated heritable genetic variation (polymorphisms). 
These mutations can be advantageous (adaptive), deleterious or neutral (having no 
effects on the fitness of an individual). A variant that increases the fitness of individuals 
will be spread to fixation (frequency = 1) by positive selection, whereas a deleterious 
variant will be eliminated by negative (or purifying) selection — a force to which all 
genes are likely subject to (Sabeti, et al. 2006; Kelley and Swanson 2008; Verrelli, et 
al. 2008; Akey 2009; Nielsen, et al. 2009; Barrett and Hoekstra 2011; Crisci, et al. 
2011; Fumagalli, et al. 2011).  
 
Some noncoding regions have been found to present hallmarks of purifying 
selection, highlighting not only the conservation of protein-coding regions (Bustamante, 
et al. 2005; Clark 2006; Clark, Aagaard and Swanson 2006; Blekhman, et al. 2008; Fu, 
et al. 2013; Moleirinho, et al. 2013), but also noncoding regions with important 
functional elements, such as microRNAs and regulatory elements (Bersaglieri, et al. 
2004; Woolfe, et al. 2004; Siepel, et al. 2005; Quach, et al. 2009; Ward and Kellis 
2012). Furthermore, other regions seem to exhibit patterns consistent with the action of 
positive and balancing selection (Nielsen, et al. 2005; Williamson, et al. 2005; Nielsen, 
et al. 2007; Akey 2009; Clark, et al. 2009; Raj, et al. 2012; Vernot, et al. 2012; 
Grossman, et al. 2013). Balancing selection favors diversity and therefore the selected 
variant never reaches fixation, maintaining two or more alleles at a single locus in a 
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population, and is more frequent than previously thought (Charlesworth 2006; Cagliani, 
et al. 2008; Andrés, et al. 2009; Fumagalli, et al. 2009; Andrés, et al. 2010; Campbell, 
et al. 2012; Bronson, et al. 2013; Leffler, et al. 2013).  
 
Natural selection continually shapes the human genome and, with the 
availability of genome-scale genotyping data it has been possible to identify various 
regions that appear to have been targeted by selective pressures. The identification of 
these variants could lead to insights into how genes predispose individuals to disease, 
and could inform the development of improved therapeutic and disease-prevention 
strategies, as many of the selected genes are disease associated (Jobling, Hurles and 
Tyler-Smith 2004; International HapMap Consortium 2005; Nielsen 2005; Zhang, 
Nielsen and Yang 2005; Suk, et al. 2011). Selective events associated in indirect ways 
to diseases could result in antagonistic pleiotropy, a phenomenon in which adaptation 
also brings deleterious effects (Clark and Swanson 2005). Furthermore, as an 
advantageous allele spreads through a population during a selective sweep, alleles in 
LD with the advantageous allele will rapidly increase in frequency (genetic 
“hitchhiking”), which can also drive deleterious disease-causing alleles to high 
frequency (Seger, et al. 2010; Huff, et al. 2012).  
 
It has been challenging to clearly identify evidence of selection in the human 
genome as variability in the genome is also strongly affected by demographic 
processes, such as population growth or bottlenecks; and by variation in the mutation 
and recombination processes. Nevertheless, there has been progress in identifying the 
role of population history, not only to help tease apart selective signals from 
demographic history but to answer the human curiosity as to our origins (Sabeti, et al. 
2002; Schaffner, et al. 2005; Voight, et al. 2005; Gutenkunst, et al. 2009; Laval, et al. 
2010; Gravel, et al. 2011). All the models agree that during the “Out of Africa” event, 
African and non-African populations diverged (over 50–100 KYA), and the environment 
and ecology of humans changed greatly. As humans spread out of Africa to the other 
continents, they experienced a vast range of new climates, diets and ecosystems. 
Humans also encountered new pathogens as they moved around the globe and moved 
into close proximity with domesticated animals and as human population densities 
increased (Akey 2009; Bustamante and Ramachandran 2009; Novembre and Di 
Rienzo 2009; Barreiro and Quintana-Murci 2010; Kim, et al. 2010; Pritchard and Di 
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Rienzo 2010; Gravel, et al. 2011; Hernandez, et al. 2011; O'Bleness, et al. 2012; 
Scally, et al. 2012; Tennessen, et al. 2012).  
 
At the rate at which the world population is currently growing, there has been an 
explosive growth expanding the global population by at least three orders of magnitude 
over the past 400 generations, reaching 7 billion people. Even though efforts have 
been made to include this explosive growth, we should be careful when looking for 
signals of positive selection or when studying complex diseases as this implies 
massive departures from population genetics equilibrium generating potential false 
positives (Keinan and Clark 2012).  
With the new sequencing techniques (The 1000 Genomes Project Consortium 
2010; Neafsey and Haas 2011), studying complex diseases and the evolution of 
genomes has become easier, due to an ablility to sequence large numbers of 
individuals at lower cost. Some panels of genetic variability generated are enriched in 
common variants, such as the HapMap Project (International HapMap Consortium 
2005; McVean, Spencer and Chaix 2005; Thorisson, et al. 2005; Frazer, et al. 2007; 
Altshuler, et al. 2010) while others are more focused on cataloging rare variants, such 
as “The 1000 Genomes Project” (f ~ 5%) (The 1000 Genomes Project Consortium 
2010). Although none of these databases completely captures the human genetic 
variation (Voight, et al. 2006; Fu, et al. 2013), they are of great use in detecting 
footprints of selection, as shown by the plethora of genome-wide scans (GWS) that 
have uncovered selective signatures. Additionally, GWS for positive selection detect 
not only recent events based on the analysis in intraspecies polymorphism but also 
older events. Selective events over a long period of time can increase the fixation rate 
of advanatgous variants, and these changes can be detected by comparing DNA 
sequences between species (Bustamante, et al. 2005; Biswas and Akey 2006; Sabeti, 
et al. 2006; Sabeti, et al. 2007; Blekhman, et al. 2008; Kosiol, et al. 2008; Akey 2009; 
Kudaravalli, et al. 2009). 
By comparing the rate of nonsynonymous changes with the rate of synonymous 
[dN/dS ratio; (Yang 2007)] or by comparison with intraspecies diversity [McDonald-
Kreitman test; (McDonald and Kreitman 1991)] it is possible to detect old selective 
events (around 6 MYA). However, a more recent signal of selection (younger than 1 
MYA) cannot be detected by multispecies comparisons. A more recent selective signal 
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is generally characterized by low levels of diversity, as a result of ‘‘hitchhiking’’, creating 
a ‘”selective sweep” (or hard sweep), which alters the typical pattern of genetic 
variation in the surrounding genomic region of an advantageous allele. Selective 
sweeps can be detected through the analysis of genetic variation within species, by 
using summary statistics such as Tajima’s D, Hudson-Kreitman-Aguadé (HKA), and Fu 
and Li’s D* tests (Hudson, Kreitman and Aguadé 1987; Tajima 1989; Fu 1997). If, 
however, the selective sweep has occurred more recently, these tests will not 
significantly depart from neutrality. In a recent selective sweep derived alleles hitchhike 
to high frequency but may not reach fixation due to an incomplete (partial) sweep or 
recombination events, resulting in a region containing many high-frequency derived 
alleles. We can assess this excess by using Fay and Wu’s H test (Fay and Wu 1999; 
Zeng, et al. 2006). Recent signatures of positive selection also result in long-range 
haplotypes, creating homozygous haplotypes that are more extended the stronger or 
more recent the selective sweep is (Extended Haplotype Homozygozity – EHH) 
(Sabeti, et al. 2002; Voight, et al. 2006). Interestingly, these signals are most of the 
time population specific, as separate populations are subject to distinct environmental 
or cultural pressures. This adaptation to a particular environment will generate 
population specific frequencies, referred to as population differentiation that can be 
detected with the FST statistic (Excoffier 2002). Classical examples of recent selective 
sweeps include skin pigmentation, malaria resistance and lactose tolerance 
(Bersaglieri, et al. 2004; Coelho, et al. 2005; McEvoy, Beleza and Shriver 2006; 
Verrelli, et al. 2006; Voight, et al. 2006; Hancock, et al. 2011) .   
Overall, studies have identified many genes showing strong evidence of 
positive selection and have demonstrated differences between populations and 
affected genomic regions. Certain gene ontology categories  including sensory 
perception, dietary changes, immunity and host-pathogen interactions, reproduction 
and proteolysis were found to be enriched in gene under selective pressures 
(Bustamante, et al. 2005; Sabeti, et al. 2006; Sabeti, et al. 2007; Kosiol, et al. 2008; 
Akey 2009; Bustamante and Ramachandran 2009; Manry, et al. 2011; Grossman, et al. 
2013). The most notable case comes from adaptation to dietary changes, where a 
polymorphism located upstream of the LCT gene was found to be under positive 
selection in Europeans, affecting LCT transcription levels and the ability of lactose to 
be digested throughout life (Bersaglieri, et al. 2004; Coelho, et al. 2005). Furthermore, 
African pastoralists (populations that rely on cattle domestication) are also able to 
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digest milk throughout life due to the convergent evolution of LCT gene (Tishkoff, et al. 
2007). LCT is one the strongest signals of a partial selective sweep in genome-wide 
scans for selection in humans (Chimpanzee Sequencing and Analysis Consortium 
2005; Voight, et al. 2006; Sabeti, et al. 2007; Williamson, et al. 2007).  
Among the plethora of human selective events are genes with interconnected 
functionality in immune response and reproduction. For example, TGM4 and MSMB 
play roles in suppressing immune response against sperm in the reproductive tract and 
they both show strong signs of positive selection (Clark and Swanson 2005). The 
innate immune response of an organism is the first barrier against invading 
microorganisms, providing immediate defense. It relies on pattern-recognition 
receptors, which recognize conserved and largely invariant microbial molecules, and 
trigger diverse mechanisms that initiate inflammatory and immune responses. They 
also activate an adaptive immune response, generating cascades such as 
phagocytosis, pro-inflammatory pathways, and the release of antimicrobial peptides. 
The best characterized innate immune genes are the TLRs, which are expressed on 
the cell surface and intracellular organelles and detect microorganisms and several 
bacterial products. Remarkably, intracellular TLRs, particularly specialized in viral 
recognition, have evolved under strong purifying selection whereas cell-surface TLRs 
have evolved under more relaxed selective constraints (Barreiro, et al. 2009).  
 
In another example, one of the most studied cases of immunity related natural 
selection includes the disease resistance to malaria infection in Africa. Malaria is 
transmitted by the mosquito Anopheles sp., carrying either Plasmodium falciparum, the 
most deadly strain, or by Plasmodium vivax. Malaria prevalence and transmission 
increased as a consequence of the transition to agriculture, where the human 
populations changed from hunter-gatherers and a nomadic lifestyle to an agriculturally 
based settling. With the agricultural development, and cattle domestication, the levels 
of insects increased greatly, as insects gather preferably around animals and still 
water. Simultaneously, with the abundance of food populations increased exponentially 
in size, increasing contact between individuals. All of these factors contributed not only 
to the transmission of malaria but also other pathogens as they transferred from 
animals to humans (Sabeti, et al. 2002; Verrelli, et al. 2006; Mackinnon and Marsh 
2010; Hedrick 2011; Rayner, et al. 2011). A number of common polymorphisms arose 
to confer resistance to malaria in African populations, some of them leading variants to 
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reach fixation (the Duffy null allele at the DARC gene), or to higher frequencies (such 
as HbS at the HBB gene and A- at the G6PD gene) (Akey, et al. 2004; Hancock, et al. 
2008; Kelley and Swanson 2008). 
 
Further cases of immunity related selection are the MHC class I and class II 
molecules, as one of the few thoroughly described cases of balancing selection  The 
MHC locus is extremely polymorphic and some of its ancestral polymorphisms have 
been maintained for millions of years; in addition, humans and chimpanzees share 11 
nonsynonymous MHC polymorphisms showing one of the rarest and oldest balancing 
selection signals (Takahata 1993; Hughes and Yeager 1998; Klein, et al. 1998; 
Prugnolle, et al. 2005; Fumagalli, et al. 2009; Garamszegi and Nunn 2011; Leffler, et 
al. 2013). As the MHC molecules determine the probability with which a given 
pathogen will be recognized by the individual's immune system, this extreme variability 
ensures the detection of many different pathogens, improving the effectiveness of the 
immune system, which is essential to the survival of hosts in the constantly changing 
pathogen spectra (Hughes and Yeager 1998; Klein, et al. 1998; Prugnolle, et al. 2005; 
Fumagalli, et al. 2009; Abi-Rached, et al. 2010; Garamszegi and Nunn 2011).   
 
Signals of positive selection and rapid evolution have also been identified in 
various taxa related to reproduction and fertility (Swanson and Vacquier 2002). These 
genes are involved in gamete recognition, seminal fluid factors, and proteins in the 
male and female reproductive tract. One example of a signature of selection has been 
found in European Americans and Han Chinese for SPAG6, a gene involved in sperm 
motility (Williamson, et al. 2007).  Another type of selection related to reproduction that 
has been found in various primate species is post-copulatory selection. Post-copulatory 
sexual selection encompasses both male–male competition in the form of sperm 
competition, and cryptic (hidden) female choice. Sperm competition predicts 
continuous adaptation, where intensity is comparable with the degree of polyandry. 
Male competition can also drive adaptation of inseminated proteins, which affect 
female behavior, as it occurs in Drosophila accessory gland proteins. Inseminated 
proteins have been shown to affect the sperm storage in the female reproductive tract, 
copulatory plug formation, ovulation, oogenesis, female receptivity to re-mating, and 
female lifespan. These can be important effects for sperm competition and sexual 
conflict, both of which may drive adaptive evolution (Swanson, et al. 2001; Wolfner 
2002; Swanson 2003b; Swanson, et al. 2004; Mueller, et al. 2005; Clark, Aagaard and 
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Swanson 2006). Similarly, in mammals genes encoding proteins involved in sperm-egg 
interaction and fertilization exhibit a particularly fast evolution. Some of them, such as 
ZP3, ADAM1, and ADAM2, have individually been shown to evolve under positive 
selection in humans, suggesting a role of positive selection on sperm-egg interaction 
(Swanson and Vacquier 2002; Swanson 2003a; Clark and Swanson 2005; Aagaard, et 
al. 2006). 
Recently, various studies have been focused on describing the close 
relationship between immunity and reproduction. A striking link between these two 
functions lies in proteins and peptides with antimicrobial activities that are expressed in 
reproductive tissues of vertebrates and invertebrates. One of those regions that contain 
genes encoding for such proteins is located on the human chromosome 20q13 and it is 
named the WFDC locus. 
1.2 The WFDC locus 
 
1.2.1 Structure and Organization 
 
The WFDC locus encodes for 17 small serine protease inhibitors that regulate 
endogenous proteases and is organized in two subloci, separated by 215 kb of 
unrelated sequence (Figure 1). The sublocus closer to the centromere (WFDC-CEN) 
includes PI3 (also referred to as elafin) and SLPI, known for their anti-viral activity, and 
the two genes without any inhibitory activity, the semenogelins (SEMG1 and SEMG2), 
which encode for the major semen proteins. The sublocus closer to the telomere 
(WFDC-TEL) includes the genes of WFDC2 (also known as HE4), a recognized 
ovarian cancer marker, and EPPIN (also known as SPINLW1), the most studied serine 
protease inhibitor of the WFDC-TEL sublocus involved in male reproduction 
(Richardson, et al. 2001; Clauss, Lilja and Lundwall 2002; Hellström, et al. 2003).  
 
This family appears to have a common origin through a series of duplications, 
but it gave rise to proteins with highly differing primary structure. The members of the 
WFDC locus have conserved first and last exons, preserving structures of importance 
for signaling, such as upstream promoter elements, signal peptide and 3' non-
translated sequences. However, the second exon has undergone rapid evolution in 
such a way that there is almost no sequence similarity (Lundwall and Lazure 1995; 
Lundwall and Ulvsback 1996; Lundwall and Clauss 2011).  
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Figure 1: Schematic representation of the 20q13 WFDC locus. Diagram showing the relative positions of the WFDC 
genes, where the WFDC locus spans 700 kb.  Its genes are organized into two subloci (centromeric and telomeric; 
WFDC-CEN and WFDC-TEL, respectively), separated by 215 kb of unrelated sequence. HNRPA1P3 pseudogene is 
indicated in light gray. 
 
Most WFDC genes are predominantly expressed in the male reproductive tract, 
even though some can be found in other tissues (Clauss, Lilja and Lundwall 2002). 
They exhibit functions involving reproduction, antimicrobial, immune, and tissue 
homoeostasis activities but, in many cases, WFDC biological functions remain poorly 
understood (Yenugu, et al. 2004; Bouchard, et al. 2006; Bingle and Vyakarnam 2008; 
Lundwall and Clauss 2011). These genes have in common the WAP domain, which 
was first identified in whey acidic protein, a predominant protein in the milk whey of 
lactating mice. It consists of ~40 amino acid residues with a characteristic disulfide 
pattern, which names the WFDC domains (Hennighausen, et al. 1982; Tsunemi, et al. 
1996). They are organized in a central core β-sheet surrounded by two external peptide 
chains that are connected by a loop and hold the protease binding site (Figure 2).  
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Figure 2: Three dimensional structure of the WAP domain from elafin (PDB reference: 2REL). β-sheets are represented 
in arrows and loops are represented by lines. The four disulfide bonds are highlighted in yellow. 
Even though most of the WFDC genes have a WAP domain, some of them also 
contain additional domains, such as the Kunitz, trappin and semenogelin domains 
(Peter, et al. 1998; Schalkwijk, Wiedow and Hirose 1999; Clauss, Lilja and Lundwall 
2002). Kunitz domains, which also confer serine protease inhibitor activity, are present 
in several WFDC genes, such as WFDC6, EPPIN, and WFDC8. In some cases, the 
WAP domain was lost and only the Kunitz domain prevails in the gene structure 
(SPINT3, SPINT4 and SPINT5) (Petersen, et al. 1996; Clauss, Lilja and Lundwall 
2002; Clauss, et al. 2011). Nonetheless, in the case of elafin, its secundary structure 
contains a trappin domain in addition to the WAP. The N-terminal region of elafin 
includes a variable number of repeats (Gly-Gln-Asp-Pro-Val-Lys) that act as an 
anchoring motif by transglutaminase crosslinking (Schalkwijk, Wiedow and Hirose 
1999). SEMG genes share a common ancestor with the WFDCs, more specifically with 
elafin. They both belong to the REST family, where the first and last exons of all genes 
are highly conserved among mammals, while the second exon is typically highly 
diverged  (Lundwall and Ulvsback 1996; Hurle, et al. 2007). The rapid evolution of the 
SEMG genes involves the expansion of the second exon, leading to a highly repetitive 
primary structure of the encoded SEMG proteins (Lundwall and Lazure 1995; Jensen-
Seaman and Li 2003). These are composed of a 60 amino acid residue repeats, with 
high amino acid identity (78%), six in SEMG1 and eight in SEMG2 (de Lamirande, et 
al. 2001; de Lamirande 2007; Malm, et al. 2007).  
 
1.2.2 Functions in reproductive biology 
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SEMGs and EPPIN have been shown to have important roles in fertility and 
sperm maturation. SEMG1 and SEMG2 are originated in the seminal vesicles, and are 
the most abundant proteins in the semen coagulum, contributing to approximately 60% 
of the ejaculate volume. The secretion from the epididymis that contains the 
spermatozoa, is only a small part of the ejaculate volume. The remaining fraction of the 
semen comes mainly from the prostate in a secretion rich in serine proteases and Zn2+. 
At ejaculation the fluids are mixed and SEMGs form a gel, entrapping the spermatozoa. 
In humans, within 20 min of ejaculation, the gel is almost completely liquefied by serine 
proteases, mainly by PSA (also known KLK3), which cleaves SEMG1 and SEMG2 into 
small fragments. Simultaneously, the spermatozoa become more motile and matured, 
ready to fertilize the egg (Lilja, Abrahamsson and Lundwall 1989; Peter, et al. 1998; 
Robert and Gagnon 1999; de Lamirande, et al. 2001; Lundwall, et al. 2002; Jonsson, et 
al. 2006; de Lamirande 2007; Lundwall 2007; Jonsson, Frohm and Malm 2010). 
Several studies have shown that EPPIN protein is localized on the surface of 
ejaculated spermatozoa, in a complex of proteins containing LCF, CLU and SEMGs 
(Wang, et al. 2007b). This protein complex is capable of modulating PSA activity and 
provides antimicrobial protection for spermatozoa in the ejaculate coagulum (O'Rand, 
et al. 2006; O'Rand, et al. 2009; O’Rand, et al. 2011; Silva, et al. 2012). The 
importance of EPPIN in male reproduction was confirmed by contraceptive studies in 
nonhuman primates, which demonstrated that male rhesus monkeys immunized with 
recombinant human EPPIN were reversibly infertile (O'Rand, et al. 2004). A more 
recent study has shown that EPPIN residues Cys102, Tyr107, and Phe117, project for 
SEMG1 into a central binding pocket, are critical for EPPIN and SEMG1 interaction and 
could be used as potential targets for the design of contraceptive drugs (Silva, et al. 
2012).  
 
Interestingly, both EPPIN and SEMGs have an important role in fertility like 
maintaining the integrity of the spermatozoa and protecting them from microbial 
infections. When the SEMGs are cleaved by PSA, the resulting peptides from SEMG1 
have been shown to have antimicrobial properties (Lundwall, et al. 2002; Bourgeon, et 
al. 2004; Edstrom, et al. 2008; Zhao, et al. 2008; Martellini, et al. 2009). Similarly, 
EPPIN has a demonstrated antibacterial activity in the reproductive tract (Yenugu, et al. 
2004; Doumas, Kolokotronis and Stefanopoulos 2005; Wang, et al. 2005; McCrudden, 
et al. 2008). It is not surprising to find such role in EPPIN, as the WAP domains have 
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been shown to have antimicrobial functions not only in human proteins but also in other 
taxa (O'Rand, et al. 2011; Smith 2011; Wilkinson, et al. 2011).  
 
 
 
 
Figure 3: Schematic diagram showing the coagulation and liquefaction cascade in the human semen. (1) Different 
components of the semen are stored separately. Orange and Purple circles represent EPPIN and the LTF/CLU, 
respectively. They are mixed upon ejaculation. (2) The prostate secretion rich in Zn
2+
 and zinc-inhibited PSA is mixed 
with the seminal fluid. It contains large amounts of SEMGs that bind to the major fraction of Zn
2+
. This induces a 
conformational change of SEMG1 enabling the formation of a gel, and decreases the concentration of free Zn
2+
. PSA is 
activated with the decreased concentration of free Zn
2+
. (3) PSA cleaves the SEMGs, which results in liquefaction of the 
gel. Motile spermatozoa and SEMG1 antimicrobial peptides from SEMG1 (green) are released (adapted from Malm et al 
2007 and Lundwall and Brattsand 2008) 
 
1.2.3 Functions in inflammation and immune response 
 
In the WFDC locus, the cases of elafin, SLPI, and WFDC2 clearly demonstrate 
the antimicrobial, antiviral and inflammatory roles of the WAP domains. Elafin and SLPI 
are pleiotropic molecules engaged in the surveillance against microbial infections at 
mucosal surfaces (Williams, et al. 2006; Weldon, et al. 2007; Weldon and Taggart 
2007; Moreau, et al. 2008; McKiernan, McElvaney and Greene 2011). They have been 
consistently associated with anti-HIV activity and in the triggering of the inflammatory 
response (Williams, et al. 2006; Weldon, et al. 2007; Weldon and Taggart 2007; 
McKiernan, McElvaney and Greene 2011).  
 
SLPI and elafin were first described as protease inhibitors while SLPI forms 
complexes with neutrophil elastase, chymotrypsin and trypsin, while elafin inhibits 
neutrophil elastase but has a more restricted spectrum of inhibition. They both 
(1) (2) (3) 
14 FCUP 
The human whey-acidic-protein Four-Disulfide Core-Domain (WFDC) cluster on 20q13 region: evolutionary 
history and role inhuman health and disease 
 
modulate chronic inflammation when binding to pathogen-derived molecules such as 
LPS and some GAGs (Wilkinson, et al. 2011). SLPI expression is enhanced in the 
presence of neutrophil elastase (Sallenave, et al. 1994), drugs and hormones, where 
the ability of glucocorticoids to induce SLPI may be partly responsible for their anti-
inflammatory action. Even though SLPI and elafin seem to have similar functions, they 
respond differently to pro-inflammatory cytokines suggesting that they are not 
redundant molecules (King, Critchley and Kelly 2003; Williams, et al. 2006; Roghanian 
and Sallenave 2008; Sallenave 2010; Wilkinson, et al. 2011). SLPI and elafin also play 
an important role in the prevention of HIV transmission. SLPI interrupts the interaction 
of the HIV virus with receptors on the host cell (McNeely, et al. 1995; McNeely, et al. 
1997; Wahl, et al. 1997) through its binding to receptors on the surface of human 
macrophages and by disrupting the binding of the HIV surface to these receptors (Ma, 
et al. 2004). On the other hand, elafin has been identified as an inhibitor of HIV 
infection in the female reproductive tract through direct interaction of elafin and HIV 
(Ghosh, et al. 2010; Drannik, Henrick and Rosenthal 2011).  
 
 
 
Figure 4: Potential model for Elafin/Trappin-2 (E/Tr) and SLPI modulation of HIV transmission, through viral recognition 
and antiviral immune-inflammatory response. (1) Tr and E inhibit HIV transcytosis through a monolayer of genital 
epithelial cells (ECs) by reducing attachment of virus to ECs; (2) E inhibits HIV infection of CD4+ T-cells by binding to 
HIV binding sites on T-cells; (3) SLPI inhibits HIV infection of macrophages by blocking binding between 
phosphatidylserine and annexin II; (4) SLPI inhibits HIV infection of CD4+ T-cells by preventing binding between HIV 
and CD4 responses (Drannik, Henrick and Rosenthal 2011). 
 
Moreover, SLPI and elafin appear to have an important role in modulating 
immune response through the NF-κB signaling pathway. The activation of NF-κB  leads 
to the transcription of numerous pro-inflammatory and cell-survival genes, however 
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when the NF-κB is upregulated it causes inflammatory and malignant diseases, such 
as breast, ovarian, prostate and lung cancer (Bouchard, et al. 2006; Cai, Tchou-Wong 
and Rom 2011). Concurrently, most types of ovarian cancer overexpress SLPI and 
non-small cell lung carcinoma patients have elevated levels of SLPI in the serum and in 
the tumoral tissues. On the other hand, elafin is upregulated in prostate-cancer cells 
when NF-κB signaling pathway is inhibited by genistein treatment, and both elafin and 
SLPI are downregulated in bladder cancer (Bouchard, et al. 2006).  
 
Similarly, WFDC2 is upregulated in ovarian cancer, is recognized to interact 
with inflammatory response proteins, such as cytokines and NF-κB, and is proposed as 
a biomarker for early stage tumors (Drapkin, et al. 2005; Bingle, et al. 2006; Bouchard, 
et al. 2006). Outside of the role in cancer progression WFDC2 has a large protease 
inhibitor spectrum and a wide activity against microbial virulence factors (Chhikara, et 
al. 2012) .  
 
 
Figure 5: Potential WAP roles in cancer (Bouchard, et al. 2006). 
Even though most of the WFDC genes are not fully functionally characterized, 
the high degree of domain conservation between them suggests a similar antibacterial 
activity and protease inhibitor functions.  
16 FCUP 
The human whey-acidic-protein Four-Disulfide Core-Domain (WFDC) cluster on 20q13 region: evolutionary 
history and role inhuman health and disease 
 
 
1.3 WFDCs Comparative Genomics 
 
The clustering of the WFDC genes in the human chromosome 20 suggests that 
they evolved by tandem duplications, where a possible early duplication created two 
genes that subsequently evolved into the WFDC-CEN and WFDC-TEL subloci. Such 
organization of the WFDC locus is present in all primates, rodent lineages, and several 
other mammals (Clauss, Lilja and Lundwall 2005; Lundwall and Clauss 2011). 
However, the low degree of sequence conservation between WFDC paralogs point 
toward an early origin in evolution (Clauss, Lilja and Lundwall 2002; Clauss, Lilja and 
Lundwall 2005).  
 
The gene organization within the human WFDC-CEN is common to other 
mammalian lineages (Figure 6). In rodents, the functional equivalent of SEMGs, the 
seminal vesicle secreted proteins Svs II-VI, have expanded by gene duplication and in 
spite of lacking sequence similarity to SEMGs, their three dimensional structure is very 
similar. The Svs genes conserved location in the sublocus supporting the hypothesis 
that SEMGs and Svs evolved from a common WFDC ancestor gene (Clauss, Lilja and 
Lundwall 2005). The WFDC-CEN sublocus of rat and mouse are very similar but Slpi 
was detected to have four paralogs in rat, in which one copy carries the conserved 
WFDC domain with a high affinity for elastase, and the remaining encode inhibitors 
with affinities towards other proteases (Clauss, Lilja and Lundwall 2005). In addition to 
Svs and Slpi genes, the rodent WFDC-CEN includes the genes encoding SWAM1 and 
SWAM2 proteins that are orthologs to WFDC15 pseudogene and WFDC12, 
respectively.  Events of WFDC gain and loss are present in several other mammals. 
These include the example of elafin in the pig which has undergone at least three 
duplications and the case of WFDC12 ortholog that was lost in the domestic dog. In 
humans, WFDC12 is highly expressed in the prostate, and it would be expected to be 
conserved in dogs, however its role could have been replaced by the neighboring 
Wfdc15, which is pseudogenizated in humans. The domestic dog also lost SEMG1 and 
SEMG2 orthologs and has no functional equivalent to SEMGs probably due to the 
absence of  seminal vesicles in this species (Clauss, Lilja and Lundwall 2005). 
 
In the WFDC-TEL sublocus, three duplications can be traced through the levels 
nucleotide/protein conservation. A first, resulting in EPPIN and WFDC6 genes and a 
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second leading to WFDC9 and WFDC11, both in the same range of divergence from 
SEMG1 and Svs2, suggesting that the duplication occurred around the time of the 
separation of the primate and murine lineages. The third duplication yield WFDC10 and 
WFDC12 genes and probably occurred before the separation of New World monkeys 
and catarrhine primates, as the conservation of nucleotides is of the same order as 
SEMG1 genes from human and New World monkeys (Lundwall and Ulvsback 1996; 
Peter, et al. 1998).  
 
In several instances, WFDC transcripts show large differences between species 
due to splicing. For example, mouse Wfdc2 contains an extra exon adding a unique 
structure at the center of the molecule not present in other orthologs (Bingle, Singleton 
and Bingle 2002). In human WFDC8, the signal peptide originates from the first and the 
second exons, whereas in mouse Wfdc8, the first exon is a 5’ UTR and the second 
exon is where the translation starts, and has no correspondence to human exons 
(Clauss, Lilja and Lundwall 2005).  
 
 
Figure 6: WFDC locus organization in mammals (adapted from Clauss et al. 2005). The arrows indicate the direction of 
transcription and approximate location of the genes. Black arrows indicate functional genes; grey arrows indicate 
pseudogenes and open arrows indicate genes enrolled in semen coagulum. 
 
1.4 Primate Adaptive Evolution 
 
Most of the primate evolution studies that focused on the WFDC locus were 
mainly centered in the WFDC-CEN, especially in SEMGs. These genes have been 
identified as genes under adaptive evolution, specifically by correlating their nucleotide 
sequences and copy-number variants to the different mating systems of various 
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primate species (Jensen-Seaman and Li 2003; Kingan, Tatar and Rand 2003; Dorus, 
et al. 2004; Carnahan and Jensen-Seaman 2008).  
 
Specifically, in monoandrous primates like gorillas and gibbons, in which 
females mate with a single male, the ejaculate is gelatinous in texture and does not 
coagulate. Conversely, polyandrous primates (or multimale-multifemale), like 
chimpanzees and macaques, in which each female mates with multiple partners per 
ovulatory period, the ejaculate forms a strong and almost rigid copulatory plug that 
prevents the insemination of females by competing males (Dixson and Anderson 2002; 
Dixson and Anderson 2004). Several studies have shown that in chimpanzees the 
length of SEMG1 has radically expanded compared to other species, increasing the 
number of potential sites for transglutaminase crosslinking and protein–protein 
interactions, which are responsible for the formation of the copulatory plug (Jensen-
Seaman and Li 2003). Interestingly, SEMG1 has reduced levels of polymorphism in 
chimpanzees that were interpreted as an evidence of a selective sweep driven by the 
intense sperm competition in this species (Kingan, Tatar and Rand 2003). Other 
studies have shown that female promiscuity and semen coagulation in primates 
correlate with the rate of SEMG2 and SEMG1 evolution (Dorus, et al. 2004; Hurle, et 
al. 2007). The pattern of strong sperm competition probably contributed to the rapid 
evolution of SEMGs (high dN/dS values) in more promiscuous primate species, while in 
the monoandrous species due to the presumed absence of sperm competition these 
proteins accumulated loss of function mutations (Hurle, et al. 2007; Carnahan and 
Jensen-Seaman 2008). Despite the controversial classification of the human mating 
system (monogamous or dispersed) SEMG1 and SEMG2 proteins were reported to 
have evolved under relaxed functional constraints in this species (Dixson and 
Anderson 2002; Dorus, et al. 2004; Hurle, et al. 2007). Other WFDC-CEN genes 
(WFDC12, PI3, and SLPI) were associated with high dN/dS ratios suggestive of strong 
patterns of adaptive evolution, even though an unambiguous correlation between gene 
mutation rates and mating systems was not confirmed (Hurle, et al. 2007). On the other 
hand, WFDC-TEL evolutionary history and interspecies comparisons has been only 
poorly explored, and to date no study has focused in the intraspecies variability of this 
sublocus (Clauss, Lilja and Lundwall 2005; Lundwall and Clauss 2011).  
 
Overall, the organization of the WFDC locus suggests a gene evolution from a 
single ancestor by multiple duplications. As most of these genes are highly expressed 
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in the male reproductive tract, it is considered that gene duplications conserved the 
important regulatory elements. Post-copulatory selection has clearly shaped some of 
the genes in this locus, with the addition of several repeats in SEMGs. Furthermore, 
other selective pressures such as pathogen infections may have shaped the evolution 
of these genes. Thus future studies of WFDC genes should make available important 
insights into the molecular mechanisms behind their gene evolution. 
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2. Aims 
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There is a lack of information on the evolution of the WFDC locus in human 
populations and the forces that have shaped its notable genetic variability. Available 
studies are piecemeal and do not focus on the evolutionary scale of modern human 
populations, but rather on signatures of selection in a more distant timescale. In 
addition, the biological roles of most of the genes at the WFDC locus remain 
uncharacterized. Taking into account the implications of the WFDCs and SEMGs in 
human health, a better understanding of the evolutionary history of these genes and a 
way to prioritize which genes should be further assessed for their biological function is 
critical.  
 
The study design included a high-throughput targeted sequencing of the WFDC 
locus, data from GWS scans for positive selection, and publically available genetic 
variation databases, which were combined and analyzed to unravel the adaptive forces 
shaping the evolution of this locus.  
 
The aims of the project were: 
 
1. Tease apart the signals of natural selection shaping the genetic 
diversity at the WFDC locus in human populations.  
Studying the genetic diversity and patterns of selection in the WFDC locus was 
accomplished in two phases: 
 
Stage I: A sequencing study to validate selective signals as proposed by a 
previous GWS for positive selection. This was a targeted, gene-centered 
approach, only performed in the populations where a selective signal was found. 
Stage II: A high-throughput targeted sequencing study that systematically 
cataloged the genomic variation across the WFDC locus in three human 
populations. This included the sequencing of all the exons and several interspaced 
noncoding regions of our locus of interest and a set of control regions to determine 
the demographic model that better fit the data, and to detect potential outliers. 
 
2. Characterize the extent of genetic diversity at the WFDC locus within 
and between hominids.   
For this systematic comparative genomics and population-based genetics analysis the 
entire WFDC locus was sequenced in three chimpanzee subspecies (P. t. troglodytes, 
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P. t. verus and P. t. ellioti) and contrasted polymorphism and genetic variation at the 
human WFDC locus. This effort was aimed at learning whether the evolutionary forces 
driving the rapid diversification of WFDC and SEMG genes differ among hominid 
species. 
 
3. Test the biological impact of the candidate variants on the genes under 
selection. 
By undertaking molecular biology and expression assays, both in vitro and in vivo 
potential consequences of the selective signals found in hominids were sought. 
 
 
Overall, this study provides insights about the biological dynamics of rapidly 
evolving genomic regions in primates, and by conducting studies on the WFDC cluster, 
it will increase the understanding of the complex evolutionary history of these genes. 
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3.1 Evolutionary history of WFDCs in human populations 
3.1.1. Differing evolutionary histories of WFDC8 (short-term balancing) in 
Europeans and SPINT4 (incomplete selective sweep) in Africans. 
Mol Biol Evol. 2011 Oct;28(10):2811-22 
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3.1 Evolutionary history of WFDCs in human populations 
3.1.2  Reproduction and Immunity Driven Natural Selection in the 
Human WFDC Locus. 
Mol Biol Evol. 2013 Apr;30(4):938-50 
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3.2. Genetic diversity and evolution of WFDCs in chimpanzees 
3.2.1. Sequence diversity of Pan troglodytes subspecies and the impact of 
WFDC6 selective constraints in reproductive immunity.  
Submitted 
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Abstract 
 
Recent efforts have attempted to describe the population structure of common chimpanzee, 
focusing on four subspecies: Pan troglodytes verus, P. t. ellioti, P. t. troglodytes, and P. t. 
schweinfurthii. However, few studies have pursued the effects of natural selection in shaping 
their response to pathogens and reproduction. Whey acidic protein (WAP) four-disulfide core 
domain (WFDC) genes and neighboring semenogelins (SEMG) genes encode proteins with 
combined roles in immunity and fertility. They display a strikingly high rate of amino acid 
replacement (dN/dS), indicative of adaptive pressures during primate evolution. In human 
populations, three signals of selection at the WFDC locus were described, possibly influencing 
the proteolytic profile and antimicrobial activities of the male reproductive tract. To evaluate the 
patterns of genomic variation and selection at the <i>WFDC</i> locus in chimpanzees, we 
sequenced 17 WFDC genes and 47 autosomal pseudogenes in 68 chimpanzees (15 P. t. 
troglodytes, 22 P. t. verus, and 31 P. t. ellioti). The genomic diversity and substructure of the 
common chimpanzee subspecies was revisited based on our data. We found a clear 
differentiation of P. t. verus from P. t. troglodytes and P. t. ellioti subspecies; further, at the 
WFDC locus, we identified a signature of strong selective constraints common to the three 
subspecies in WFDC6 - a recent paralog of the epididymal protease inhibitor EPPIN. Overall, 
chimpanzees and humans do not display similar footprints of selection across the WFDC locus, 
possibly due to different selective pressures between the two species related to immune 
response and reproductive biology. 
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Introduction 
 
Common chimpanzees and bonobos are different species of the Pan genus (P. 
troglodytes and P. paniscus, respectively), separated by the geographical barrier of the 
Congo River. Common chimpanzees are further divided into subspecies across tropical 
Africa (1, 2). The issue of genomic diversity and substructure among the different 
chimpanzee subspecies is controversial and of great interest. Briefly, P. troglodytes 
was traditionally divided in three subspecies: P. t. verus, located in western Africa 
occupying the Upper Guinea region; P. t. troglodytes extending throughout central 
Africa; and P. t. schweinfurthii living in eastern Africa. Later, the analysis of 
mitochondrial DNA (mtDNA) variation led to the proposal of a fourth chimpanzee 
subspecies, P. t. ellioti  (also known as P. t. vellerosus), occurring in the Gulf of Guinea 
(Nigeria and Cameroon) in a region limited by the Niger and Sanaga rivers (Fig S1) (2-
5). Recent studies support the differentiation of P. t. ellioti from P. t. troglodytes using 
ancestry-informative markers, enabling the identification of the four subspecies (2, 6). 
P.t. verus branched from the last common chimpanzee ancestor ~0.46 million years 
ago (mya), and P. t. ellioti diverged from P. t. troglodytes and P. t. schweinfurthii ∼0.32 
mya. Even though occasional hybridization occurs between P. t. ellioti and P. t. 
troglodytes in the wild, these subspecies remain as major genetic isolates (2). Studies 
regarding chimpanzee simian immunodeficiency virus (SIVcpz) also support these 
findings, given that only P. t. troglodytes and P. t. schweinfurthii are infected in the wild 
(>30% prevalence), and P. t. ellioti, only get infected when kept in captivity with P. t. 
troglodytes (7, 8). SIVcpz is one of many infectious agents transferred to humans from 
chimpanzees originating the human immunodeficiency virus (HIV) (9). Therefore, a 
better characterization of episodes of natural selection in chimpanzees may provide 
ways to further understand susceptibility to pathogens in hominoids, and to improve the 
conservation of wild chimpanzees. 
 
 Ecological changes in the natural habitat of P. troglodytes have modeled immune 
response to pathogens and reproductive-driven phenotypes (10). A genomic locus that 
is involved in both immune response and reproduction is the whey acidic protein (WAP) 
four-disulfide core domain (WFDC) locus (Fig 1). WFDC genes (17 in total) encode 
small serine protease inhibitors with functions of regulating endogenous proteases (11, 
12). Neighboring genes, semenogelin 1 and 2 (SEMG1 and SEMG2) encode the main 
proteins of the seminal coagulum (12-14).  WFDC and SEMG genes evolved from the 
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same common ancestor and maintain some similar functions involving antimicrobial, 
immune, and male reproduction activities (15-17). Well-characterized genes at the 
WFDC locus include peptidase inhibitor 3 (PI3; also known as elafin) and secretory 
leucocyte proteinase inhibitor (SLPI), both pleiotropic molecules synthesized at 
mucosal surfaces that play a role in the surveillance against microbial and viral 
infections, including HIV-1 (18). This locus also includes the epididymal protease 
inhibitor EPPIN (also known as SPINLW1), which coats the surface of human 
spermatozoa, binds to SEMG1, and modulates the activity of prostate-specific antigen 
(PSA) altogether providing antimicrobial protection for spermatozoa (19-21). SEMG1 
and SEMG2 play critical roles in semen clotting and in antimicrobial and antiviral 
protection for spermatozoa in the female reproductive tract (20, 22). WFDC and SEMG 
genes were shown to be targets of adaptive evolution in primates, where SEMGs dN/dS 
values were positively correlated with female promiscuity. Specifically, in monoandrous 
primates in which females mate with a single male (e.g. humans, gorillas, and 
gibbons), the ejaculate is gelatinous in contrary to polyandrous primates, in which 
females mate with multiple partners per ovulatory period (e.g. chimpanzees and 
macaques), the ejaculate forms a rigid copulatory plug that prevents the insemination 
of females by competing males (23, 24). In chimpanzees, the copulatory plug formation 
is associated with a SEMG1 length expansion causing an increase in protein 
crosslinking (25).  
 
In human populations, the WFDC locus presents complex selective signals, 
including recent balancing selection on WFDC8 in Europeans, and positive selection in 
SEMG1 in Asians (26). In order to evaluate the patterns of genomic variation and 
selection at the WFDC locus in chimpanzees, we sequenced 18 WFDC genes and 47 
control regions in 68 common chimpanzees from the subspecies P. t. troglodytes, P. t. 
verus, and P. t. ellioti. Overall, we generated a total of ~13 Mb of high-quality sequence 
data, identified 1268 Single Nucleotide Polymorphisms (SNPs), and calculated 
summary statistics of population variation for 71 loci. The controversial issue of 
genomic diversity among the different chimpanzee subspecies was also revisited 
based on our generated data. We found a clear differentiation of P. t. verus from P. t. 
troglodytes and P. t. ellioti subspecies and in general, for WFDC genes, we did not find 
departures from diversity levels observed in neutral evolving regions. Notwithstanding, 
we identified a signature of strong selective constraints common to the three studied 
subspecies and centered in the EPPIN-like gene, WFDC6. In several primate species, 
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WFDC6 has lost the ability to inhibit PSA and in others it appears to have accumulated 
different deleterious mutations. Conversely, in chimpanzees and humans, the seven 
disulfide bridges, known to confer antimicrobial properties to WFDC genes, are 
preserved in WFDC6.  The fact that chimpanzees have a polyandrous mating system 
and as a promiscuous species they are particularly likely to be exposed to sexually 
transmitted pathogens, lead us to propose that strong conservation of WFDC6 function 
has been necessary in chimpanzees due to its crucial role in innate immunity of the 
reproductive tract.  
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Results 
 
Polymorphism Levels and Population Structure 
 
 We generated sequence data from 68 chimpanzees for all WFDC exons 
distributed across 54 amplicons and 47 neutrally evolving control regions, for a total of 
13 Mb (Table S1). This resulted in the identification of 419 SNPs in the control regions 
and 849 SNPs in the WFDC locus. Despite the high-quality sequence data, the 
patterns of variation in SEMG1 among individuals cannot be analyzed due to a variable 
and highly repetitive region (9 to 13 copies) in this gene (25). The modular nature of 
SEMG1 precluded a consistent and unambiguous sequence alignment; therefore, the 
SNPs located in this repetitive region were removed from the analysis for quality 
purposes. A total of 766 fixed differences were identified in comparison with the human 
genome reference. Twenty-five indels (insertions/deletions) were found, 24 of which 
were located in introns, UTRs and intergenic regions. One remaining indel located in 
WFDC6 was identified in a single chromosome (f=0.02). Indels were excluded from all 
analyses, due to their distinct mutation rate and to the low overlap with functional 
regions, which are unlikely to affect protein function or expression. Additionally, from 
the 456 human-chimpanzee fixed differences located in the WFDC locus only 19 were 
within coding regions and chimpanzee-specific. Of these, 17 were non-synonymous 
(NSyn) and most of them were classified as benign by Polyphen v2 and SIFT (Table 
S4b).   
 
To assess the selective pressures shaping the diversity in WFDC genes, we 
first characterized the levels of differentiation level between subspecies at the control 
regions and WFDC locus, by using FST  (27) and principal component analysis (PCA) 
(28). The pairwise FST values show lower differentiation between P. t. troglodytes and 
P. t. ellioti (0.15) than each of them compared with P. t. verus (0.3761 and 0.3255, 
respectively). The differentiation levels of WFDC genes are not significantly higher than 
in the control regions, suggesting the differentiation in the WFDCs has been mainly 
shaped by the demographic history of each subspecies (Fig S3A). The first two 
principal components (PC1 and PC2) separate P. t. verus from the other two 
subspecies, and the third principal component appears to not separate completely P. t. 
troglodytes from P. t. ellioti (Fig S4). Contrary to previous studies we could not 
separate the three subspecies using PC analysis (2, 6). We further examined the 
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shared ancestry levels of the individuals, by performing a Bayesian model-based 
clustering approach available in the STRUCTURE software (29, 30). The analyses 
were performed blinded to a population label and two groups (K=2) were recovered, 
despite the value for maximum likelihood (KMAX) being 3 (Fig S5). The subspecies P. 
t. troglodytes and P. t. ellioti could not be confidently distinguished. 
 
To characterize the within subspecies variation, we analyzed the folded site 
frequency spectrum (SFS) for all SNPs highlighting synonymous (Syn) and NSyn sites 
among WFDC genes (Fig 2A and B) and in the control regions (Fig S2A). Despite the 
higher number of NSyn sites in the WFDC genes, these are maintained at low 
frequencies in the overall species, consistent with the predicted mildly deleterious 
effects (Table S4). For each WFDC gene, we calculated summary statistics such as 
nucleotide diversity (π), Tajima’s D (31), Fu and Li’s D (32), Fay and Wu’s H (33, 34), 
and HKA (35) (Table S3). 
 
Analyses of SFS and summary statistics show P. t. troglodytes as the 
subspecies with the highest nucleotide diversity levels, and P. t. verus as the most 
homogeneous subspecies (Fig S2B; Table S3). Both P. t. troglodytes and P. t. ellioti 
Tajima’s D values are skewed toward negative values, mostly due to their large 
effective population size and a population expansion that is estimated to have occurred 
around 50,000 years ago (kya) (36). Nonetheless, P. t. verus Tajima’s D values are 
less negative than the other two subspecies, which is likely to result from an extreme 
decrease in population size and genetic drift (36-38). Overall, the analyses of the 
summary statistics of WFDC genes do not show widespread significant departure from 
neutrality, showing only mildly negative or positive values.  
 
Selection Tests 
 
To determine if specific WFDC genes have been under selective pressures in 
one or all chimpanzee subspecies, we started by comparing the summary statistics for 
each WFDC gene with the empirical distribution of π and Tajima’s D in the control 
regions (Fig S7). Only WFDC6 and EPPIN show unusual patterns in P. t. troglodytes 
(Fig S7). Although in this subspecies the allele frequency spectrum is generally skewed 
toward rare alleles, the Tajima’s D values of WFDC6 (-2.073; P-value = 1-4) and EPPIN 
(-1.811; P-value = 0.025) present the lowest values of control and WFDC regions. 
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WFDC6 also presented a low Tajima’s D value (-2.1039) and significant HKA (P = 
0.013) when combining all individuals sequenced. The other WFDC genes did not 
show significant P-values pointing to a neutral evolution based on subspecies genetic 
diversity (Table S3). To confirm WFDC6 and EPPIN departure from neutrality, we 
performed 105 coalescent simulations under three different demographic scenarios: 
Constant model, population expansion dated 50 kya, and a best-fit model for P. t. 
troglodytes (36). WFDC6 presents a significantly negative Tajima’s D value compared 
to all models, but EPPIN loses significance when taking into account the demographic 
history of  P. t. troglodytes [(36); Table S5].  
 
The hypothesis of a recent positive selection was excluded due to absence of 
LD blocks and homogeneous haplotypes in P. t. troglodytes (Fig S6), which prevent 
long-range haplotype tests from being calculated. To address the hypothesis of an 
older selective sweep we performed the McDonald-Kreitman test (MKT), which did not 
show departures from neutrality in either WFDC6 (P-value = 0.74) or EPPIN (P-value = 
0.75). Notwithstanding, population differentiation (FST statistic) in the WFDC6-EPPIN 
region is the lowest in the WFDC locus (Fig S3B), and the networks built to assess the 
WFDC6 and EPPIN haplotype structure show that WFDC6 has a star-shaped 
genealogy shared among all subspecies (Fig 3; Fig S8). The findings show that in 
WFDC6 all NSyn variants are maintained a very low frequencies and that the fixed 
difference K79E, predicted to alter protein function in EPPIN, is also present in 
bonobos (>1Mya). This suggests strong purifying selection as the likeliest cause for 
WFDC6 patterns of diversity.  
 
To determine the levels of selective constraints operating at WFDC6 and 
EPPIN, we aligned the publicly available sequences of both genes for 8 primate 
species (chimpanzee, human, gorilla, orangutan, gibbon, rhesus monkey, baboon and 
marmoset). The alignment shows that EPPIN has been conserved in all the species.  
WFDC6 has released constraints with signals of pseudogenization in orangutan, 
rhesus and baboon and appears to be absent in marmoset (Fig S10). Evidences for 
WFDC6 pseudogenization includes a premature stop codon (W86X) in orangutan, a 
very early stop codon (S4X) and a five amino acid deletion (28 to 32) in rhesus 
monkey, and a frameshift mutation (T99fs139X) shared between rhesus and baboon. 
Also striking is the loss of two disulfide bridges in the Kunitz domain for all the 
primates, the species-specific loss of one disulfide bridge in the WAP domain from 
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gorilla and gibbon; and the loss of the SEMG1-binding residue in gibbon. Furthermore, 
the active site conferring PSA inhibitory activity to EPPIN, in WFDC6 was modified 
from a leucine to a tryptophan (residue 87) in most primates, and to a stop codon in 
orangutan (Fig S9). 
 
We calculated dN/dS (; dS – synonymous substitution rate, and dN - non-
synonymous substitution rate) ratios for the paralogs WFDC6 and EPPIN, under 
alternative models of gene evolution, for the entire sequence dataset after the 
exclusion of WFDC6 pseudogenes (orangutan, rhesus and baboon sequences). In 
cases where no selection is operating, ω should be equal to one, below one when 
purifying selection is acting to preserve protein sequence, and significantly exceed one 
when positive selection is acting to drive divergence of protein sequence. We 
estimated a single ω value for the entire phylogeny (one-ratio), in which we assumed 
no differentiation in WFDC6 and EPPIN selective pressures. The observed value (ω = 
0.4739) is lower than one suggesting an overall conservation of WFDC6 and EPPIN 
(Table S6) (39). As these two proteins are very similar, we examined if the two 
paralogs have been subject to different selective constraints, and applied the two-ratio 
model, considering the branches that correspond to WFDC6 and to EPPIN clades. The 
ω value for WFDC6 was close to 1 (ωWFDC6 = 0.8846) and almost two times higher than 
EPPIN (ωEPPIN = 0.4738) but they did not differ significantly from the one-ratio model (-
2Δl = 1.04; P-value = 0.35). To determine if WFDC6 was under different selective 
constraints in chimpanzees, we performed two more tests: a three-ratio model, where 
we define the human and chimpanzee and their ancestral as one clade, and another 
three-ratio model, where we define only the chimpanzee WFDC6 as an independent 
clade. Although our results suggest that WFDC6 might have experienced very different 
selective pressures, as shown by the human-chimpanzee ωancWFDC6 = 1.1656, and by 
the chimpanzee ωWFDC6 = 0.5886, none of the new tests indicate a significant departure 
from the two-ratio model (Table S6). However, the lack of significance might be related 
to the small dataset tested and to the short sequence length (only 131 codons).   
 
Discussion 
 
Here, we studied the sequence diversity at the WFDC locus and 47 neutrally 
evolving regions chosen to control for demographic effects in three Pan troglodytes 
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subspecies, P. t. troglodytes, P. t. ellioti, and P. t. verus. In our dataset, we inferred the 
strength of the selective pressures acting in WFDC locus after retrieving the structural 
and geographical differentiation of the three chimpanzee subspecies. This analysis 
shows that P. t. verus is the least diverse subspecies and a clear defined genetic entity, 
while P. t. ellioti and P. t. troglodytes subspecies are more diverse and hardly 
discriminated even with a set of 1268 autosomal SNPs. In the WFDC locus, we 
pinpointed a single selective signal, which has a high degree of inter-population 
homogeneity and identifies WFDC6 as a gene under purifying selection in 
chimpanzees. We hypothesize that these selective constraints were driven by a 
response to sexually transmitted pathogens, as Pan troglodytes is a promiscuous 
species and gets infected by a plethora of infectious diseases in the wild.  
 The controversial issue of genomic diversity and substructure of the common 
chimpanzee subspecies was revisited based on the variation data collected for this 
study. Most studies addressing the genetic variation in Pan troglodytes focus on 
sequencing mtDNA and study microsatellites, sometimes combined with ascertained 
autosomal markers, to infer demographic history (2, 6). The contribution of our data to 
the complex question of chimpanzee demographic history is modest. This can be due 
to the lack of markers in the 47 control regions (419 SNPs) to discriminate P. t. ellioti 
and, P. t. troglodytes; and to the fact that the WFDC locus may be not the best 
representative of the overall genome diversity in chimpanzees. The WFDC region has 
been pinpointed as being under adaptive evolution in previous studies (40-42), 
potentially reducing genetic distance estimates used to infer demographic history.  
Nevertheless, we detected a consistent differentiation of P. t. verus from the 
other two subspecies, and confirmed that the nucleotide diversity of P. t. verus is more 
similar to humans. Generally, P. t. troglodytes is the subspecies with the highest levels 
of diversity, and P. t. ellioti does not differ significantly (2, 6). As expected, a larger 
effective population size in P. t. troglodytes explains the higher levels of diversity, and 
the negative Tajima’s D trend is consistent with a history of population expansion (36, 
38, 43-45). These trends are also clear in P. t. ellioti, suggesting a similar population 
history and relatedness (6, 8). Despite P. t. verus and humans having similar levels of 
nucleotide diversity in WFDCs, the patterns of LD are considerably different. Some 
progress has been made regarding recombination rates in chimpanzees, and the only 
genome-wide available catalog, PanMap, was calculated from 10 individuals of the P. t. 
verus subspecies. This rate in the WFDC region is in the same of order of magnitude 
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as in humans (~ 0.2 cM/Mb) but only a few and narrow haplotype blocks were identified 
in P. t. verus subspecies.   
 
The signatures of selection identified in the human WFDC locus are mainly 
associated with homogeneous long-range haplotypes and variants located at SEMG1 
(Asians), WFDC8 (Europeans), and SPINT4 (Africans) indicating a recent increase in 
the frequency by selection and not by demographic events (26). In chimpanzees, we 
assessed the signatures of positive selection by circumventing the effects of 
demography and comparing the WFDC genes with the empirical distribution built from  
47 neutrally evolving regions of the chimpanzee genome, as we did previously in 
humans (26).  Even though we could not detect LD blocks or extended haplotypes in 
our sequenced data, we find lower levels of nucleotide diversity in WFDC6 and EPPIN 
genes while compared with other chimpanzee loci. Both genes present levels of 
nucleotide diversity that are similar to humans, in all subspecies. They also present 
significantly negative Tajima’s D values in the total number of individuals analyzed and 
in P. t. troglodytes, using either coalescent simulations or empirical comparisons. The 
significantly negative HKA P-value obtained for the total sample set together with the 
low subspecies differentiation indicated by FST and the low frequencies of NSyn 
variants is suggestive of a signature of an old event of purifying selection in WFDC6 
and EPPIN in Pan troglodytes.  
 
To our knowledge, no experimental studies were performed to determine 
WFDC6 biological functions. However, WFDC6 is considered a recent paralog of 
EPPIN, with 71% of sequence similarity and a very similar pattern of expression in 
male reproductive tissues (15). At the protein level, WFDC6 and EPPIN share the 
same domains (WAP and Kunitz), and thus we might assume that WFDC6 has similar 
functions to EPPIN, including binding to SEMG1. EPPIN is known to protect SEMG1 
from premature cleavage by its natural protease, PSA, a protease inhibitor activity 
conferred by L87 residue (P1 reactive site) located in the Kunitz domain. Other 
recognized roles of EPPIN are its antimicrobial and antiviral activities, providing 
protection of the spermatozoa (15). Due to its important functions in reproduction in 
primates, it is not unexpected that some level of purifying selection is acting on EPPIN 
to prevent NSyn mutations from altering its important biological functions. Even in 
primates experiencing lower levels of post-copulatory selection and lower semen 
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coagulum thickness like gorilla (41), it seems that the role of EPPIN in modulating the 
cleavage of SEMG1 is not affected. However, WFDC6, which shows the strongest 
signature of purifying selection in chimpanzees does not share the same leucine 
residue at the reactive site, instead it has in position 87 a tryptophan (W). It is also 
noticeable that the majority of the replacements seen in WFDC6 include cysteines from 
the Kunitz domain, which in EPPIN are engaged in disulfide bonds. Therefore, we 
hypothesize that the serine-protease activity of WFDC6 would be impaired or targeted 
to a different protease other than PSA. On the other hand, the WAP domain has a 
highly conserved amino acidic composition between both genes, and the maintenance 
of the disulfide bridges suggest the antimicrobial properties of this domain will be 
maintained. The WAP motif-containing proteins are functionally diverse, including 
serine-protease inhibition (11),  immunity (46), antiviral (18, 47), and tumorogenesis 
(48).  
 
Disease transmission during mating provides a connection between 
reproduction and immunity, where sexually transmitted diseases (STDs) can affect 
fitness of individuals by imposing different selective pressures on their hosts. Previous 
studies found a positive correlation between levels of leukocytes (indicator of 
immunocompetence) and several proxies of female sexual promiscuity among species 
of primates with different mating systems (49-51). The lack of associations with several 
other social, ecological and life-history variables led to the hypothesis that increased 
levels of transmission of STDs in promiscuous species have resulted in the evolution of 
a greater investment in immune response (52, 53). Chimpanzees are classified as one 
of the most promiscuous primate species, where previous signals of rapid evolution of 
sperm proteins (SEMG1 and SEMG2) were found (25, 40, 41). Instead, humans, 
gorillas and gibbons are not promiscuous, maintaining a monoandrous mating system 
being less subject to STDs.  
 
We hypothesize that chimpanzees, as a promiscuous species, are likely to be 
more exposed to STDs (50, 52, 54). After the duplication event that originated WFDC6, 
an episode of rapid evolution may have occurred allowing for the accumulation of 
amino acid replacements. Later in chimpanzee evolution, the newly originated WFDC6 
appears to have been preserved by strong selective constraints, perhaps representing 
an adaptive response to a higher load of pathogens. Conversely, in less promiscuous 
species like orangutan, rhesus and baboon the signals of pseudogenization present on 
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WFDC6 seem to be associated with more relaxed constraints (higher ω values) and 
lower pathogen exposure or to the exploitation of different mechanisms of immune 
defense (50, 51, 53, 55). However, as WFDC6 biological functions and target 
molecules have not been explored yet, our hypothesis regarding the purifying selective 
pressures cannot be totally unraveled.  
 
Overall, our data provides support for a clear genetic differentiation of P. t. 
verus from the remaining common chimpanzee’s subspecies, and for a single 
departure of neutrality in the WFDC locus in chimpanzees due to strong selective 
constrains acting on WFDC6. We hypothesize that the latter may be due to an adaptive 
process associated to the expanded antimicrobial spectrum of WFDCs in the male 
reproductive tract.  
 
Methods 
 
DNA samples and sequence generation 
 
The DNA samples include 68 chimpanzees, including Central African 
subspecies, P. t. troglodytes (15 individuals), Western African subspecies, P. t. verus 
(22 individuals) and the Gulf of Guinea subspecies, P. t. ellioti (31 individuals). (Table 
S.1).  We studied the genetic variation in the WFDC locus by sequencing the coding 
regions of 18 WFDC and SEMG genes (comprising a total of 66 exons) and a number 
of intervening noncoding regions (spaced every ~10 kb). Additionally, we sequenced 
47 pseudogenes located in unrelated, neutrally evolving regions across the 
chimpanzee genome, used as control regions, as previously used (26, 56) (Table S.2).  
Primers for amplification and sequencing were designed based on the Human Genome 
Reference Sequence (March 2006 assembly - v36.1), available at the UCSC Genome 
Browser (genome.ucsc.edu). All samples were PCR-amplified and analyzed by 
bidirectional Sanger sequencing. Further details about PCR and DNA sequencing are 
available from the authors upon request. The sequences were aligned to the Human 
Genome v26.1 and polymorphic sites and fixed differences were detected  with phred-
phrap-consed package (57). To ensure sequence quality, we discarded variant sites in 
the first and last 75 bp of each amplicon segment. We manually curated sites found to 
have discordant genotypes in different amplicons. The ancestral state of each SNP 
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was inferred by comparison with the human, orangutan, and macaque genome 
sequences [(56, 58); genome.ucsc.edu]. 
 
Statistical analysis 
 
Summary statistics of population genetic variation were calculated using 
SLIDER (http://genapps.uchicago.edu/slider/index.html). We assessed statistical 
significance of summary statistics using an empirical comparison to the control regions, 
by calculating the upper and lower 2.5 percentiles of each distribution. Specifically, we 
used the sequenced control regions to perform an empirical comparison of nucleotide 
diversity (π) and Tajima’s D values for each WFDC gene in each population. As a 
result, we circumvent the need to specify a history of demographic events shaping the 
genetic diversity in these three subspecies. For the WFDC genes that presented 
summary statistic values in the tail of the empirical distribution in P. t. troglodytes , we 
ran 105coalescent simulations using “ms” (59) and with estimates of  mutation rate 
parameters estimated from the sequenced data with SLIDER. For the population 
recombination rate we used the PANMAP estimates of chimpanzee recombination. We 
assumed demographic models that included constant population size and historic 
events as previously inferred (Jody Hey (2010) and Daniel Wegmann (2010)). For each 
model, we calculated a null distribution of summary statistics values and calculated the 
2.5th and 97.5th percentiles.  
 
We performed HKA test considering all subspecies in DNAsp 5.1 and using a 
Maximum Likelihood method that incorporates values for multiple neutrally evolving 
regions (35). MKT was calculated in DNAsp v5.1 using humans as outgroup and 
assuming two types of sites: putatively neutral sites (Syn) and functional sites (NSyn) 
(60, 61). 
 
We assessed the subspecies differentiation levels by calculating the FST  
statistic and PCA for each SNP (27, 28). We used a locus-by-locus AMOVA, using 
20,000 simulations, which was performed by Arlequin using its default values(constant 
model (62). The EIGENSOFT software package was used for PCA (28). We performed 
cluster analysis using STRUCTURE version 2.3 software package (30), assuming 
admixture and correlated allele frequencies. Fifty iterations of the data at each K =1–5 
with 500,000 Markov Chain Monte Carlo (MCMC) burn-in steps and 500,000 MCMC 
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iterations. STRUCTURE output was processed with CLUMPP and plotted with 
DISTRUCT (63). We used STRUCTURE harvester to determine the best K estimate. 
Population structure analyses were performed blinded to a priori population labels. 
 
Haplotype phasing for all samples was inferred separately for the WFDC-CEN and 
WFDC-TEL sub-loci using PHASE2.1 (64, 65). Haplotypes were independently 
inputted in Haploview 4.2 (66) to calculate LD statistics, r2 and D’, and to identify LD  
and haplotype blocks (67). The potential functional effects at the protein level of 
nonsynonymous SNPs and fixed differences were inferred using PolyPhen-2v (68) and 
SIFT (69).  
 
 Maximum likelihoods estimates of dN/dS () were carried out using the codeml 
program from the software package Phylogenetic Analysis by Maximum Likelihood - 
PAML version 4.2 (39). To run PAML, we first reconstructed a phylogenetic tree 
(DNAml from Phylogeny Inference Package (PHYLIP - 
http://evolution.genetics.washington.edu/phylip.html). We used the genomic sequences 
from human (Homo sapiens), chimpanzee (Pan troglodytes), gorilla (Gorilla gorilla), 
orangutan (Pongo pygmaeus), gibbon (Nomascus leucogenys), rhesus monkey 
(Macaca mulatta), baboon (Papio anubis), and marmoset (Callithrix jacchus). They 
were retrieved from public databases using EPPIN isoform 1 (Uniprot: O95925) and 
WFDC6 isoform 1 (Uniprot:  Q9BQY6) as BLAT templates. Pan paniscus was not 
included in the analysis as the cDNA sequence is equal to Pan troglodytes. The 
phylogenetic tree diverged from the known primate phylogeny in the position of 
orangutan and gibbon branches. To test for variable selective pressures among 
branches, we performed the branch model using either the null model (one ω ratio for 
the entire tree) or nested models (two-ratios, three-ratios, four-ratios for the tree, 
defined as depicted in Fig S10) (70, 71). The values of ω > 1 were considered as 
evidences of positive selection, and the values ω < 1 were considered as an indication 
of purifying selection. The significance of each model was assessed from twice the 
variance of likelihoods (-2Δl) using χ2 statistic. 
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Table 1: Summary Statistics for all the WFDC genes in Pan troglodytes. 
Gene 
a
L 
b
S 
c
π  
d
Ɵw 
e
D 
f
D* 
g
H 
h
P 
(HKA) 
WFDC5 5536 45 7.78 8.25 -0.174 -0.182 1.41 0.675 
WFDC12 1323 24 2.48 4.39 -1.25 -1.08 0.723 0.664 
PI3 3377 32 4.32 5.85 -0.776 -0.378 6.52 0.445 
SEMG1 3305 45 4.00 8.20 -1.57 0.336 -1.04 0.146 
SEMG2 4324 47 3.58 8.57 -1.78 -0.352 5.07 0.816 
SLPI 4709 46 6.68 8.38 -0.621 0.639 7.66 0.247 
WFDC2 3984 34 5.35 6.2 -0.406 -0.248 0.656 0.104 
SPINT3 3727 44 5.30 8.04 -1.04 -1.59 36.9 0.008 
WFDC6 2807 31 1.63 5.67 -2.10 -2.90 -1.52 0.013 
WFDC7 3233 38 3.16 6.96 -1.65 -2.09 16.9 0.018 
WFDC8 7179 56 4.82 10.2 -1.64 -2.18 6.13 0.115 
WFDC9/10A 6863 67 7.24 12.2 -1.28 -1.86 19.4 0.386 
WFDC11 5037 71 10.1 13.0 -0.708 -0.529 25.8 0.014 
WFDC10B/13 7365 59 6.85 10.8 -1.13 -1.54 -4.13 0.105 
SPINT4 3527 30 2.21 5.50 -1.76 -1.95 16.1 0.173 
WFDC3 7572 93 10.6 17.0 -1.19 -1.02 17.8 0.071 
 
a
 L = Legth sequenced (bp). 
b
 S = number of segregating sites. 
c
 Nucleotide diversity per base pair (x 10
-4
) 
d 
Watterson’s estimator of Ө (4Neµ) (Watterson 1975) per base pair (x 10
-4
).   
e
 D = Tajima’s D statistic (Tajima 1989). 
f
 D* = Fu and Li’s D* test  (Fu and Li 1993) 
g
 Fay and Wu H test  (Fay and Wu 2002; Zeng et al. 2006) 
h
 HKA test P-value  (Hudson, Kreitman and Aguadé 1987) 
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Figure 1: Schematic representation of the 20q13 WFDC gene locus, showing the relative positions of the WFDC genes. 
As depicted, the WFDC locus spans 700 kb and its genes are organized into two subloci (centromeric and telomeric; 
WFDC-CEN and WFDC-TEL, respectively), separated by 215 kb of unrelated sequence. 
 
 
 
 
Figure 2: Folded site frequency spectrum (folded SFS) for the species resequenced. The x-axis depicts the frequency 
of the allele frequency bin in the generated data set, whereas the y axis represents the number of alleles found within 
each frequency bin. Syn, synonymous changes; NSyn, nonsynonymous changes. (A) folded SFS in WFDC locus; (B) 
folded SFS of WFDC locus highlighting coding mutations. 
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Figure 3: Inferred network haplotypes at the WFDC6. Each circle represents a unique haplotype, and its area is 
proportional to its frequency. Within each circle, P. t. verus, P. t. ellioti, and P. t. troglodytes are labeled in green, purple 
and orange, respectively. The mutations that differentiate each haplotype are shown along each branch. The inferred 
network haplotype of WFDC6 shows a star-like structure characteristic of a population expansion, combined with 
purifying selection.  
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3.3. Biological assessment of candidate genes 
3. 3. 1. Characterization of the Human WFDC8:  Evolutionary history and 
differential allele expression  
In preparation   
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Abstract 
 
The whey acidic protein (WAP) four-disulfide core domain (WFDC) locus located on 
human chromosome 20q13, spans 17 WFDC genes with WAP and/or Kunitz domains. 
The WFDCs are small-secreted molecules known for their roles in innate immunity, 
reproduction, and regulation of endogenous proteases. WFDC8 was pinpointed as 
target of balancing selection in the Europeans. The putative candidate variant -44A 
(rs7273669A) is located near the 5’UTR, and was predicted to affect gene expression 
by abolishing the binding site of two transcription factors. We explored the activity of 
WFDC8 in humans, by studying its conservation across 12 mammalian species, and by 
analyzing patterns of expression linked to -44A allele. We show that WFDC8 has been 
conserved throughout mammalian evolution and we provide in vivo and in vitro 
evidence for an effect of -44(G/A) on gene expression. Furthermore, we propose a 
differential allele expression dependent of the cellular and/or tissue background. The 
divergent expression effects of -44(G/A) in different tissues strengthens the balancing 
selection hypothesis, highlighting the balanced effect of the polymorphisms in WFDC8 
expression in human tissues. 
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Introduction 
 
The whey acidic protein (WAP) four-disulfide core domain (WFDC) locus, 
located on human chromosome 20q13, encodes small-secreted peptides, with roles in 
innate immunity, reproduction, and regulation of endogenous proteases [1-6].  
The majority of WFDC molecules contain one or more WAP domains and a few 
of these proteins include other domains such as trappin (e. g. PI3); or Kunitz protease 
inhibitor domains (e. g. EPPIN and WFDC8) [7, 2]. Peptidase inhibitor 3 (PI3, also 
known as elafin) and secretory leukocyte peptidase inhibitor (SLPI) are the most 
studied members of the WFDC locus and encode pleiotropic proteins involved in 
recognizing microbial infections at mucosal surfaces and are also thought to be 
involved in sperm maturation [8-11]. SEMG1 and SEMG2 are nearby genes that share 
conserved flanking regions with WFDCs, and encode the main protein components of 
the semen coagulum. SEMGs have combined roles in male reproduction and pathogen 
response; when crosslinked SEMGs entrap spermatozoa in the coagulum and when 
cleaved into small peptides SEMGs present antimicrobial activity [6,12-14]. Another 
example of a thoroughly studied WFDC member is EPPIN, which binds to SEMG1 and 
protects it from premature cleavage by its natural protease – Prostate Specific Antigen 
(PSA, or kallikrein-3). EPPIN has remarkable implications in reproductive biology since 
it participates in spermatozoa maturation and in their protection from microbial attack 
[3,12,13,15-17]. To our knowledge, the biological properties of the other WFDC genes 
remain poorly characterized as it is the case of WFDC8. This gene encodes a protein 
with three WAP domains and one Kunitz domain, which is expected to combine 
antimicrobial and antiprotease properties [5]. Its rat homologue Wfdc8, was shown to 
present a gene expression dependent of androgens and inducted by 
lipopolysaccharides (LPS) and its protein to display a potent antibacterial activity [18]. 
 
In humans WFDC8 was identified in the semen [19,20], the loss of its gene 
expression was associated with a fertility impairment after vas deferent renamastosis 
and in Hutterite pedigrees WFDC8 appears to be associated with transmission 
distortion [21]. Moreover, WFDC8 was previously shown to display a signature of 
balancing selection in Europeans associated to a -44(G/A) polymorphism (rs7273669), 
located in the 5’ region of WFDC8 gene. This polymorphism was predicted to alter 
gene expression by abolishing the binding site of two transcription factors [22,23]. 
Balancing selection is an evolutionary process in which genetic variation is preserved 
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throughout time and it is generally associated with an advantage of heterozygotes. 
Such examples include carriers of sickle cell anemia, which are resistant to 
Plasmodium falciparum infection (malaria) and the large inter individual variation of 
MHC locus, which protects humans against a large spectrum of pathogens [24-31]. 
Importantly, signals of balancing selection appear to be more common in genes that 
are involved in host-pathogen interactions and immune response [32-37].  
 
Here, we describe the patterns of WFDC8 conservation and the frequency 
distribution of -44(G/A) polymorphism in different populations of European origin and 
we evaluate the impact of -44(G/A) polymorphism on WFDC8 expression by means of 
allele-specific amplification and luciferase assays. We demonstrate that WFDC8 has 
been conserved throughout mammalian evolution and we provide evidence for an 
effect of -44(G/A) on gene expression that depends on the cellular background.  
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Methods 
 
Phylogenetic analysis 
 
WFDC8 cDNA sequences were extracted from public databases 
(Supplementary Table S1) and their phylogeny was built using the maximum likelihood 
method implemented in the DNAml program from the Phylogeny Inference Package 
(PHYLIP – http://evolution.genetics.washington.edu/phylip.html). Maximum likelihood 
estimates of dN/dS, were carried out using the codeml program from the software 
package Phylogenetic Analysis by Maximum Likelihood - PAML version 4.5. The 
following likelihood rate tests (LRTs) were performed:  1) the branch model which 
compares a single dN/dS value obtained for all lineages (M0) with a model assuming 
different dN/dS values for each lineage (free-ratio); 2) the site models, which allow the 
dN/dS value to vary among sites of the protein and compare models of neutrality with 
positive selection (M1-M2 and M7-M8). Values of dN/dS > 1 were considered as 
evidence of positive selection and the values of dN/dS < 1 were regarded as an 
indicative of purifying selection. The significance of each nested model was obtained 
from twice the variation of likelihoods (2l) using a 2 statistic. The Bayes empirical 
Bayes (BEB) was used to calculate posterior probabilities of site classes, in order to 
identify sites under positive selection for the significant LRTs [38]. 
 
Tissue Expression 
 
To investigate the pattern of distribution of WFDC8 we analyzed 19 cDNA 
samples from different healthy organs. Except for the first-strand cDNA from leukocytes 
(Clontech), the tissue cDNA samples were synthesized by reverse transcriptase 
methods using as templates the RNA from the First Choice Human Total RNA Survey 
Panel (Ambion). Reverse transcription was performed using the Superscript III RT PCR 
system (Life Technologies) according to the manufacturer’s protocol. The primers used 
for amplification of the cDNA of WFDC8 were 5’- GGA GTG GAC TTC TGC AAT GCT 
GA-3’ and 3’- TCA TGA GGC ACA GCG CTG GCT-5’. A segment of the house-
keeping gene GAPDH was employed as internal control using the forward primer 5’-
TCA AGG CTG AGA ACG GGA AG -3’ and the reverse primers 5’-AGA GGG GGC 
AGA GAT GAT GA-3’ and 3’-CAG TAG AGG CAG GGA TGA TG-5’. For amplification, 
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we used the following cycling conditions: 95 ºC for 15 min and 35 cycles of 94 ºC for 30 
s, 62 ºC for 30 s and 72 ºC for 1 min and extension time for 30 min at 60 ºC. 
Amplification fragments were separated by 9% polyacrylamide gel electrophoresis. 
 
Allele-specific expression in Ovarian Tissues 
 
Genomic DNA (gDNA) and total mRNA was extracted from 12 frozen ovarian 
samples donated by the Tumor and Tissue Bank from Saint John Hospital (Porto, 
Portugal). For the extraction of gDNA we used QIAamp DNA Mini and Blood Mini kit 
(Qiagen) following the manufacturer’s instructions. For the purification of total mRNA 
we used first Tripure Isolation reagent (Roche Applied Science). Then, to remove 
possible gDNA contamination, mRNA was treated with DNase I (Ambion) and 
precipitated with acidic phenol-chloroform (Ambion). Double stranded cDNA was 
synthesized from total RNA using the reverse transcriptase protocol referred above. 
To evaluate the impact of -44(G/A) polymorphism in gene expression we 
genotyped the marker rs2250860 located in the WFDC8 coding region. This SNP was 
selected due to its strong association (D’= 1 and r2=1) with -44(G/A) polymorphism in a 
sample of individuals with ancestry in northern or western Europe (CEU sample from 
HapMap project) and it was used as a proxy for allele-specific expression. To certify 
the association of rs2250860 and -44(G/A) in our sample, we Sanger-sequenced both 
SNPs using the gDNA extracted from the 12 ovarian tissues. TaqMan Gene 
Expression Assay design for rs2250860 (Applied Biosystems) and TaqMan PCR 
technology was used in experiments of allele-specific expression. The analysis was 
carried out in the cDNA samples from heterozygotes individuals and a gDNA sample 
from a heterozygous individual was used as reference for 50:50 ratio. Reactions were 
prepared as recommended for the genotyping assay, using Taqman master mix 
(Applied Biosystems), the two primers,and FAM- and VIC labeled probes, each 
designed to specifically anneal to one of the alleles of rs2250860. The genotyping was  
run on an ABI PRISM 7500 RT-PCR system. The experiments were repeated at 
least twice. The same protocol was used to quantify the differential levels of allelic 
expression for each sample, with the addition of a series of dilutions from a gDNA 
sample of a heterozygous were used to generate a standard curve. A threshold of 35 
Ct was used to consider allele expression. Relative expression quantitation was 
extrapolated from linear regression for the single sample presenting both alleles 
expression above the 35 Ct. This experiment was run in triplicate.     
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Plasmid construction 
 
A segment of the 5’ WFDC8 region (positions -351 to 115 relative to the 
translation start site) was amplified by PCR from individuals with known genotypes (AA 
and GG). The PCR was performed using the primers 5’- ACA TTT AGC AAG GTA 
GGC GT-3’ and 5’-GAC CAC TCT AAC TTC TAT GT-3’. The PCR product was first 
cloned into a  pCR 4-TOPO-TA cloning vector (Life Technologies), digested with SacII 
and XhoI and ligated 5’ of the Luciferase sequence of the pGL3-Promoter vector. All 
plasmids were sequenced before transfection. 
 
Cell culture 
 
Human Cervix Adenocarcinoma (HeLa) and Colorectal Cancer cell lines (Caco-
2,) were cultured in Dulbecco's Modified Eagle Medium (DMEM; Life Technologies) 
supplemented with 10% fetal bovine serum (FBS; Life Technologies) and 
penicillin/streptomycin antibiotics.  
 
Transient transfection 
 
Cells (~105) were seeded into a 24-well plate 24 hours before transfection. 
Plasmid constructs were co-transfected with phRL-TK (Promega) at a 2:1 ratio using 
lipofectamine agent (Life Technologies). Twenty-four hours after transfection, cells 
were harvested and luciferase activity was measured by Dual-Luciferase Reporter 
Assay System (Promega) according to the manufacturer's protocol. The result was 
expressed as the ratio between firefly and Renilla luciferase. Fifteen replicates were 
performed for each experiment. Independent t-tests were performed in SPSS 15.0 
(SPSS, Inc., Chicago, IL) and the null hypothesis was rejected when P < 0.05. 
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Results 
 
Evolutionary study of WFDC8 
 
To investigate the evolution of WFDC8 and its levels of conservation, we 
performed a series of phylogenetic analyses using the coding sequences of 12 
mammalian species: Homo sapiens, Pan troglodytes, Pan paniscus, Gorilla gorilla, 
Pongo abelii, Nomascus leucogenys, Papio anubis, Macaca mulatta, Saimiri 
boliviensis, Mus musculus, Rattus norvegicus, and Canis lupus familiaris. The 
organization of WFDC8 in 3 WAP and 1 Kunitz domains is conserved in all species 
except for P. abelii,  in which the terminal WAP domain was lost (Figure 1A). The 30 
cysteines present in the H. sapiens sequence are conserved in the remaining species 
pointing to the maintenance of the 15 disulfide bridges in the WFDC8 molecule 
throughout mammalian evolution (Figure 1A).  
 
To explore the nature of the selective pressures acting on WFDC8 we 
calculated dN/dS ratios (dN and dS correspond to non-synonymous and synonymous 
substitution rates, respectively) assuming opposite evolutionary scenarios. The low 
dN/dS estimate (0.4709) obtained for the 12 mammals phylogeny suggests an overall 
conserved evolution of WFDC8. We also tested the hypothesis of some codon 
positions were evolving under positive selection in WFDC8. Although most sites are 
constrained, a few amino acid positions (2.6 %) are likely to be under positive selection 
in WFDC8 (34R, 45P, 73T, 139E, 156K, 171D and 252K) including the one located in 
protease target region of the Kunitz domain (Table 1; Figure 1A).  
 
Frequency distribution of -44G/A polymorphism 
 
To determine the frequency distribution of the -44G/A polymorphism in a larger 
set of individuals with European ancestry we inquired the 1000 genomes Project 
database (http://www.1000genomes.org). In the total sample comprising 379 
Europeans individuals the frequency of heterozygotes (48.8 %) is slightly higher than 
expected but not enough to cause a departure from the Hardy-Weinberg equilibrium 
(HWE). The split of samples by populations (CEU, TSI, GRB, FIN and IBS) and sex 
uncovered some level of differentiation in heterozygotes frequencies where only the 
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British females (GBR) show departure from HWE (P-value = 0.01) (Supplementary 
Figure 1).  
Tissue expression of WFDC8 
 
To investigate WFDC8 expression a panel of 19 human tissues (cDNA) was 
screened by PCR. Our results show that the expression of WFDC8 is higher in testis, 
residual in bladder, brain and ovaries and absent in the remaining tissues (Figure 2). 
 
Allele-specific Expression of WFDC8  
 
To test the differential expression of –44G/A polymorphism we sequenced two 
first strand cDNA libraries for WFDC8, a first library from ovaries (normalized pool of 15 
individual samples with European ancestry; Clontech) and another one from testis 
(normalized pool of 45 samples with European ancestry; Clontech). Given the 
observed frequencies of -44A and -44G alleles (~50%) the analysis of the surrogate 
marker rs2205806 suggested an expression bias towards -44A allele in ovaries (allele 
1 or G) but not in testis (Figure 3A). Within the 12 ovarian samples, we identified nine 
heterozygous for –44G/A polymorphism, all of which were heterozygous for rs2205806 
(Supplementary Table S2). The cDNA samples from the nine heterozygotes were 
selected for the TaqMan rs2205806 assay to confirm the biased expression of -44A 
allele. Despite the low expression of WFDC8 in ovaries, which prevented the 
amplification of rs2205806 marker in three samples, the remaining samples showed an 
imbalance towards -44A allele (Figure 3B). The quantification of relative allele 
expression in the sample with better signal pointed to a three times higher expression 
of -44A allele. 
 
 
To further characterize the functional effect of -44G/A polymorphism, we 
constructed two report vectors -44G and -44A and transfected two cell lines: HeLa and 
Caco-2. The two cell lines yield contrasting results, while in HeLa -44A allele leads to 
an expression increase, in Caco-2 cells the same allele reduces WFDC8 expression 
(Figure 4). 
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Discussion 
 
Many genes with roles in immunity have evolved under balancing selection to 
ensure their function and variability to respond to pathogen infections.  WFDC proteins 
contain different domains, which are thought to confer antimicrobial properties to 
protect host from pathogen infections and spermatozoa from bacterial attack [2]. Most 
of the WFDCs with known biological functions have combined activities in immunity 
and reproduction. For example, EPPIN encodes for a protein with an active role in 
protecting spermatozoa from bacterial infections while helping to maturate 
spermatozoa for fertilization. For the particular case of WFDC8, no specific biological 
function has been attributed, nor has a protease inhibitor activity been cataloged. 
However, accordingly to the recent findings made for its rat homologue, WFDC8 is 
likely to have an important role in host-pathogen interaction and male fertility [18].  
 
Comparative and phylogenetic analysis of WFDC8 in 12 mammalian species 
showed that all cystein residues and disulfide bridges were preserved during evolution. 
Overall, WFDC8 has been conserved except for a few amino acids under positive 
selection. This is the case of E139 residue, located in the reactive center of the Kunitz 
domain, which suggests a fast evolution of WFDC8 to counteract the activity of 
different proteases. Conversely, the maintenance of the 15 disulfide bridges in WFDC8 
indicates a possible conservation of antimicrobial function in most mammalians. 
 
The signature of balancing selection reported for Europeans in WFDC8 is 
characterized by the occurrence of two intermediate frequency haplotypes 
(approximately 50%), which are defined by opposite alleles of the -44G/A 
polymorphism (rs7273669). The haplotype carrying -44A allele was found to extend 
around 200 kb in the WFDC locus as if it had  recently arisen in human history. 
Notwithstanding, the frequency distribution of the -44G/A polymorphism in the larger 
set of individuals with European ancestry is close to 50% and did not differ significantly 
among populations. Even with such larger sample, we could not detect an excess of 
heterozygotes as theoretically predicted for an event of balancing selection. This lack 
of significance may indicate that the sample size is not enough to detect a bias in 
heterozygous frequency or that selective effect is not associated with an heterozygous 
advantage. However, if there is indeed a transmission distortion associated to one of 
the WFDC8 haplotypes, it would be expected to find an excess of heterozygous due to 
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bias in the segregation of one allele. Nonetheless, the sample size in Hutterite 
pedigrees is not large enough to confidently support this deviation and thus the result 
could be due to chance fluctuations in transmission rate [21].  
 
The analysis of tissue patterns confirmed that WFDC8 is manly expressed in 
testis, though it can be also found at lower levels in other tissues such as ovaries, 
bladder, and brain. Importantly, for the ovaries we demonstrate that WFDC8 
expression is affected by genotype, in which the -44A allele is up to 3 times more 
expressed than -44G allele. Although we could not analyze other tissues, this finding 
may not hold true for other tissues since no hint of allelic imbalance was detected in the 
testis cDNA library resulting from the pooling of 45 samples with European ancestry. 
Accordingly, the in vitro experiments performed for the opposite allele configurations -
44A and -44G yielded contrasting results depending of the cellular model used. In 
HeLa cells, the -44A allele led to increased expression as observed for the in vivo 
model of ovaries. Conversely, in Caco-2 cells the -44A allele led to a reduced 
expression. Altogether, these findings suggest that the same variant -44A might have 
contrasting effects on WFDC8 expression depending on cellular or tissue background.  
In an evolutionary perspective, WFDC8 might be under balancing selection due 
to a fine tuned regulation of gene expression in which being a heterozygous may be 
advantageous or, on the other hand, the slight increase expression in ovaries can have 
a beneficial effect in female fertility by conferring an higher antimicrobial potential to 
female reproductive system without compromising the activity of proteases with a role 
in fertilization.  
 
In conclusion, WFDC8 is highly conserved in mammalian lineages highlighting 
the possibility of an important role in host-pathogen interaction and fertility. Further 
assessment of the biological role of WFDC8 cataloging its protease inhibitory and 
antibacterial activity might elucidate on the heterozygote advantage in European 
populations. 
 
98 FCUP 
The human whey-acidic-protein Four-Disulfide Core-Domain (WFDC) cluster on 20q13 region: evolutionary 
history and role inhuman health and disease 
 
References 
[1] A. Lundwall, A. Clauss, Identification of a novel protease inhibitor gene that is highly 
expressed in the prostate, Biochemical and biophysical research communications 
290 (2002) 452-456. 
[2] A. Clauss, H. Lilja, A. Lundwall, The evolution of a genetic locus encoding small 
serine proteinase inhibitors, Biochemical and biophysical research communications 
333 (2005) 383-389. 
[3] S. Yenugu, R.T. Richardson, P. Sivashanmugam, Z. Wang, G. O'Rand M, F.S. 
French, S.H. Hall, Antimicrobial activity of human EPPIN, an androgen-regulated, 
sperm-bound protein with a whey acidic protein motif, Biology of reproduction 71 
(2004) 1484-1490. 
[4] D. Bouchard, D. Morisset, Y. Bourbonnais, G.M. Tremblay, Proteins with whey-
acidic-protein motifs and cancer, The Lancet Oncology 7 (2006) 167-174. 
[5] C.D. Bingle, A. Vyakarnam, Novel innate immune functions of the whey acidic 
protein family, Trends in immunology 29 (2008) 444-453. 
[6] A. Lundwall, A. Clauss, Genes encoding WFDC- and Kunitz-type protease inhibitor 
domains: are they related?, Biochemical Society transactions 39 (2011) 1398-1402. 
[7] L. Bingle, S.S. Cross, A.S. High, W.A. Wallace, D. Rassl, G. Yuan, I. Hellstrom, 
M.A. Campos, C.D. Bingle, WFDC2 (HE4): a potential role in the innate immunity of 
the oral cavity and respiratory tract and the development of adenocarcinomas of the 
lung, Respiratory research 7 (2006) 61. 
[8] S.E. Williams, T.I. Brown, A. Roghanian, J.M. Sallenave, SLPI and elafin: one glove, 
many fingers, Clinical science 110 (2006) 21-35. 
[9] S. Weldon, N. McGarry, C.C. Taggar, N.G. McElvaney, The role of secretory 
leucoprotease inhibitor in the resolution of inflammatory responses, Biochemical 
Society Transactions 35 (2007) 3. 
[10] S. Weldon, C.C. Taggart, Innate host defense functions of secretory leucoprotease 
inhibitor, Experimental lung research 33 (2007) 485-491. 
[11] P.J. McKiernan, N.G. McElvaney, C.M. Greene, SLPI and inflammatory lung 
disease in females, Biochemical Society transactions 39 (2011) 1421-1426. 
[12] A.M. Edstrom, J. Malm, B. Frohm, J.A. Martellini, A. Giwercman, M. Morgelin, A.M. 
Cole, O.E. Sorensen, The major bactericidal activity of human seminal plasma is 
zinc-dependent and derived from fragmentation of the semenogelins, J Immunol 181 
(2008) 3413-3421. 
FCUP 
The human whey-acidic-protein Four-Disulfide Core-Domain (WFDC) cluster on 20q13 region: 
evolutionary history and role inhuman health and disease 
99 
 
[13] F. Bourgeon, B. Evrard, M. Brillard-Bourdet, D. Colleu, B. Jegou, C. Pineau, 
Involvement of semenogelin-derived peptides in the antibacterial activity of human 
seminal plasma, Biology of reproduction 70 (2004) 768-774. 
[14] J.A. Martellini, A.L. Cole, N. Venkataraman, G.A. Quinn, P. Svoboda, B.K. 
Gangrade, J. Pohl, O.E. Sorensen, A.M. Cole, Cationic polypeptides contribute to 
the anti-HIV-1 activity of human seminal plasma, FASEB J 23 (2009) 3609-3618. 
[15] M. Robert, C. Gagnon, Semenogelin I: a coagulum forming, multifunctional 
seminal vesicle protein, Cell. Mol. Life Sci. 55 (1999) 16. 
[16] Z. Wang, E.E. Widgren, P. Sivashanmugam, M.G. O'Rand, R.T. Richardson, 
Association of eppin with semenogelin on human spermatozoa, Biology of 
reproduction 72 (2005) 1064-1070. 
[17] H. Zhao, W.H. Lee, J.H. Shen, H. Li, Y. Zhang, Identification of novel semenogelin 
I-derived antimicrobial peptide from liquefied human seminal plasma, Peptides 29 
(2008) 505-511. 
[18] A. Rajesh, G. Madhubabu, S. Yenugu, Identification and characterization of Wfdc 
gene expression in the male reproductive tract of the rat, Molecular reproduction 
and development 78 (2011) 633-641. 
[19] I. Batruch, I. Lecker, D. Kagedan, C.R. Smith, B.J. Mullen, E. Grober, K.C. Lo, E.P. 
Diamandis, K.A. Jarvi, Proteomic analysis of seminal plasma from normal volunteers 
and post-vasectomy patients identifies over 2000 proteins and candidate biomarkers 
of the urogenital system, J Proteome Res 10 (2011) 941-953. 
[20] D. Kagedan, I. Lecker, I. Batruch, C. Smith, I. Kaploun, K. Lo, E. Grober, E.P. 
Diamandis, K.A. Jarvi, Characterization of the seminal plasma proteome in men with 
prostatitis by mass spectrometry, Clin Proteomics 9 (2012) 2. 
[21] W.K. Meyer, B. Arbeithuber, C. Ober, T. Ebner, I. Tiemann-Boege, R.R. Hudson, 
M. Przeworski, Evaluating the evidence for transmission distortion in human 
pedigrees, Genetics 191 (2012) 215-232. 
[22] Z. Ferreira, B. Hurle, J. Rocha, S. Seixas, Differing evolutionary histories of 
WFDC8 (short-term balancing) in Europeans and SPINT4 (incomplete selective 
sweep) in Africans, Molecular Biology and Evolution 28 (2011) 2811-2822. 
[23] Z. Ferreira, S. Seixas, A.M. Andres, W.W. Kretzschmar, J.C. Mullikin, P.F. 
Cherukuri, P. Cruz, W.J. Swanson, N.C.S. Program, A.G. Clark, E.D. Green, B. 
Hurle, Reproduction and Immunity-Driven Natural Selection in the Human WFDC 
Locus, Mol Biol Evol (2013). 
100 FCUP 
The human whey-acidic-protein Four-Disulfide Core-Domain (WFDC) cluster on 20q13 region: evolutionary 
history and role inhuman health and disease 
 
[24] Y. Koda, H. Tachida, M. Soejima, O. Takenaka, H. Kimura, Ancient origin of the 
null allele se(428) of the human ABO-secretor locus (FUT2), J Mol Evol 50 (2000) 
243-248. 
[25] B.C. Verrelli, S.A. Tishkoff, A.C. Stone, J.W. Touchman, Contrasting histories of 
G6PD molecular evolution and malarial resistance in humans and chimpanzees, 
Molecular Biology and Evolution 23 (2006) 1592-1601. 
[26] M. Fumagalli, M. Sironi, U. Pozzoli, A. Ferrer-Admetlla, L. Pattini, R. Nielsen, 
Signatures of environmental genetic adaptation pinpoint pathogens as the main 
selective pressure through human evolution, PLoS Genetics 7 (2011) e1002355. 
[27] G. Wlasiuk, M.W. Nachman, Adaptation and constraint at Toll-like receptors in 
primates, Molecular Biology and Evolution 27 (2010) 2172-2186. 
[28] L.B. Barreiro, L. Quintana-Murci, From evolutionary genetics to human 
immunology: how selection shapes host defence genes, Nature reviews. Genetics 
11 (2010) 17-30. 
[29] L.Z. Garamszegi, C.L. Nunn, Parasite-mediated evolution of the functional part of 
the MHC in primates, Journal of evolutionary biology 24 (2011) 184-195. 
[30] H. Areal, J. Abrantes, P.J. Esteves, Signatures of positive selection in Toll-like 
receptor (TLR) genes in mammals, BMC evolutionary biology 11 (2011) 368. 
[31] A.K. Azad, W. Sadee, L.S. Schlesinger, Innate immune gene polymorphisms in 
tuberculosis, Infect Immun 80 (2012) 3343-3359. 
[32] B.C. Verrelli, J.H. McDonald, G. Argyropoulos, G. Destro-Bisol, A. Froment, A. 
Drousiotou, G. Lefranc, A.N. Helal, J. Loiselet, S.A. Tishkoff, Evidence for balancing 
selection from nucleotide sequence analyses of human G6PD, Am J Hum Genet 71 
(2002) 1112-1128. 
[33] F. Prugnolle, A. Manica, M. Charpentier, J.F. Guegan, V. Guernier, F. Balloux, 
Pathogen-driven selection and worldwide HLA class I diversity, Curr Biol 15 (2005) 
1022-1027. 
[34] L. Abi-Rached, A.K. Moesta, R. Rajalingam, L.A. Guethlein, P. Parham, Human-
specific evolution and adaptation led to major qualitative differences in the variable 
receptors of human and chimpanzee natural killer cells, PLoS Genetics 6 (2010) 
e1001192. 
[35] A.M. Andres, M.Y. Dennis, W.W. Kretzschmar, J.L. Cannons, S.Q. Lee-Lin, B. 
Hurle, P.L. Schwartzberg, S.H. Williamson, C.D. Bustamante, R. Nielsen, A.G. 
Clark, E.D. Green, Balancing selection maintains a form of ERAP2 that undergoes 
FCUP 
The human whey-acidic-protein Four-Disulfide Core-Domain (WFDC) cluster on 20q13 region: 
evolutionary history and role inhuman health and disease 
101 
 
nonsense-mediated decay and affects antigen presentation, PLoS Genetics 6 
(2010) e1001157. 
[36] W. Ferguson, S. Dvora, R.W. Fikes, A.C. Stone, S. Boissinot, Long-term balancing 
selection at the antiviral gene OAS1 in central African chimpanzees, Molecular 
Biology and Evolution 29 (2012) 1093-1103. 
[37] E.M. Leffler, Z. Gao, S. Pfeifer, L. Ségurel, A. Auton, O. Venn, R. Bowden, R. 
Bontrop, J.D. Wall, G. Sella, P. Donnelly, G. McVean, M. Przeworski, Multiple 
Instances of Ancient Balancing Selection Shared Between Humans and 
Chimpanzees, Science (2013). 
[38] Z. Yang, PAML 4: Phylogenetic Analysis by Maximum Likelihood, Mol Biol Evol 24 
(2007) 1586-1591. 
 
  
102 FCUP 
The human whey-acidic-protein Four-Disulfide Core-Domain (WFDC) cluster on 20q13 region: evolutionary 
history and role inhuman health and disease 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Parameter Estimates and Likelihood Scores under different models. 
 
 
 
 
 
 
  -2Δl Model Comparisons 
 Free Ratio 
vs M0 
M0 vs. M3 M1 vs. M2 M7 vs. M8 
WFDC8 68.4327 254.5853 16.34434 23.76999 
 Parameter Estimates under M8 Positively Selected Sites 
 ω (p1) = 
0.2217 
β (p0) = 0.7783 34R; 45P; 73T; 139E; 156K; 171D; 252E 
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Figure 1: Alignment of WFDC8 in 12 mammalian species. Cysteines are marked in light green. Sites positively selected 
sites with posterior probabilities >0.95 are indicated in red. WAP domains are marked orange, Kunitz domain is marked 
purple and WFDC8 reactive center is highlighted with the red box.  
 
 
 
Figure 2: WFDC8 expression patterns in tissue panel. Lane: MW – Molecular Weigh 1- Bladder; 2- Brain; 3- Colon; 4- 
Heart; 5- Liver; 6- Adipose Tissue; 7- Cervix; 8- Esophagus; 9- Kidney; 10- Lung; 11- Ovary; 12- Prostate; 13- Small 
Intestine; 14- Testis; 15- Placenta; 16- Skeletal Muscle; 17- Spleen; 18- Thymus; 19- Leukocyte 20- Negative Control. 
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Figure 3: WFDC8 allelic expression in testis and ovaries (a) Sanger sequencing of ovaries (above) and testis (below) 
cDNA library; (b)  Pairwise correlation analysis of the mean log2 allelic expression ratios for ovary samples, cDNA 
libraries, and Genomic DNA. Green dots represent 50:50 ratios; red dots represent higer expression of allele 1 (-44A) 
and the black dot the negative control. 
 
Figure 4: Luciferase activity of WFDC8 pGL3[luc]promoter with the two allelic variants -44G and -44A. Luciferase 
activity was measured in 15 replicates. 
a b 
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The study of WFDC and SEMG genes in hominids reveals contrasting 
evolutionary patterns in humans and chimpanzees with potential implications for both 
human health and chimpanzee conservation. A remarkable heterogeneity of 
evolutionary forces acting on these genes was detected. In humans, distinctive signals 
of natural selection were identified in different populations: short-term balancing 
selection in WFDC8 in Europeans; incomplete selective sweep of SPINT4 in Africans; 
and selection on standing variation of SEMG1 in Asians. In chimpanzees, a single 
signal of strong purifying selection was detected in WFDC6 and EPPIN, common to 
three P. trologlodytes subspecies. Overall, the evolution of the WFDC locus in humans 
and chimpanzees is expected to portray the differences in traits of pathogen resistance 
and reproductive biology in hominids. 
 
4.1. Signals of Selection in WFDCs in Humans 
 
Despite the critical contribution of the GWS in the detection of the strongest 
selective signals (hard sweeps) and in the understanding of the genetic basics of 
human adaptations, the current view of the field proposes a significant role of milder 
selective events (soft sweeps and selection on standing variation), as more frequent 
among humans and rarely captured by classical GWS (Pritchard, Pickrell and Coop 
2010; Hernandez, et al. 2011). In recent studies positive selection was predicted to 
have targeted only 0.5% of nonsynonymous substitutions in the last 250,000 years of 
human evolution, positing the arising of adaptive substitutions as rare events. However, 
many of the recent signals of selection in humans are frequently associated with 
expression of quantitative trait loci (eQTLs), which include variants located in functional 
binding motifs of enhancers, promoters and 3’UTR (Hindorff et al., 2009; Lindblad-Toh 
et al., 2011; Vernot et al., 2012; Wang et al., 1995).  
 
Most of the genes identified by the GWS for positive selection are classical 
targets of adaptive responses, such as skin color, lactose metabolism, and malaria 
resistance in which candidate variants exhibited remarkable signals (SLC25A5, LCT 
and HBB) attributable to the combination of strong of selective forces acting at very 
recent times (less than 50.000 years ago) (Bersaglieri, et al. 2004; Coelho, et al. 2005; 
McEvoy, Beleza and Shriver 2006; Kelley and Swanson 2008; Akey 2009). 
Nevertheless, the identification of a selective signal in less characterized genes that 
are not associated with a specific trait or phenotype, may turn the recognition of the 
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underlying mutation into a difficult task. In such instances candidate variants of 
selection may need to be functionally evaluated to address potential correlation 
between genotype and phenotype. Thus in some cases, the candidate genes gain 
support because they lie in functional pathways and in GO categories enriched in 
targets of positive selection, such as spermatogenesis and the immune response 
(Clark and Swanson 2005; Biswas and Akey 2006; Sabeti, et al. 2006; Blekhman, et al. 
2008; Barrett and Hoekstra 2011), just like in the case of the WFDC locus.   
 
The WFDC locus was first identified as a potential target of positive selection in 
humans, in the GWS performed by Voight et al (2006), where various regions were 
identified based on the integrated Haplotype Score (iHS) and HapMap Project data 
(Phase I/II). The genes that were suggested as being under positive selection in the 
GWS were WFDC6 and EPPIN in Europeans, and WFDC10A, WFDC11, WFDC10B, 
WFDC13 and SPINT4 in Africans. However, this positive selection signal was not 
consistently detected in a number of GWS based in other statistics and/or databases. It 
is noteworthy that typically GWS usually report only the top 1% of the empirical 
distributions, which usually correspond to strongest cases of positive selection (hard 
sweeps) (Ronald and Akey 2005; Biswas and Akey 2006; Sabeti, et al. 2006; Sabeti, et 
al. 2007; Barreiro, et al. 2008; Kelley and Swanson 2008; Tennessen, Madeoy and 
Akey 2010). Milder selective signals, such as the ones found in the WFDC region 
within the 1 to 5% range of the empirical distribution may receive less attention 
(Pritchard and Di Rienzo 2010). In addition, GWS for positive selection are based in 
large databases of human variation (HapMap Project, Perlegen, and more recently the 
1000 Genomes Project) which suffer from various degrees of ascertainment bias 
depending on the genotyping methodology used (SNP assignment or low-coverage 
sequencing). Hence potential targets of positive selection found in GWS, especially 
those with milder signal, require a systematic analysis of the candidate regions under 
selection.  
 
The teasing apart of signals of natural selection shaping the genetic diversity at 
the WFDC locus in human populations was performed in two stages: Stage I was a 
sequencing study that validated selective signals proposed by the GWS scan by Voight 
et al (2006); in Stage II a high-throughput targeted sequencing study was performed 
that systematically cataloged the genomic variation across the WFDC locus in three 
human populations. The signatures of selection that were found through GWS for 
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positive selection by Voight et al (2006) were further explored through deep Sanger 
sequencing that allowed for the performance of genetic diversity analyses in the genes 
that showed unusual patterns of diversity (Article 1). This analysis re-centered the 
signal from WFDC6 and EPPIN in Europeans to neighboring gene WFDC8, and in a 
similar fashion, narrowed down the candidate gene in Africa populations to SPINT4. In 
addition, the sequencing effort identified potential candidate variants of selection that 
would have not otherwise been identified using only GWS studies. In stage II, a 
Sanger sequencing strategy was used to systematically catalog all the genomic 
variation in coding regions (and some noncoding) and in a set of neutral evolving 
control regions (47 pseudogenes). The latter were used to define the demographic 
model that better suited the data. To this end, the model by Gutenkunst et al (2009) 
was selected out of a set of 7 different models that were tested. This model estimates 
the Out-of-Africa and European-Asian splits to have occurred 220 kya and 21.2 kya, 
respectively. In addition, this model also assumes a recent expansion of Europeans 
and Asians and migration between these two populations.   
 
 
The most recent demographic scenario for human populations by Gravel et al   
(2011) was also used to assess the significance of outliers under Gutenkunst et al 
(2009). However, the two models are quite similar, and the model by Gravel et al 
(2011) benefits from the data generated by the “1000 Genomes Project”. In the “1000 
Genomes Project” the use of next-generation DNA sequencing technologies in the 
analysis of thousands of samples from different population background allowed for the 
characterization of less frequent and younger genetic variation, which may be more 
informative regarding more recent demographic events. Indeed, an excess of rare 
variants (at a frequency ≤ 0.5%) was detected in the 1000 Genomes dataset which is 
likely to be due to a recent explosive growth of human populations. As mentioned 
previously, over the last 400 generations, the world population has expanded at least 
three orders of magnitude, reaching 7 billion people. Importantly, this excess of rare 
variants may affect the inference of positive selection signals as it implies massive 
departures from population genetics equilibrium potential causing a increment in the 
number of false positives (Jobling, Hurles and Tyler-Smith 2004; Gutenkunst, et al. 
2009; Gravel, et al. 2011; Roberts 2011; Keinan and Clark 2012).  
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Overall these studies demonstrated that most of the WFDC genes evolve 
neutrally, showing standard patterns of genetic diversity. Still, a few exceptions 
demonstrated non-standard genetic diversity levels in both phases of the study: In 
particular, WFDC8 showed to be under recent balancing selection in Europeans; 
SPINT4 is suggested to be under an incomplete selective sweep in Africans; and 
SEMG1 has demonstrated patterns of genetic variation that suggest the action of 
selection on standing variation in Asian populations.  
 
Specifically in Europeans, a newly identified signal arose from WFDC8 that 
presented mixed features like a long range haplotype associated with the -44A variant 
an atypical deep-root tree topology, which was interpreted as a signal of short-term 
balancing selection (Article 1). This signal was unexpected as balancing selection was  
thought to occur infrequently in the human genome. Moreover, it is likely to represent 
one of a few robust signals of balancing selection previously described in the literature. 
(Charlesworth 2006; Andrés, et al. 2009; Fumagalli, et al. 2009). It was hypothesized 
that the candidate variant -44A could potentially down regulate gene expression in the 
male reproductive tract, balancing the proteolytic activity as well as antiinflammatory 
and antibacterial activity. Furthermore, the recent balancing selective signal in 
Europeans surrounding WFDC8 was further confirmed in the high-throughput 
sequencing study (Article 2). Taking into account these results, the signal of recent 
balancing selection in WFDC8, is indeed, the most robust signal of the three identified 
in the WFDC locus, being confirmed with remarkable concordance independently of 
sample scheme in CEU population. The significantly positive Tajima’s D is confirmed 
by all demographic scenarios studied (Sabeti, et al. 2005; Schaffner, et al. 2005; 
Voight, et al. 2005; Gutenkunst, et al. 2009), including the most recent demographic 
model designed by Gravel (2011). Not only was the WFDC8 signal detected by a GWS 
for positive selection and confirmed by both Sanger sequencing efforts, it is also 
supported by the European population panel from the 1000 Genomes Project 
(Appendix 2; Supplementary Table S5).  
 
In Africans SPINT4 showed unusually high values of nucleotide diversity, a 
significant Fay and Wu’s H value, and a haplotype configuration [Ser73+98A] with 
frequencies of 80%. Taken together these data were interpreted as an incomplete 
selective sweep signal. Similarly to the situation of WFDC8, this is a new report 
suggesting selective pressures in this gene (Article 1). The SPINT4 Ser73 replacement 
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leads to a modified Kunitz domain (of reduced inhibitory activity) and 98A maintains an 
active trans-activator binding site, which may increase the innate immunity function 
without compromising the proteolytic features (necessary for fertility) of male secretions 
(Article 1). In addition, despite most WFDC genes being under purifying selection 
(demonstrated by low frequency NSyn variants) the follow-up sequencing study 
suggested Gly73Ser as a variant under positive selection due to elevated population 
frequency and the most elevated FST values in Africans (Article 2). The 1000 Genomes 
Project database, however, does not support the nonneutral evolution of SPINT4 in 
African populations, detected by the GWS (Appendix 2; Supplementary Table S5). 
 
Interestingly, both candidate variants of selection, the -44A allele in WFDC8 and 
[Ser73+98A] in SPINT4 were proposed to confer a selective advantage through a fine 
regulation of their combined activities as serine protease inhibitors, anti-inflammatory, 
and antibacterial molecules. As these genes are not yet characterized, the 
interpretation of these results would benefit from a functional characterization of the 
candidate variants and how it affects not only the expression levels of these proteins 
but also their biological roles.  
 
A number of previous studies have shown that the genes located in the WFDC-
CEN present signals of accelerated evolution in primates and rodents (Jensen-Seaman 
and Li 2003; Kingan, Tatar and Rand 2003; Dorus, et al. 2004; Hurle, et al. 2007; 
Ramm, et al. 2008). SEMGs, PI3, SLPI and WFDC5 showed high dN/dS values, 
demonstrating signals of positive selection in primates (Hurle, et al. 2007), and the 
evolutionary rate of SEMG2 was positively correlated with promiscuity (Dorus, et al. 
2004). Despite these signals that provide evidence of selection, none of the genes 
located at the WFDC-CEN locus displayed low empirical values in the previous GWS, 
most likely because the iHS statistics are designed to capture variants that have not yet 
reached fixation and are associated with long homogeneous haplotypes (Voight, et al. 
2006).  
 
When a high-throughput sequencing study was performed, new evidence 
suggested that SEMG1 was yet another gene that did not fit the standard patterns of 
diversity in Asian populations. This signal had not been previously described and was 
associated with a skew toward low-frequency variants and significant P-values when 
corrected for demography. The selective signal was further supported by haplotype 
112 FCUP 
The human whey-acidic-protein Four-Disulfide Core-Domain (WFDC) cluster on 20q13 region: evolutionary 
history and role inhuman health and disease 
 
based tests (Hudson haplotype test, DIND, and EHH/REHH) centered on the PI3-
SEMG2-SEMG1-SLPI region. In this case, the best candidate variant of positive 
selection was Ser56 (rs2301366) located on the second exon of SEMG1. At the 
functional level, the Thr56Ser change is expected to impact the antimicrobial and 
antiviral activity of N-terminal SEMG1 peptides in both male and female reproductive 
tracts (Robert and Gagnon 1999; Bourgeon, et al. 2004; Edstrom, et al. 2008; Zhao, et 
al. 2008; Martellini, et al. 2009). However, the occurrence of Thr56Ser at an 80% 
frequency in Asians and in other populations at intermediate frequencies, together with 
the fact that SEMG1 was not detected in the GWS of Voight et al (2006), lead to the 
proposal of SEMG1 being an example of a gene under selection on standing variation 
(soft sweep) (Przeworski, Coop and Wall 2005; Pritchard and Di Rienzo 2010; 
Hernandez, et al. 2011). Conversely, the SEMG1 signal in Asians presents a 
significantly low Tajima’s D in the 1000 Genomes Project database, even when sample 
size was increased (Appendix 2; Supplementary Table S5). 
 
Importantly, selection on standing variation may underlie SEMG1 and SPINT4 
signals which, depending on the value of frequency of the advantageous variant at the 
time of the selective event, can lead to a large variance in allele frequency spectra and 
in haplotype patterns leading to confounding and complex selective signals. Such 
results are in agreement with the reported findings of soft sweeps being more common 
in humans. However these signals are still largely undetected when using the classical 
statistical methods and require a candidate gene centered approach, as complex 
pleiotropic selective signals are hardly captured by classical GWS (Pritchard and Di 
Rienzo 2010; Pritchard, Pickrell and Coop 2010; Hernandez, et al. 2011).   
 
The 1000 Genomes Project made publicly available a significant amount of 
samples that represent 21 human populations to a total of 1092 low coverage genomes 
and exome sequences with 50x coverage. Even though they do not yet completely 
replace deeper coverage and high-quality Sanger sequencing studies, this data can be 
of great use to survey the genomic diversity of human populations, to find potential 
outliers and to select a subsample dataset that could be sequenced and analyzed to 
confirm results. The 1000 Genomes Project database underrepresents low-frequency 
variants in the low coverage regions, which could be a disadvantage when trying to 
detect signals of positive selection. A signature of selection that modifies the site 
frequency spectrum (for example, resulting in an increase of singletons and 
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doubletons) would likely remain undetected if only relying on the genetic variability 
available in this database. Nonetheless, the coherence of two of the three uncovered 
signals through high-throughput Sanger sequencing combined with the 1000 Genomes 
database further highlights that WFDC8 and SEMG1 are genes evolving under non-
neutral pressures. 
 
WFDC selective signals suggest heterogeneous responses to geographical 
environmental changes with very population specific signals that can hypothetically be 
correlated with the large heterogeneity of pathogenic agents and infectious burden 
across the globe (Novembre and Di Rienzo 2009; Fumagalli, et al. 2011; Hancock, et 
al. 2011). However, only future studies with more detailed information about pathogen 
diversity combined with a detailed study of antimicrobial properties of candidate 
variants may grasp the environment-gene interaction that has shaped WFDC8, SEMG1 
and SPINT4. Besides, other unknown biological function(s) of the WFDC genes cannot 
be discarded as selective driven forces of WFDCs, like for instance, a regulation of 
proteolysis in the reproductive track or in other tissues. 
 
On the other hand, additional relevant information can be obtained from the 
WFDC genetic variation in ethnically diverse populations to address the extent and the 
strength of selective pressures acting in this locus. Various studies argue that biological 
mechanisms underlying a given adaptive phenotype may vary across populations, 
resulting from the same or different variants. For example, mutations at the FUT2 gene 
differ among Eurasian and African populations, demonstrating a complex picture which 
points toward natural selection and its different actions stratified according to 
geography (Ferrer-Admetlla, et al. 2009). Similarly, in the G6PD gene a different 
variant from the one observed in Africans is found in Southeast Asians, reducing 
Plasmodium vivax but not P. falciparum infection and indicating the first malaria 
pathogen as the major driving force behind the strong selective signal for G6PD in 
Southeast Asians (Louicharoen, et al. 2009; Hedrick 2011). In addition, the newly 
available genome datasets representing various populations have revived interest in 
the study of geographic correlations between allele frequencies and environmental 
variables. Various studies suggest that genes that are potential susceptibility loci in 
common human diseases have marked inter-ethnic differences in prevalence. An 
example is the correlation of AGT and CYP3A variants with the higher prevalence of 
hypertension, and in particular salt-sensitive hypertension, in African Americans 
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compared with European Americans, reflecting adaptations to hot equatorial climates in 
ancestral African populations (Thompson, et al. 2004; Coop, et al. 2009; Novembre 
and Di Rienzo 2009). 
 
 Overall, a deeper understanding of the evolutionary processes that generate 
genetic differences between populations, and an improved knowledge on how natural 
selection affects the different human populations will hopefully provide spatial patterns 
of genetic variation and help to determine better ways to prevent diseases in a 
particular human population. 
 
4.2 Signals of Selection of WFDCs in Chimpanzees 
 
To better describe the evolution of WFDCs and characterize the extent of 
genetic diversity shared within and between hominoids, a systematic comparative 
genomics and population genetics analysis was performed utilizing high-throughput 
sequencing. The WFDC locus and the same 47 control regions were Sanger 
sequenced in three chimpanzee subspecies (P. t. troglodytes, P. t. verus and P. t. 
ellioti) and were contrasted in terms of polymorphism and genetic variation. In addition 
to studying the genetic variability in WFDC genes, the description of the subspecies of 
the sequenced individuals was also of interest.  
 
The common chimpanzee, Pan troglodytes, and bonobos, P. paniscus, are two 
different species currently habiting in West and Central Africa, separated by the 
geographical barrier of the Congo River (Figure 7). Common chimpanzees are further 
divided into four subspecies: P. t. verus, located in western Africa and occupying the 
Upper Guinea region; P. t. troglodytes extending throughout central Africa; P. t. 
schweinfurthii living in eastern Africa; and P. t. ellioti, that occurs in the Gulf of Guinea 
(Nigeria and Cameroon) in a region limited by the Niger and Sanaga rivers (Figure 7).  
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Figure 7: Geographic distribution of Pan troglodytes and P. paniscus in Africa (adapted from Gonder et al. 
2011). 
 
Although the demographic history of chimpanzees is described in less detail 
than humans, several studies support an elevated effective population size for P. 
troglodytes around 0.50 million years ago. Furthermore, P. t. verus is known to share a 
common ancestor with the remaining subspecies approximately 0.46 mya, and P. t. 
troglodytes and P. t. schweinfurthii to have diverged 0.10 mya. P. t. ellioti was 
proposed to have separated around 0.32 mya.  At the genetic level P. t. verus shows 
the most striking differences between subspecies; P. t. verus are currently isolated 
from other chimpanzees and undergone strong population bottlenecks, which had 
eliminated most of the pre-existing diversity of this subspecies. Consequently, 
nucleotide diversity in these western chimpanzees reached low levels such as that 
described for humans. Furthermore, hybridization seems to occur occasionally in the 
wild between P. t. ellioti and P. t. troglodytes, although they are thought to be 
genetically isolated from each other (Gonder, Disotell and Oates 2006; Stone, et al. 
2010; Gonder, et al. 2011; Bowden, et al. 2012). 
 
Accordingly, when the WFDC region was analyzed there was a need to 
circumvent the lack of demographic information regarding the three subspecies 
sampled (Article 3). To that end, the control regions (neutrally evolving regions) were 
used in an attempt to describe the genetic variation in these three populations and to 
the state of knowledge on the differentiation of P. t. ellioti. In contrast to other studies, 
the results shown were not conclusive when considering P. t. ellioti as a genetically 
isolated subspecies. Previous studies have used the same set of individuals, but it 
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appears that the markers used here are not sufficient to discriminate the two closely 
related subspecies (P. t. ellioti and P. t. troglodytes), even with the addition of markers 
from the WFDC locus to a total of 1268 SNP markers. This finding suggests that the 
markers used in this study are not the recommended type to determine population 
structure and differentiation. Most of the studies that successfully describe P. t. ellioti 
as a separate subspecies used markers with high mutation rates (mtDNA and 
microsatellites), which contain more information about genetic diversity between 
populations (Gonder, et al. 2011; Bowden, et al. 2012). Moreover, when using 
autosomal SNP markers such as the ones in this study, additional markers should be 
genotyped and further confirmation of individual relationship with mtDNA should be 
undertaken (Bowden, et al. 2012).  
 
Despite the aforementioned results, the empirical distribution built from the 
control regions did lead to the discovery of a signature of selection in WFDC6 and 
EPPIN in P. t. troglodytes: two paralog WFDC genes under purifying selection. The 
negative Tajima’s D values obtained for these two genes were compared with the lower 
percentile of empirical distribution built with neutral regions. Coalescent simulations 
corrected for demography of P. t. troglodytes also supported a significant result for 
WFDC6 but not for EPPIN. In the case of WFDC6, strong purifying selection seems the 
most probable basis for the departure of neutrality. This hypothesis is sustained by the 
low levels of population differentiation present in all sampled subspecies and the 
absence of a reliable candidate variant of positive selection. Additionally, the dN/dS 
ratios of WFDC6 and EPPIN (71% similarity) suggest a rapid evolution of WFDC6 after 
gene duplication, followed by a period of strong functional constraints. Both WFDC6 
and EPPIN present evidence of purifying selection, potentially due to their roles in 
reproduction and immunity in primates.  
 
WFDC6 and EPPIN are recent parologs which share the same WAP and Kunitz 
domains, and conserved most of the disulfide bridges crucial to the maintenance of 
WFDC three dimensional structures, antimicrobial and antiviral activities, immunity, and 
tumorogenic features. However, WFDC6 diverges from EPPIN in the composition of 
the amino acid located at the reactive site, with several substitutions pointing to a 
probable loss of PSA inhibitory activity. Due to chimpanzees’ multimale/multifemale 
mating systems and promiscuity, they are more likely to be exposed to sexually 
transmitted pathogens in which the conservation of an additional antimicrobial protein, 
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like WFDC6, would be advantageous. Disease transmission during mating provides a 
connection between reproduction and immunity, where sexually transmitted diseases 
can affect fitness of individuals by imposing different selective pressures on their hosts. 
Hence, the pseudogenization of WFDC6 observed in other primate species 
(orangutans and baboons) may be correlated with a lower pathogen load in unimale 
mating systems or through different immunological mechanisms linked to non-WFDC 
genes. 
 
Consistent with the evolution of WFDC6, other genes involved in reproduction 
have been correlated with multimale/multifemale mating systems and female 
promiscuity. This is the case in SEMG2, which was found to have undergone an 
accelerated evolution in chimpanzees. However, no evidence of selection was detected 
at the intraspecific level for SEMG2 (Article 3). This result suggests that event of 
positive selection in SEMG2 is ancestral to chimpanzee diversification and it is only 
measurable through multispecies comparisons.  
 
In the particular case of chimpanzees, it is possible that the large effective 
population size caused the identification of recent selective events to be more difficult. 
In fact, the evidence for recent positive selection in chimpanzee populations is reduced 
to a few examples that could alternatively be explained by the low awareness of the 
evolutionary forces affecting the site frequency spectrum in chimpanzees. Only recently 
have efforts been made to generate large genetic variation data that may allow further 
developments in this field of research (Wegmann and Excoffier 2010; Hai Yang Hu1. 
and Liang3 2011; Hobolth, et al. 2011; Auton, et al. 2012; Bowden, et al. 2012; Scally, 
et al. 2012). Here, the public database PanMap may have an important contribution as 
it allowed for completion of the first chimpanzee recombination map [PanMap; (Auton, 
et al. 2012)]. However, PanMap relies only on P. t. verus data, which is the most 
homogeneous chimpanzee subspecies.  
 
Not surprisingly, the evolution of other genes involved in reproduction has been 
correlated with multimale/multifemale mating systems and promiscuity such as 
SEMG2, which is under rapid evolution in chimpanzees. However, this signal is an 
older positive selection event that was detected by multispecies comparisons but, it 
was not consistent at the intraspecific level in SEMG2 (Article 3). The evolutionary 
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study of the WFDC genes would have benefited from a deeper understanding of how 
the chimpanzee genome and populations evolved until the present date.  
 
4.3 WFDCs in Hominids 
 
Even though humans and chimpanzees are two closely related species, their 
mating systems and immune responses are highly diverged. Humans occupy most 
geographical areas of the world and thus, are exposed to a wide range of different 
environments and consequently, are subjected to very different selective pressures. 
Accordingly, the WFDC genes appear to have been targeted by more recent selective 
events in humans than chimpanzees, which might be correlated with human migrations 
to different geographical regions. In humans, the signals of positive selection are 
population specific, centered in WFDC8, SPINT4 and SEMG1, in Europeans, Africans, 
and Asians respectively (Article 1 and 2). Conversely, in chimpanzees which have 
been confined to the African tropical area, the signal of purifying selection in WFDC6 is 
likely to affect the entire species equally (Article 3).  
 
The heterogeneity of selective signals observed among WFDC genes in 
humans suggests the occurrence of multiple adaptive hits in different environments, 
possibly correlated with the presence or absence of different pathogens per 
geographical region (Prugnolle, et al. 2005; Balaresque, Ballereau and Jobling 2007; 
Bhushan, et al. 2009; Fumagalli, et al. 2009; Wlasiuk and Nachman 2010a; Fumagalli, 
et al. 2011; Seixas, et al. 2011). On the other hand, chimpanzees seem to conserve 
WFDC6 and EPPIN, in order to potentially target a larger spectrum of proteases and to 
increase antimicrobial potential in a possible response to the selective pressures 
caused by STDs (Chimpanzee Sequencing and Analysis Consortium 2005). Previous 
studies have demonstrated the direct correlation between indicators of 
immunocompetence (such as increased levels of leukocytes) and proxies of female 
sexual promiscuity among primates with different mating systems, however no 
correlation with other social and ecological variables was reported (Nunn, Gittleman 
and Antonovics 2000; Nunn 2002b, 2002a; Nunn, et al. 2003; Holmes 2004; Wlasiuk 
and Nachman 2010a, 2010b; Garamszegi and Nunn 2011). This further emphasizes 
that promiscuous species like chimpanzees, as opposed to humans, are more exposed 
to STDs, which has induced a greater investment in genes enrolled in immune 
response (Wlasiuk and Nachman 2010a, 2010b). Biologically, the absence of 
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replication in the signals between humans and chimpanzees suggests major selective 
forces to be driven by different exposures to pathogens.  
 
Due to the intimate relationship between evolutionary rates of SEMGs, the 
signals of SEMGs and WFDCs in humans and chimpanzees were found to be 
uncorrelated. The SEMGs have an active role in reproductive biology and are thought 
to be under non-neutral evolution, nevertheless SEMGs behave differently in humans 
than in chimpanzees. SEMG1 which shows a signal of recent selection in Asians 
associated with an NSyn variant (Ser56); has been shown in primates to be under 
rapid evolution, partially due to a rapid expansion of a repetitive stretch which enables 
the crosslinking of SEMG proteins in the semen coagulum (Jensen-Seaman and Li 
2003; Kingan, Tatar and Rand 2003; Jobling, Hurles and Tyler-Smith 2004; Carnahan 
and Jensen-Seaman 2008; Ramm, et al. 2008). However, the evolutionary rate of 
SEMG1 does not seem to be correlated with promiscuity levels in primates (Hurle, et 
al. 2007). Conversely, SEMG2 has demonstrated signals of adaptive evolution in 
primates by demonstrating a correlation between NSyn substitutions and the mean of 
male partners per periovulatory period of a female (Dorus, et al. 2004). The evolution of 
SEMG2 is accelerated in polyandrous primates relative to monandrous primates, 
showcasing the intimate relationship between sexual selection and the molecular 
evolution of reproductive genes. Despite the evidence for selection targeting WFDC 
and SEMGs genes due to their roles in reproduction and host-pathogen interaction, the 
genes under selection in humans and chimpanzees do not overlap. SEMG1 is the only 
exception, even though the selective forces driving the evolution of this gene are not 
the same. In chimpanzees, SEMG1 evolution appears to be driven by its role in post 
copulatory selection in order to thicken the semen coagulum through increased 
crosslinking events, even though dN/dS ratios do not support this observation (de 
Lamirande, et al. 2001; Jensen-Seaman and Li 2003; Kingan, Tatar and Rand 2003; de 
Lamirande 2007; Malm, et al. 2007). Conversely, in humans, the SEMG1 signal of 
selection is probably due to host-pathogen interactions in the reproductive tract in 
Asian populations.  
 
Around 5.4 million years ago humans and chimpanzees started to diverge 
(Patterson, et al. 2006), which subjected them to various environment changes and 
population history leaving signatures of their evolutionary history at the genomic level. 
In general, chimpanzees exhibit higher levels of differentiation between subspecies due 
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to their large effective size, than humans between populations. The only exceptions to 
this global pattern are WFDC6 and EPPIN which, due to strong purifying selection in 
chimpanzees, present nucleotide diversity levels in the same order of magnitude as 
that observed in humans.  
 
The extension of LD blocks in the WFDC locus largely differs between humans 
and chimpanzees and while in humans varies from 10 kb to 100 kb, on average; in 
chimpanzee LD blocks are nearly absent or encompass a few kb. Again, this could be 
due to a higher effective population size of chimpanzees and to the fact that 
recombination hotspots are not shared between these two species (Ptak, et al. 2005; 
Fledel-Alon, et al. 2009; Baudat, et al. 2010; Fledel-Alon, et al. 2011; Segurel, Leffler 
and Przeworski 2011). Even though the recombination rates among humans and 
chimpanzees do not significantly differ, haplotype blocks in chimpanzees are not 
localized in the same regions and the nucleotide diversity levels are a significantly 
higher in chimpanzees (Ptak, et al. 2004; Ptak, Voelpel and Przeworski 2004; Frazer, 
et al. 2007; Auton, et al. 2012). In fact, this may have had an impact on the detection of 
signals of positive selection in chimpanzees. The higher nucleotide diversity and lack of 
long homogeneous haplotypes may have influenced the ability to detect recent 
selective sweeps as most of the statistical tests and background evolutionary history 
are human centric.  
 
4.4 Biological relevance of genes under selection 
 
Most of the WFDC genes with known biological functions have combined 
activities in immunity and reproduction. For cases like WFDC8, to which no specific 
biological function has been attributed, it is important to follow up on the biological 
significance of candidate genes. A number of GWS for positive selection and Genome-
Wide Association Studies (GWAS) have pinpointed candidate genes and genomic 
regions for future study, which include genetic factors affecting insulin resistance, 
cancer susceptibility, immunity disorders and others. However, these studies only 
nominate candidates, and it takes biological insight and studies of molecular pathways 
to learn how they affect human health. Even for genes with well described roles and 
recognized molecular pathways, it remains hard to predict the effects of common 
variants (Dermitzakis and Clark 2009). With the release of the 1000 Genomes Project 
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and the efforts to accurately characterize copy number variation, the methodology for 
identifying genetic differences between cases and controls is heading toward a golden 
opportunity for making substantial progress in unraveling disease susceptibility and 
advancing a deeper understanding of the biological significance of genetic variation 
(Tillier and Charlebois 2009; The 1000 Genomes Project Consortium 2010; Mills, et al. 
2011). Despite the current release of data for even rarer variants in very large and well-
designed cohort samples, functional characterization of candidate genes should be 
persued to better understand the effects of individual genes in tissue orientated 
networks. 
 
One of the main motivations of this comprehensive study of the WFDC locus 
was to prioritize the most interesting genes and genetic variants for biological 
characterization to test the biological impact of the candidate genes under positive 
selection. Preliminary characterization was focused on WFDC8, as this gene 
demonstrated a very robust and unexpected balancing selection signal that was very 
striking even when compared with other genes under balancing selection in the 
literature (Charlesworth 2006; Andrés, et al. 2009; Fumagalli, et al. 2009; Andrés, et al. 
2010). In addition, the location of the candidate variant -44A in a putative regulatory 
element made the experimental design relatively straight forward using a luciferase 
reporter assay. In addition, by undertaking molecular biology and expression assays in 
vivo the potential consequences of the selective signal found in European populations 
were assessed.  
 
WFDC8 was shown to display a signature of balancing selection in Europeans 
associated with a -44(G/A) polymorphism (rs7273669), located in the 5’ region of 
WFDC8, which was predicted to alter gene expression by abolishing the binding site of 
two transcription factors (Article 1 and 2). In a recent study, the rat homolog, Wfdc8 
was characterized and identified as an androgen dependent gene induced by LPS, and 
at the protein level, Wfdc8 was found to display a potent antibacterial activity (Rajesh, 
Madhubabu and Yenugu 2011). Furthermore,  comparative analysis of orthologs in 
twelve mammalian lineages, demonstrates that WFDC8 preserves from rodents to 
humans three WAP and one Kunitz domains, which are expected to combine 
antimicrobial and antiprotease properties (Bingle and Vyakarnam 2008). However, 
some residues are likely to have been targeted by positive selection, as is the case of 
E139, located in the reactive center of the Kunitz domain, which might have evolved 
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faster in WFDC8 to counteract the activity of different proteases. Conversely, the 
maintenance of the 15 disulfide bridges in WFDC8 indicates a possible conservation of 
antimicrobial function in most mammals. 
 
To determine the effect of the candidate variant -44(G/A), a series of expression 
assays were performed. Although the antimicrobial or anti-protease properties of 
WFDC8 were not confirmed, its expression was found to be higher in testis and lower 
in ovaries, bladder, and brain tissues in a panel of 19 tissues tested. Moreover, the 
effect of the candidate variant -44G/A in WFDC8 expression was also investigated in 
vivo, by the genotyping of a surrogate marker in complete LD with -44(G/A) and in vitro 
by performing luciferase expression assays in two different cell lines. Preliminary 
results gathered from in vivo and in vitro experiments were not consistent: Specifically, 
while the in vivo assays carried out in ovaries suggest a threefold expression increase 
of the -44A allele, in vitro results suggest -44A increased expression in HeLa but not in 
Caco-2 cell lines. 
 
The effect of -44G/A polymorphism in WFDC8 expression appears to depend 
on the cellular context and thus balancing selection may be acting to a fine tuned 
regulation of gene expression, in which being a heterozygous may be advantageous. 
Importantly, WFDC8 protein was already identified in semen (Batruch, et al. 2011; 
Kagedan, et al. 2012) and the loss of its gene expression was associated with a fertility 
impairment after vas deferent renamastosis (Batruch, et al. 2011) and in Hutterite 
populations WFDC8 appears to be associated with transmission distortion (Meyer, et 
al. 2012).  
 
The identification of disease genes and variants is not meaningful unless 
biological processes leading to a phenotype are followed up by a deep functional 
characterization. Furthermore, biological processes underlying a disease phenotype 
may vary among tissues, where different molecular backgrounds can impact the 
resulting cellular outcome, as demonstrated by the different effect of the WFDC8 
candidate variant in two different cell lines. Therefore, inference of gene regulatory 
networks and biological context are imperative to make better educated guesses on 
candidate genes studies.  
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4.5 Implications in Human health 
 
Most of the genes in the WFDC locus have not been associated with 
repercussions in human health, but a few studies regarding these genes have pointed 
out potential deleterious effects of common variants in fertility and disease 
susceptibility. For instance, in vivo, eppin-semenogelin binding is a critical step in the 
removal of semenogelin during semen liquefaction, making eppin a target for male 
contraception (O'Rand, et al. 2009). Other studies have examined the effect of anti-
eppin antibodies in fertile male monkeys and the effect of recombinant human 
semenogelin on human sperm motility. In human semen, anti-eppin antibodies 
significantly decreased the progressive motility of spermatozoa by decreasing total 
distance traveled, straight-line distance, and velocity (Richardson, et al. 2001; O'Rand, 
et al. 2004; Wang, et al. 2007a; O'Rand, et al. 2011; O’Rand, et al. 2011; O'Rand and 
Widgren 2012).  
 
In a study of human male infertility centered in EPPIN, two variants were 
associated with different male infertility phenotypes. The variant rs2231829 located 5’ 
of the EPPIN transcription start was associated with a significant decreased risk of 
idiopathic infertility, and the variant rs11594 located in EPPIN’s fourth exon was 
associated with an increased risk of idiopathic infertility and abnormal semen 
parameters (Ding, et al. 2010). Conversely, mass spectrometry studies have identified 
SEMG2 as one of the few proteins with differences in semen protein profiles of fertile 
and infertile men; where SEMG2 was nearly absent in the semen of infertile men 
(Thacker, et al. 2011). In addition, seminal plasma motility inhibitors (SPMIs) resulting 
from the proteolytic cleavage of SEMG1 and SEMG2, are thought to be correlated with 
sperm motility, as they appear to remain on the surface of sperm after liquefaction. This 
might account for some disorders of sperm motility observed in infertile men with 
asthenozoospermia (Terai, et al. 2010).  
 
EPPIN and SEMGs implications for human health are not restricted to infertility. 
The effects of SEMGs overexpression on prostate cancer and cell proliferation suggest 
that they can be used in the prognosis of cancer progression after radical 
prostatectomy (Canacci, et al. 2011). Secreted SEMG1, SEMG2, and EPPIN were all 
significantly lower in carcinoma patients than in individuals with benign or prostatic 
intraepithelial neoplasia (Izumi, Zheng and Miyamoto 2011; Izumi, et al. 2012). 
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However, the biological significance of SEMGs overexpression in prostate cancer still 
remains to be fully developed (Canacci, et al. 2011). Furthermore, EPPIN protein 
complex components in sperm cells including SEMG1, one isoform of CLU, and two 
isoforms of LTF, were found to be enhanced in type-1 and type-2 diabetic individuals. 
The correlation is not yet deeply understood, but it could possibly results from a 
response to enduring hyperglycemia and enhanced oxidative stress (Paasch, et al. 
2011).  
 
Semen is known to be the main vehicle of transmission of the HIV virus, with 
most of the studies showing that SEMG1-derived peptides have a protective anti-HIV 
activity (Martellini, et al. 2009). One recent study has, however, questioned the anti-HIV  
properties of cationic peptides resulting from the SEMG1 and SEMG2 cleavage, in 
which a subset of SEMG-derived fragments appear to greatly enhance HIV infection 
(Roan, et al. 2011). On the other hand, the antiviral activity of SEMG peptides was 
demonstrated by one peptide fragment of SEMG1 that was purified from seminal 
plasma. The peptide showed a transient anti-HIV activity that, after prolonged exposure 
to proteases was degraded, losing their antiviral activity (Martellini, et al. 2009). In 
contrast to semen samples from healthy individuals that greatly enhance HIV infection, 
SEMGs-deficient semen samples from patients with ejaculatory duct obstruction do not 
present enhanced HIV activity (Roan, et al. 2011). In lieu of these controversial 
observations, the role of SEMG-derived peptides in immune response require 
additional clarification and the characterization of the Thr56Ser variant, associated with 
a selection signal, should also be pursued. 
 
 
The examples of SEMGs and EPPIN implications in human health are valuable 
approximations for the roles of genes under selection such as WFDC8 and SPINT4 in 
infertility, immune response and even complex disorders like diabetes. The importance 
of following up and determining the biological significance of candidate genes under 
selection cannot be minimized in the quest to describe the pathways they are involved 
in, and the repercussions of these genes in disease susceptibility.  
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This work lends support to the notion that genes related to host-pathogen 
interactions and reproductive biology, such as the WFDC genes, are usual targets of 
natural selection. 
 
It highlights and elucidates signals of natural selection that have shaped 
the genetic diversity at the WFDC locus in human populations. Three different 
WFDC genes are evolving under selection in three different human populations, 
suggesting these genes are under different selective pressures and are responding to 
different pathogen loads in various geographic areas (Article 1 and Article 2). These 
signals are as follows: 
 
A signal of recent balancing selection centered in WFDC8 in Europeans and 
associated to the variant -44(G/A) in the 5’ gene region, was newly identified and 
demonstrated to be the most robust signal as it was detected in Stage I and II of 
the sequencing studies and further confirmed in the 1000 Genomes Project 
database. 
 
In African populations, an incomplete selective sweep signal was discovered 
around SPINT4, where the haplotypic configuration Ser73+98A were determined 
to be the most probable candidate variants. 
 
In Asian populations, a new signal of selection around SEMG1 was detected in 
Stage II. SEMG1 appears to be under selection on standing variation, where a 
pre-existing variant Thr56Ser reached high frequency. In addition, this signal was 
confirmed in the 1000 Genomes Project database. 
 
This study highlights that genome-wide scans for natural selection are indeed 
designed to detect mostly hard sweeps. In the wider context, it confirms that soft 
sweeps and polygenic adaptation, which may actually be more common than classical 
selective sweeps, are possibly being missed by GWS studies.  
 
This work also demonstrates that the genetic diversity levels at the WFDC 
locus within and between hominids are divergent. No overlap in selective 
footprints was detected at the WFDC locus between humans and chimpanzees 
(Article 3). 
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A plausible hypothesis is that the gene WFDC6, a paralog of EPPIN, may have 
evolved in order to provide additional response to pathogen infections and is being 
maintained divergent from EPPIN by purifying selection. Given that chimpanzees are a 
promiscuous species, a possibility is that they are subjected to more sexually 
transmitted diseases where the rapid evolution of WFDC6 may be a response to such 
selective pressure.  
 
Furthermore, the characterization of the demographic history of the sampled 
chimpanzee subspecies (P. t. troglodytes, P. t. ellioti and P. t. verus) by using high 
quality sequence data and approximately one thousand markers was unsuccessful. 
The choice of the genetic markers is an important aspect in studies of demographic 
history and different markers with higher mutation rates should be added in future 
research to help reach this goal. 
 
It provides preliminary results on the biological impact of one of the 
candidate genes, WFDC8, under recent balancing selection. The balancing 
selection signal of WFDC8 was confirmed in multiple ways, and the additional variation 
of this gene may provide a more timely response to environmental and cellular 
background changes (Article 4). Highly conserved in 12 mammalian species, WFDC8 
probably maintains its antimicrobial role, as its rat homolog does. Although preliminary 
in vitro and in vivo studies suggest a functional impact of the candidate variant -44A in 
the expression and regulation of WFDC8, an improved experimental design will be 
needed to clarify this issue. 
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Supplementary Tables 
Supplementary Table S1: HapMap Phase II individuals (Coriell repository) selected for the re-sequencing and 
genotyping studies. Samples that were typed for the SNP rs7273669 using the BseRI restriction enzyme assay (but not 
re-sequenced) are indicated by an asterisk (*). 
 
Population Individuals 
CEU NA6985, NA12751, NA12875, NA12003, NA12006, NA12156, NA11994, NA12057, 
NA12248, NA11993, NA07056, NA06994, NA07022, NA07000, NA12155, NA12144, 
NA12004, NA12005, NA11881, NA11831, NA12056, NA12145, NA12249, NA06993,* 
NA07034,* NA07055,* NA07345,* NA07357,* NA11829,* NA11830,* 6a14,*16,* 
NA11832,* NA11839,* NA11840,* NA11882,* NA11992,* NA11995,* 13a27,*28,* 
NA12043,* NA12044,* NA12146,* NA12154,* NA12234,* NA12236,* NA12239,* 
NA12264,* NA12716,* NA12717,* NA12750,* NA12760,* NA12761,* NA12762,* 
NA12763,* NA12812,* NA12813,* NA12814,* NA12815,* NA12872,* NA12873,* 
NA12874,* NA18501,* NA18502,* NA18504,* NA18505,* NA18508,* NA18516,* 
NA18522,* NA18852,* NA18855,* NA18858,* NA18859,* NA18862,* NA18871,* 
NA18912,* NA19099,* NA19101,* NA19127,* NA19128,* NA19137,* NA19140,* 
NA19159,* NA19238,* NA12891,* NA12892* 
Yoruba NA_18501, NA_18502, NA_18504, NA_18505, NA_18508, NA_18516, NA_18522, 
NA_18852, NA_18855, NA_18858, NA_18859, NA_18862, NA_18871, NA_18912, 
NA_19099, NA_19101, NA_19127, NA_19128, NA_19137, NA_19140, NA_19159, 
NA_19238, NA18507*, NA18517*, NA18523*, NA18853*, NA18856*, NA18861*, 
NA18870*, NA18913*, NA19092*, NA19093*, NA19098*, NA19102*, NA19116*, 
NA19119*, NA19130*, NA19131*, NA19138*, NA19141*, NA19143*, NA19144*, 
NA19152*, NA19153*, NA19238*, NA19160*, NA19171*, NA19172*, NA19192*, 
NA19193*, NA19200*, NA19201*, NA19203*, NA19204*, NA19206*, NA19207*, 
NA19209*, NA19210*, NA19222*, NA19223*, NA19238*, NA19239 
JPT+CHB NA_18576*, NA_18943*, NA_19000*, NA_18978*, NA_18940*, NA_18635*, 
NA_18620*, NA_18572*, NA_18992*, NA_18563*, NA_18573*, NA_18545*, 
NA_18594*, CD18609*, NA_18577*, NA_18566*, NA_18948*, NA_18555*, 
NA_18529*, NA_18582*, NA_18532*, NA_18524*, NA_18998*, NA_18636*, 
NA_18633*, NA_18611*, NA_18997*, NA_18593*, NA_18552*, NA_18947*, 
NA_18999*, NA_18990*, NA_18980*, NA_18637*, NA_18561*, NA_18558*, 
NA_18537*, NA_19007*, NA_18991*, NA_18579*, NA_18967*, NA_18969*, 
NA_19012*, NA_19003*, NA_18987*, NA_18975*, NA_18956*, NA_18571*, 
NA_18976*, NA_19005*, NA_18961*, NA_18949*, NA_18562*, NA_18592*, 
NA_18951*, NA_18942*, NA_18995*, NA_18964*, NA_18959*, NA_18603*, 
NA_18953*, NA_18526*, NA_18547*, NA_18540*, NA_18994*, NA_18974*, 
NA_18550*, NA_18968*, NA_18944*, NA_18966*, NA_18972*, NA_18970*, 
NA_18960*, NA_18965*, NA_18632*, NA_18624*, NA_18612*, NA_18608*, 
NA_18605*, NA_18945*, NA_18981*, NA_18973*, NA_18952*, NA_18622*, 
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NA_18542*, NA_18623*, NA_18621*, NA_18570*, NA_18564* 
Supplementary Figures 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure S1: Sliding windows of diversity for HapMap Phase II haplotypes. “A” and “B” correspond to the 
200 kb cluster region centered on EPPIN for CEU and C and D to the 200 kb cluster region centered on SPINT4 for 
YRI. The window length used was 20 SNPs with a step size of 5 SNPs. The window midpoint is indicated in x-axis. 
WFDC8 extends from 145 to 224 SNPs and SPINT4 from 63 to 71 SNPs.  - genetic diversity; S- number of variable 
SNPs.   
 
 
Supplementary Figure S2: Empirical distributions of Tajima’s D and  built using the 316 genes surveyed by 
SeattleSNPs (http://pga.gs.washington.edu/. Genes within the upper extreme of the distribution are marked in grey. 
Gene classes with values close to survey genes are indicated by WFDC gene name. A and B: CEU samples – 
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SeattleSNPs panels 1 to 3. C and D: YRI sample –  SeattleSNPs panel 2. E and F: African-American (AA) descent 
samples – SeattleSNPs panels 1 to 3.  
 
 
 
 
 
 
 
 
Supplementary Figure S3:  Gene genealogy tree of WFDC6 and EPPIN as estimated by Genetree. Time is scaled in 
millions of years (MY). 
 
Supplementary Figure S4: Gene genealogy trees as estimated by Genetree for SPINT4 branch corresponding to 
Ser73+98A haplotype. Tree calculated assuming no selection (A). Tree calculated assuming the maximum 
likelihood of the 
WFDC6
CEU population
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Supplementary Tables 
 
Supplementary Table S1: Regions of the genome sequenced. 
 
Chr 20 coordinates* Gene 
WFDC-CEN 
43,171,507-43,177,217 WFDC5 (WAP four-disulfide core domain 5) 
43,185,481-43,186,520 WFDC12 (WAP four-disulfide core domain 12) 
43,236,912-43,238,599 PI3 (elafin) 
43,269,088-43,271,823 SEMG1 (semenogelin 1) 
43,269,088-43,286,513 SEMG2 (semenogelin 2) 
43,314,293-43,316,620 SLPI (secretory leukocyte peptidase inhibitor) 
WFDC-TEL 
43,541,899-43,543,586 WFDC2 (WAP four-disulfide core domain 2) 
43,574,515-43,577,678 SPINT3 
43,596,250-43,601,548 WFDC6 (WAP four-disulfide core domain 6) 
43,602,679-43,609,442 SPINLW1 (WAP four-disulfide core domain 7) 
43,613,815-43,641,379 WFDC8 (WAP four-disulfide core domain 8) 
43,669,992-43,693,321 WFDC9 (WAP four-disulfide core domain 9) 
43,691,799-43,693,245 WFDC10a (WAP four-disulfide core domain 10a) 
43,710,616-43,732,292 WFDC11 (WAP four-disulfide core domain 11) 
43,746,704-43,767,072 WFDC10b (WAP four-disulfide core domain 10b) 
43,764,069-43,770,870 WFDC13 (WAP four-disulfide core domain 13) 
43,784,402-43,787,749 SPINT4 
43,836,254-43,853,954 WFDC3 (WAP four-disulfide core domain 3) 
 
#
Control Regions (from Andres, 2010) 
 
Ψ ID Chrromosome coordinate Gene and chr of origin Processed Ψs per genome 
     Human Chimp Ora
ng 
Rhesus 
 
ENCODE 
        
Ψ:79794   chr11:5505093-5505962 Unknown   1 1 1 1 
NON-ENCODE         
Ψ:89 chr1:38020719-38021144 C14ORF138 @ Chr14 1 1 1 0 
Ψ:127271 chr1:224666087-224666538 Unknown   1 3 2 4 
Ψ:511 chr1:181191136-181191557 NCR1 @ Chr19 1 1 1 1 
Ψ:716 chr1:245414326-245414818 PEX5 @ Chr12 1 1 1 1 
Ψ:189 chr1:61892410-61893166 SPR @ Chr2 1 1 1 1 
Ψ:414 chr1:156412265-156414162 ELL2 @ Chr5 3 3 3 3 
Ψ:725 chr2:7794021-7794677 PSMB1 @ Chr6 1 1 ORF 2? 
Ψ:881 chr2:76338812-76339387 NP @ Chr14 1 1 1 1 + 
ORF 
Ψ:919 chr2:101503725-101504888 PRCP @ Chr11 1 1 1 1 
Ψ:10377 chr2:146951393-146952148 Unknown   1 1 1 1 
Ψ:10800 chr2:158526147-158527646 MTA3 @ Chr2 1 1 1 ND 
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Ψ:1317 chr3:34889168-34890350 FECH @ Chr18 1 1 1 1 
Ψ:1390 chr3:59496630-59497181 Unknown   2 2 2 2 
Ψ:131502 chr3:81498830-81499811 Unknown   1 1 1 ND 
Ψ:1588 chr3:146885050-146885571 GM2A @ Chr5 2 2 2 2 
Ψ:75498 chr4:36184061-36186883 FBXO38 @ Chr5 1 1 1 1 
Ψ:1886 chr4:89667737-89668341 CD53 @ Chr1 1 1 1 1 
Ψ:18262 chr4:176732748-176734338 ADAM29 @ Chr4 2 2 2 2 
Ψ:1835 chr4:68730627-68731081 Unknown   1 1 1 1 
Ψ:2117 chr5:29141432-29142101 C14ORF45 @ Chr14 1 1 1 1 
Ψ:19453 chr5:133084092-133084524 DPH4 @ Chr11 1 1 1 1 
Ψ:2934 chr6:139701013-139702410 DNAJC7 @ Chr17 2 2 2 3 
Ψ:3153 chr7:55279435-55280868 SLC19A3 @ Chr2 2 2 2 2 
Ψ:20740 chr7:128120741-128121217 IMP3 @ Chr15 2 2 2 2 
Ψ:3607 chr8:60632574-60632998 NUDT15 @ Chr13 2 2 + 1 
ORF 
2 2 
Ψ:3693 chr8:97208019-97209206 Unknown   1 1 1 1 
Ψ:69522 chr9:6185935-6186853 GTF3A @ Chr13 5 5 5 5 
Ψ:21854 chr9:21685170-21686842 KHSRP @ Chr19 1 1 1 1 
Ψ:4067 chr9:106130426-106131316 WDR45L @ Chr17 3 2 + 1 
ORF 
2 + 
1 
ORF 
2 
Ψ:4320 chr10:79498396-79499304 GNAI2 @ Chr3 3 3 2 1 
Ψ:4547 chr11:40061840-40062643 ZCCHC9 @ Chr5 3 2 3 3 
Ψ:4837 chr11:113829007-113830057 CCRN4L @ Chr4 1 1 1 2 
Ψ:4765 chr11:91708853-91709310 NDUFB11 @ ChrX 1 1 1 1 + 1 
ORF 
Ψ:4913 chr12:7650698-7651196 CLTA @ Chr9 2 2 2 2 
Ψ:5244 chr12:107199014-107200142 APOBEC3F @ Chr22 1 1 1 1 
Ψ:5055 chr12:44124847-44125485 MESDC2 @ Chr15 1 1 1 1 
Ψ:73106 chr13:24217272-24218374 IRX1 @ Chr5 1 1 1 1 
Ψ:5504 chr13:89442087-89443147 PEX12 @ Chr17 1 1 1 0 
Ψ:5477 chr13:74300713-74302220 RIOK3 @ Chr18 1 1 1 1 
Ψ:5700 chr14:61368336-61368840 COX4I1 @ Chr16 2 1 2 2 + 1 
ORF 
Ψ:62081 chr14:88646206-88647320 MPPE1 @ Chr18 2 1 1 1 
Ψ:6310 chr16:82710324-82711542 PLK-1 @ Chr16 2 2 2 2 
Ψ:6549 chr17:66136577-66137001 Unknown   1 1 1 1 
Ψ:26649 chr19:18012148-18012866 APOA1BP @ Chr1 2 2 2 2 
Ψ:6997 chr20:21429964-21430620 GSTM3 @ Chr1 1 1 1 2 
Ψ:7045 chr20:37391075-37391973 ATG3 @ Chr3 1 2 1 1 
Ψ:7112 chr21:15051781-15052541 POLR2C @ Chr16 1 1 1 1 
Ψ:7176 chr21:45316169-45316649 Unknown   1 1 1 1 
 
* Chromosome coordinates are based in the human march 2006 assembly (hg18; genome.ucsc.edu) 
 
# 
These loci were selected using the following filters: Processed ψs (according to the annotation in ψ.org); Minimum 
length of 400 bp; Unlinked to each other; ot OR, not ribosomal RNA (according to the annotation in ψ.org); With 
chimpanzee, orangutan and rhesus orthologues; No overlap with UCSC genes; No overlap with highly conserved 
regions (most conserved, UCSC); Average genome recombination rate; Processed ψs in single copy in human and 
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chimpanzee genomes were preferred. (When this was not possible, one ψ per family was accepted provided that the 
members of the family had 90% identity or less among them.) 
 
Supplementary Table S1: HapMap 
Phase I/II samples sequenced. 
Population 
Sample numbers 
 
YRI (25) 
 
NA18502, NA18517, NA18507, NA18523, NA18505, 
NA18861, NA18508, NA18858, NA18516, NA18522, 
NA18501, NA19102, NA19172, NA19116, NA18504, 
NA18853, NA18856, NA18870, NA18871, NA18912, 
NA19093, NA19137, NA19138, NA19171, NA19200 
CEU (21) 
 
NA11832, NA11840, NA11993, NA12004, NA12156, 
NA12813, NA11995, NA12006, NA06985, NA12044, 
NA11829, NA11830, NA11831, NA11992, NA11994, 
NA12154, NA12155, NA12003, NA12005, NA11840, 
NA12813 
CHB (20) 
 
NA18526, NA18529, NA18532, NA18537, NA18540, 
NA18542, NA18545, NA18547, NA18550, NA18552, 
NA18555, NA18564, NA18566, NA18570, NA18571, 
NA18573, NA18576, NA18577, NA18579, NA18582 
JPT (5) NA18942, NA18947, NA18956, NA18980, NA18992 
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Supplementary Table S2: a) SNPs nonsynonymous  b) Fixed Differences nonsynonymous analysis with SIFT and 
PolyPhen v2. 
 
a) Nonsynonymous and Stop mutations 
 
SNP ID Protein Frequency Residue Expected  
Codon 
Found  
Codon 
SIFT PolyPhen 
rs79417830 WFDC5 0.05 S103L TCG TTG Tolerated Benign 
rs17422688 WFDC5 0.05 H97Y CAC TAC Tolerated Benign 
rs115077112 WFDC12 0.01 A20V GCT GTT Affect protein 
function 
Possibly 
damaging 
rs17333103 PI3 0.08 T17M ACG ATG Tolerated Benign 
rs2664581 PI3 0.08 T34P ACT CCT Tolerated Benign 
rs151106234 PI3 0.01 K36N AAA AAT Tolerated Benign 
  SEMG1 0.01 G26D GGT GAT Affect protein 
function 
Possibly 
damaging 
rs2301366 SEMG1 0.33 S79T TCC ACC Tolerated Benign 
rs61729393 SEMG1 0.02 L100Q CTA CAA Affect protein 
function 
Probably 
damaging 
rs75447646 SEMG1 0.01 S193N AGT AAT Tolerated Benign 
rs141417035 SEMG1 0.01 R208C CGT TGT Affect protein 
function 
Probably 
damaging 
rs2233886 SEMG1 0.02 S312R AGC CGC Affect protein function 
rs139222986 SEMG1 0.02 Q327R CAA CGA Tolerated Benign 
rs61730001 SEMG1 0.02 Q357R CAA CGA Tolerated Benign 
rs151126678 SEMG1 0.02 H359Q CAC CAA Tolerated Benign 
  SEMG1 0.01 R372C CGC TGC Tolerated Benign 
rs2233887 SEMG1 0.02 R372L CGC CTC Affect protein 
function 
Benign 
  SEMG1 0.01 R447H CGT CAT Tolerated Benign 
 SEMG2 0.01 S34R AGC AGT Tolerated Benign 
rs2233896 SEMG2 0.07 Q43K CAA AAA Tolerated Benign 
rs2233897 SEMG2 0.04 T57A ACT GCT Tolerated Probably 
damaging 
rs144655663 SEMG2 0.01 R208L CGT CTT Tolerated Benign 
rs2233901 SEMG2 0.1 S274N AGT AAT Tolerated Benign 
rs2233903 SEMG2 0.08 H279Y CAT TAT Affect protein 
function 
Probably 
damaging 
  SEMG2 0.01 D336Y GAT TAT Tolerated Probably 
damaging 
rs2071650 SEMG2 0.1 G368R GGT CGT Tolerated Possibly 
damaging 
rs144708311 SEMG2 0.01 R417H CGT CAT Tolerated Possibly 
damaging 
rs116547998 SEMG2 0.02 E463K GAA AAA Tolerated Probably 
damaging 
rs148116830 SEMG2 0.01 E475* GAA TAA Stop   
rs6032259 SPINT3 0.45 L77S CGA GAA Tolerated Benign 
rs73305953 SPINT3 0.06 F54S TTC TCC Affect protein 
function 
Probably 
damaging 
rs118187173 WFDC8 0.02 P155Q CCA CAA Affect protein 
function 
Benign 
rs2250860 WFDC8 0.26 N137S AAT AGT Tolerated Benign 
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rs2272955 WFDC8 0.17 M96T ATG ACG Tolerated Benign 
  WFDC8 0.01 K73N AAG AAT Tolerated Benign 
rs79465015 WFDC8 0.02 M39T ATG ACG Tolerated Benign 
  WFDC9 0.01 D29G GAT GGT Tolerated Benign 
rs2245898 WFDC9 0.42 N27T AAC ACC Tolerated Benign 
rs16990631 SPINT4 0.08 A30E GCG GAG Tolerated Possibly 
damaging 
rs6017667 SPINT4 0.44 G73S GGC AGC Affect protein 
function 
Probably 
damaging 
  SPINT4 0.01 P98S CCA TCA Tolerated Benign 
rs58353703 WFDC10A 0.01 Q30L CAG CTG Affect protein 
function 
Possibly 
damaging 
rs232729 WFDC10B 0.13 L8P CTT CCT Tolerated Benign 
rs76083103 WFDC3 0.04 N217K AAC AAG Tolerated Benign 
rs80158904 WFDC3 0.02 R81G CGG GGG Tolerated Benign 
  WFDC3 0.48 D75N GAT AAT Tolerated Possibly 
damaging 
  WFDC3 0.45 R74K AGA AAA Tolerated Benign 
rs73122754 WFDC3 0.01 R63L CGG CTG Tolerated Benign 
rs6032538 WFDC3 0.36 H36D CAT GAT Tolerated Benign 
 
b) Fixed Differences nonsynonymous 
 
 
Position 
(chr20) Human Chimp Orang Macaque 
AA 
subs Gene PolyPhen SIFT 
43186462 V A A A V14A WFDC12 Benign 
Affect 
protein 
function 
43186463 V I I I V14I WFDC12 Benign 
Affect 
protein 
function  
43269459 F S S S F36 S SEMG1 Benign Tolerated 
43269641 Q E E E Q97E SEMG1 Benign Tolerated 
43270493 L I ? ? L381I SEMG1 Benign Tolerated 
43270494 L Q ? ? L381Q SEMG1 Benign Tolerated 
43270499 A P ? ? A383P SEMG1 Benign Tolerated 
43270673 Q E ? ? Q441E SEMG1 Benign Tolerated 
43283919 W R R R W78R SEMG2 Benign Tolerated 
43284163 C Y Y Y C159Y SEMG2 Benign Tolerated 
43284553 P Q Q Q P289Q SEMG2 Benign Tolerated 
43284582 H N N N H299N SEMG2 Benign Tolerated 
43285180 I T T T I494T SEMG2 Benign Tolerated 
43285287 K E E E K534E SEMG2 Benign Tolerated 
43600054 P L L L P62L WFDC6 Benign Tolerated 
43624268 F L L L F11L WFDC8 Benign Tolerated 
43672210 V I I M V9I WFDC9 Benign Tolerated 
43710782 G E E E G85E WFDC11 Benign Tolerated 
43746903 I V V V I84V WFDC10B Benign Tolerated 
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Supplementary Table S3: Summary statistics for WFDC locus genes. 
 
Gene Pop 
a
S Length 
b
π  
c
Ɵw 
d
D 
P-
value 
e
 D* 
P-
value 
f
H' 
P-
value 
g
p 
(HKA) 
h
p 
(MWUhigh) 
WFDC5 CHB+JPT 15 3787 1.85 3.35 -1.37 0.149 -2.11 0.12 0.17 0.496 0.351 0.945 
WFDC12 CHB+JPT 9 2756 0.98 2.02 -1.45 0.099 -1.95 0.09 -0.43 0.316 0.882 0.928 
PI3 CHB+JPT 17 4546 1.68 3.82 -1.76 0.041 -3.40 0.12 -3.79 0.018 0.692 0.966 
SEMG1 CHB+JPT 9 3964 0.76 2.02 -1.75 0.058 -2.60 0.14 -1.79 0.084 0.928 0.928 
SEMG2 CHB+JPT 11 3658 0.93 2.47 -1.82 0.048 -3.16 0.24 -3.55 0.018 0.429 0.978 
SLPI CHB+JPT 16 5366 2.76 3.60 -0.72 0.333 0.72 0.08 -2.85 0.037 0.841 0.680 
WFDC2 CHB+JPT 6 3978 1.48 1.35 0.26 0.360 0.32 0.28 -0.42 0.313 0.931 0.333 
SPINT3 CHB+JPT 4 3722 1.04 0.91 0.34 0.277 1.00 0.04 0.91 0.030 0.207 0.265 
WFDC6 CHB+JPT 9 2803 1.62 2.02 -0.57 0.431 0.03 0.22 -0.24 0.345 0.371 0.462 
EPPIN CHB+JPT 12 3431 2.72 2.68 0.05 0.151 1.48 0.00 0.05 0.499 0.091 0.101 
WFDC8 CHB+JPT 31 7169 5.01 7.01 -0.97 0.167 1.06 0.06 -3.71 0.019 0.126 0.852 
WFDC9/10A CHB+JPT 24 6855 8.11 5.39 1.65 0.079 1.11 0.05 -0.48 0.347 0.694 0.048 
WFDC11 CHB+JPT 13 5032 4.23 2.94 1.34 0.139 1.51 0.01 0.54 0.205 0.236 0.087 
WFDC10B/13 CHB+JPT 17 7356 4.42 3.81 0.50 0.175 -0.05 0.22 -0.80 0.232 0.560 0.159 
SPINT4 CHB+JPT 14 3521 5.03 3.26 1.72 0.077 1.06 0.07 0.72 0.107 0.049 0.075 
WFDC3 CHB+JPT 45 7562 13.50 10.10 1.15 0.160 0.62 0.12 0.46 0.228 0.030 0.131 
WFDC5 CEU 8 3787 2.08 2.02 0.09 0.368 0.06 0.30 0.60 0.208 0.957 0.242 
WFDC12 CEU 6 2756 2.12 1.53 1.11 0.158 1.21 0.07 0.78 0.084 0.562 0.106 
PI3 CEU 21 4546 6.54 5.33 0.80 0.228 1.04 0.07 -1.30 0.156 0.364 0.129 
SEMG1 CEU 8 3964 2.09 2.02 0.10 0.344 0.69 0.12 -0.57 0.255 0.893 0.215 
SEMG2 CEU 6 3658 1.71 1.52 0.35 0.339 1.21 0.06 -2.18 0.066 0.194 0.232 
SLPI CEU 10 5366 1.86 2.56 -0.88 0.227 -1.82 0.34 -2.60 0.040 0.679 0.505 
WFDC2 CEU 6 3978 0.80 1.53 -1.38 0.088 -2.66 0.06 -1.68 0.102 0.969 0.757 
SPINT3 CEU 4 3722 1.16 1.04 0.30 0.364 -1.08 0.27 -0.24 0.357 0.696 0.184 
WFDC6 CEU 3 2803 0.61 0.80 -0.59 0.320 -1.48 0.13 0.49 0.285 0.596 0.552 
EPPIN CEU 3 3431 0.81 0.72 0.28 0.287 -0.32 0.42 0.71 0.094 0.872 0.267 
WFDC8 CEU 27 7169 10.70 6.89 2.02 0.041 0.01 0.46 -0.25 0.406 0.143 0.009 
WFDC9/10A CEU 24 6855 7.93 6.10 1.07 0.186 0.87 0.12 -0.51 0.313 0.548 0.094 
WFDC11 CEU 14 5032 2.93 3.56 -0.60 0.268 0.27 0.35 -1.70 0.112 0.136 0.479 
WFDC10B/13 CEU 13 7356 3.70 3.30 0.40 0.244 -0.27 0.38 -0.13 0.391 0.848 0.130 
SPINT4 CEU 9 3521 3.69 2.32 1.88 0.058 0.74 0.17 -1.06 0.206 0.109 0.061 
WFDC3 CEU 31 7562 11.50 7.95 1.63 0.071 1.09 0.04 0.30 0.360 0.197 0.035 
WFDC5 YRI 11 3787 2.64 2.47 0.21 0.116 0.29 0.17 0.77 0.136 0.762 0.140 
WFDC12 YRI 14 2756 2.79 3.13 -0.33 0.351 -0.39 0.49 0.08 0.271 0.914 0.301 
PI3 YRI 34 4546 4.70 7.60 -1.29 0.118 0.66 0.10 -1.71 0.016 0.409 0.833 
SEMG1 YRI 20 3964 2.70 4.48 -1.27 0.242 0.21 0.18 0.12 0.296 0.655 0.760 
SEMG2 YRI 18 3658 2.82 4.02 -0.95 0.375 0.84 0.06 -1.68 0.021 0.557 0.483 
SLPI YRI 29 5366 6.20 6.50 -0.15 0.182 0.17 0.19 -0.31 0.143 0.617 0.181 
WFDC2 YRI 10 3978 2.49 2.23 0.34 0.125 0.78 0.11 0.10 0.277 0.945 0.085 
SPINT3 YRI 11 3722 1.33 2.46 -1.34 0.136 -1.43 0.82 -1.60 0.022 0.234 0.809 
WFDC6 YRI 12 2803 2.04 2.71 -0.75 0.449 0.94 0.05 0.13 0.302 0.541 0.352 
EPPIN YRI 17 3431 3.01 3.81 -0.67 0.350 0.79 0.07 0.33 0.479 0.075 0.242 
WFDC8 YRI 38 7169 10.50 8.56 0.78 0.072 0.36 0.20 -0.88 0.067 0.300 0.061 
WFDC9/10A YRI 33 6855 8.85 7.40 0.66 0.090 0.87 0.06 0.35 0.412 0.861 0.054 
WFDC11 YRI 18 5032 4.60 4.03 0.45 0.134 0.44 0.18 0.49 0.456 0.388 0.117 
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WFDC10B/13 YRI 37 7356 7.08 8.34 -0.52 0.271 0.77 0.04 0.43 0.489 0.230 0.150 
SPINT4 YRI 18 3521 2.86 4.17 -1.03 0.172 -0.76 0.34 -0.62 0.093 0.084 0.706 
WFDC3 YRI 55 7562 14.10 12.30 0.50 0.088 0.72 0.05 0.52 0.445 0.100 0.070 
 
 
a
 S = number of segregating sites. 
b 
Watterson’s estimator of Ө (4Neµ) (Watterson 1975) per base pair (x 10
-4
).   
c
 Nucleotide diversity per base pair (x 10
-4
) 
d
 Tajima’s D statistic (Tajima 1989). 
e
 Fu & Li D* statistic (Fu and Li 1993) 
f
 Corrected Fay and Wu H test  (Fay and Wu 2002 and Zeng et al. 2006) 
g
 P-value of HKA test (Hudson, Kreitman, Aguadé 1987) 
h
 P-value of MWUhigh test (Andrés et al., 2009) 
Supplementary Table S4: Summary statistics for WFDC locus genes in the 1000 genomes dataset, performed using 
SLIDER. 
 
Gene Population Length 
a
S      
b
π (10
-4
) 
c
Ɵw 
d
Tajima's D 
e
Fu & Li D* 
WFDC5 CHB + JPT 3788 17 1.3421263 0.000691 -1.1935 -0.8464 
WFDC12 CHB + JPT 2762 14 1.5648111 0.0007804 -0.6457 0.1111 
PI3 CHB + JPT 4558 28 1.3402799 0.0009459 -1.8297 -1.6737 
SEMG1 CHB + JPT 3972 25 0.8050052 0.0009691 -2.0666 -3.9752 
SEMG2 CHB + JPT 3664 14 0.6341285 0.0005883 -1.6628 -1.9543 
SLPI CHB + JPT 5247 28 2.974262 0.0008216 -0.8233 0.6021 
WFDC2 CHB + JPT 3990 15 3.4546218 0.0005788 1.185 -0.4528 
SPINT3 CHB + JPT 3730 25 3.8286212 0.001032 -0.014 -0.0685 
WFDC6 CHB + JPT 2811 13 1.9446779 0.0007121 -0.0659 -1.4313 
EPPIN CHB + JPT 3233 15 1.9801155 0.0007144 -0.3409 -0.4528 
WFDC8 CHB + JPT 7189 44 4.3929822 0.0009424 -0.9829 0.6087 
WFDC9/10A CHB + JPT 6870 33 8.8730859 0.0007396 2.0234 0.8591 
WFDC11 CHB + JPT 5042 22 4.5206572 0.0006718 0.8573 -1.9024 
WFDC10B/12 CHB + JPT 7374 26 4.0535615 0.0005429 0.033 -2.8532 
SPINT4 CHB + JPT 3530 33 10.84003 0.0014394 3.0729 0.449 
WFDC3 CHB + JPT 7582 44 10.708893 0.0008935 1.6237 -1.4283 
WFDC5 CEU 3788 14 2.8524398 0.0006446 0.4291 0.2845 
WFDC12 CEU 2762 12 3.7390851 0.0007578 1.9447 1.4424 
PI3 CEU 4558 27 4.8184897 0.0010332 0.0657 -0.5158 
SEMG1 CEU 3972 13 1.6558871 0.0005709 -0.6781 -2.4283 
SEMG2 CEU 3664 16 1.7599658 0.0007617 -0.9664 -2.9829 
SLPI CEU 5247 27 2.6329971 0.0008975 -1.2486 -0.1076 
WFDC2 CEU 3990 13 1.2455184 0.0005683 -1.1332 -0.4697 
SPINT3 CEU 3730 16 4.0205297 0.0007482 1.1531 -1.2598 
WFDC6 CEU 2811 6 1.0904993 0.0003723 0.087 -1.9902 
EPPIN CEU 3233 6 1.0656938 0.0003237 0.038 0.0537 
WFDC8 CEU 7189 43 12.826326 0.0010433 2.1116 1.0398 
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WFDC9/10A CEU 6870 40 11.834331 0.0010155 2.057 1.8619 
WFDC11 CEU 5042 18 4.6422702 0.0006227 1.2782 0.6173 
WFDC10B/12 CEU 3530 35 10.076526 0.0017293 1.8975 -0.293 
SPINT4 CEU 7374 24 4.6894216 0.0005677 0.3354 0.0929 
WFDC3 CEU 7582 41 9.3882599 0.0009432 0.9263 -0.8532 
WFDC5 YRI 3788 19 3.2246865 0.0008731 -0.0672 -0.3477 
WFDC12 YRI 2762 20 3.3670713 0.0012605 -0.0891 1.7482 
PI3 YRI 4558 32 3.9328703 0.0012221 -0.8482 1.3107 
SEMG1 YRI 3972 26 2.2172896 0.0011394 -1.436 -0.1882 
SEMG2 YRI 3664 20 2.3281056 0.0009502 -0.8986 0.2503 
SLPI YRI 5247 36 7.6492865 0.0011943 0.6447 1.7751 
WFDC2 YRI 3990 21 3.6158577 0.0009162 -0.0296 0.8109 
SPINT3 YRI 3730 32 5.2212913 0.0014934 -0.1807 0.5829 
WFDC6 YRI 2811 18 2.797198 0.0011146 -0.286 -0.4535 
EPPIN YRI 3233 25 3.3676545 0.001346 -0.6334 0.1623 
WFDC8 YRI 7189 62 13.967005 0.0015012 0.8978 -0.0326 
WFDC9/10A YRI 6870 47 11.791325 0.0011909 1.3204 1.4403 
WFDC11 YRI 5042 21 5.4833263 0.000725 1.3665 0.8109 
WFDC10B/13 YRI 7374 53 7.1873641 0.0012511 -0.6672 0.3216 
SPINT4 YRI 3530 40 7.7484559 0.0019725 0.333 1.242 
WFDC3 YRI 7582 52 11.871137 0.0011938 0.9394 1.3027 
 
 
a
 S = number of segregating sites. 
b 
Watterson’s estimator of Ө (4Neµ) (Watterson 1975) per base pair (x 10
-4
).   
c
 Nucleotide diversity per base pair (x 10
-4
) 
d
 Tajima’s D statistic (Tajima 1989). 
e
 Fu & Li D* statistic (Fu and Li 1993) 
 
Supplementary Table S5: Independence (χ
2
) and correlation (Kendall's τ and Spearman's ρ) tests between the 
equivalent summary statistics distributions of the 1000 genomes and the sequenced data. 
 
 π (10-4) Ɵw Tajima's D Fu & Li D* 
χ2  0.025 0.902 0.999 0.159 
Kendall's τ 0.674 0.654 0.619 0.150 
Spearman's ρ 0.850 0.829 0.808 0.216 
 
 
Supplementary Table S6: Command lines used in the ms program to test Gutenkunst model. 
 
ms command line without outgroup: 
 
ms 142 REPETITIONS -s SEGSITES RECOMBINATION_RATE -I 3 50 42 50  -n 1 
1.682020 -n 2 3.736830 -n 3 7.292050 -eg 0 2 116.010723 -eg 0 3 160.246047 -ma x 
0.881098 0.561966 0.881098 x 2.797460 0.561966 2.797460 x -ej 0.028985 3 2 -en 
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0.028985 2 0.287184 -ema 0.028985 3 x 7.293140 x 7.293140 x x x x x -ej 0.197963 2 
1 -en 0.303501 1 1 
 
ms command line with outgroup: 
 
ms 143  REPETITIONS -s SEGSITES RECOMBINATION_RATE -I 4 50 42 50 1 -n 1 
1.682020 -n 2 3.736830 -n 3 7.292050 -n 4 1.3699 -eg 0 2 116.010723 -eg 0 3 
160.246047 -ma x 0.881098 0.561966 0 0.881098 x 2.797460 0 0.561966 2.797460 x 
0 0 0 0 x -ej 0.028985 3 2 -en 0.028985 2 0.287184 -ema 0.028985 4 x 7.293140 x 0 
7.293140 x x 0 x x x x 0 0 x x -ej 0.197963 2 1 -en 0.303501 1 1 -em 16.4300 1 4 0 -em 
16.4300 4 1 0 -ej 3.69492340746 4 1 
 
 
REPETITIONS = 10.000 
SEGSITES = Segregating sites calculated for each population for each gene independently. 
RECOMBINATION RATE = Calculated using the UCSC browser, 0.20 cM/Mb, in the WFDC region. 
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Supplementary Figure S1: FST statistics (Excoffier 2002) used to describe the proportion of genetic variance 
attributable to between-population (European vs. Asian, African vs European, and African vs Asian) effects in the 
WFDC-CEN (A), C) and E)) and WFDC-TEL (B), D), and F)). To identify SNPs presenting extreme levels of FST, we 
compared the observed FST at each SNP within the WFDC region with a locus-by-locus AMOVA of the control regions 
(10,000 permutations) using 20,000 simulations, performed by Arlequin (Excoffier, Laval, Schneider 2005). 
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Supplementary Figure S2: Histogram representation of A) Tajima’s D,  B) Fu and Li’s D, C) Fay and Wu’s H and D) 
MWUhigh P-values, showing a clear augmentation of low P-values. 
 
 
 
Supplementary Figure S3: Empirical distributions of A)  and B) Tajima’s D, determined from the neutral control 
genomic regions in each population. Dashed lines represent upper and lower 2.5 percentiles, calculated using the SPSS 
statistics software package, version 20 (IBM Corporation: Chicago, IL, USA, 2010). 
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Supplementary Figure S4: The corresponding principal components plots for the sequences of the centromeric A) and 
telomeric B) sub-loci downloaded from the 1000 Genomes Project. A Principal Component Analysis (PCA) was 
performed using EigenSoft (Patterson 2006). 80% of the variation is explained by PC1. 
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Supplementary Figure S5: WFDC8 site frequency spectrum in the three different sequenced populations (Africa, Asian 
and European).  
 
 
 
 
 
Supplementary Figure S6:  Site Frequency Spectrum (SFS) of the corresponding centromeric A) and C) and telomeric 
B) and D) sub-loci data downloaded from 1000 genomes and from the Complete Genomics Diversity Panel.  
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Supplementary Figure S7: Allele Frequency Spectrum of the same regions and individuals sequenced by Sanger 
sequencing and in the 1000 genomes project dataset. 
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Appendix III 
Supplementary Material Article 3 
Sequence diversity of Pan troglodytes subspecies and the impact of 
WFDC6 selective constraints in reproductive immunity.  
(submitted) 
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Supplementary Tables 
Supplementary Table S1:  Regions of the genome sequenced.  
WFDC locus region 
 
Chr 20 coordinates* Gene 
WFDC-CEN 
43,171,507-43,177,217 WFDC5 (WAP four-disulfide core domain 5) 
43,185,481-43,186,520 WFDC12 (WAP four-disulfide core domain 12) 
43,236,912-43,238,599 PI3 (elafin) 
43,269,088-43,271,823 SEMG1 (semenogelin 1) 
43,269,088-43,286,513 SEMG2 (semenogelin 2) 
43,314,293-43,316,620 SLPI (secretory leukocyte peptidase inhibitor) 
WFDC-TEL 
43,541,899-43,543,586 WFDC2 (WAP four-disulfide core domain 2) 
43,574,515-43,577,678 SPINT3 
43,596,250-43,601,548 WFDC6 (WAP four-disulfide core domain 6) 
43,602,679-43,609,442 SPINLW1 (WAP four-disulfide core domain 7) 
43,613,815-43,641,379 WFDC8 (WAP four-disulfide core domain 8) 
43,669,992-43,693,321 WFDC9 (WAP four-disulfide core domain 9) 
43,691,799-43,693,245 WFDC10a (WAP four-disulfide core domain 10a) 
43,710,616-43,732,292 WFDC11 (WAP four-disulfide core domain 11) 
43,746,704-43,767,072 WFDC10b (WAP four-disulfide core domain 10b) 
43,764,069-43,770,870 WFDC13 (WAP four-disulfide core domain 13) 
43,784,402-43,787,749 SPINT4 
43,836,254-43,853,954 WFDC3 (WAP four-disulfide core domain 3) 
 
#
Control Regions (from Andres, 2010) 
 
Ψ ID Chrromosome coordinate Gene and chr of origin Processed Ψs per genome 
     Human Chimp Oran Rhesus 
 
ENCODE 
        
Ψ:79794 chr11:5505093-5505962 Unknown   1 1 1 1 
NON-
ENCODE 
        
Ψ:89 chr1:38020719-38021144 C14ORF138 @ Chr14 1 1 1 0 
Ψ:127271 chr1:224666087-
224666538 
Unknown   1 3 2 4 
Ψ:511 chr1:181191136-
181191557 
NCR1 @ Chr19 1 1 1 1 
Ψ:716 chr1:245414326-
245414818 
PEX5 @ Chr12 1 1 1 1 
Ψ:189 chr1:61892410-61893166 SPR @ Chr2 1 1 1 1 
Ψ:414 chr1:156412265-
156414162 
ELL2 @ Chr5 3 3 3 3 
Ψ:725 chr2:7794021-7794677 PSMB1 @ Chr6 1 1 ORF 2? 
Ψ:881 chr2:76338812-76339387 NP @ Chr14 1 1 1 1 + ORF 
Ψ:919 chr2:101503725-
101504888 
PRCP @ Chr11 1 1 1 1 
Ψ:10377 chr2:146951393-
146952148 
Unknown   1 1 1 1 
Ψ:10800 chr2:158526147-
158527646 
MTA3 @ Chr2 1 1 1 ND 
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Ψ:1317 chr3:34889168-34890350 FECH @ Chr18 1 1 1 1 
Ψ:1390 chr3:59496630-59497181 Unknown   2 2 2 2 
Ψ:131502 chr3:81498830-81499811 Unknown   1 1 1 ND 
Ψ:1588 chr3:146885050-
146885571 
GM2A @ Chr5 2 2 2 2 
Ψ:75498 chr4:36184061-36186883 FBXO38 @ Chr5 1 1 1 1 
Ψ:1886 chr4:89667737-89668341 CD53 @ Chr1 1 1 1 1 
Ψ:18262 chr4:176732748-
176734338 
ADAM29 @ Chr4 2 2 2 2 
Ψ:1835 chr4:68730627-68731081 Unknown   1 1 1 1 
Ψ:2117 chr5:29141432-29142101 C14ORF45 @ Chr14 1 1 1 1 
Ψ:19453 chr5:133084092-
133084524 
DPH4 @ Chr11 1 1 1 1 
Ψ:2934 chr6:139701013-
139702410 
DNAJC7 @ Chr17 2 2 2 3 
Ψ:3153 chr7:55279435-55280868 SLC19A3 @ Chr2 2 2 2 2 
Ψ:20740 chr7:128120741-
128121217 
IMP3 @ Chr15 2 2 2 2 
Ψ:3607 chr8:60632574-60632998 NUDT15 @ Chr13 2 2 + 1 
ORF 
2 2 
Ψ:3693 chr8:97208019-97209206 Unknown   1 1 1 1 
Ψ:69522 chr9:6185935-6186853 GTF3A @ Chr13 5 5 5 5 
Ψ:21854 chr9:21685170-21686842 KHSRP @ Chr19 1 1 1 1 
Ψ:4067 chr9:106130426-
106131316 
WDR45L @ Chr17 3 2 + 1 
ORF 
2 + 1 ORF 2 
Ψ:4320 chr10:79498396-
79499304 
GNAI2 @ Chr3 3 3 2 1 
Ψ:4547 chr11:40061840-
40062643 
ZCCHC9 @ Chr5 3 2 3 3 
Ψ:4837 chr11:113829007-
113830057 
CCRN4L @ Chr4 1 1 1 2 
Ψ:4765 chr11:91708853-
91709310 
NDUFB11 @ ChrX 1 1 1 1 + 
1 
ORF 
Ψ:4913 chr12:7650698-7651196 CLTA @ Chr9 2 2 2 2 
Ψ:5244 chr12:107199014-
107200142 
APOBEC3F @ Chr22 1 1 1 1 
Ψ:5055 chr12:44124847-
44125485 
MESDC2 @ Chr15 1 1 1 1 
Ψ:73106 chr13:24217272-
24218374 
IRX1 @ Chr5 1 1 1 1 
Ψ:5504 chr13:89442087-
89443147 
PEX12 @ Chr17 1 1 1 0 
Ψ:5477 chr13:74300713-
74302220 
RIOK3 @ Chr18 1 1 1 1 
Ψ:5700 chr14:61368336-
61368840 
COX4I1 @ Chr16 2 1 2 2 + 
1 
ORF 
Ψ:62081 chr14:88646206-
88647320 
MPPE1 @ Chr18 2 1 1 1 
Ψ:6310 chr16:82710324-
82711542 
PLK-1 @ Chr16 2 2 2 2 
Ψ:6549 chr17:66136577-
66137001 
Unknown   1 1 1 1 
Ψ:26649 chr19:18012148-
18012866 
APOA1BP @ Chr1 2 2 2 2 
Ψ:6997 chr20:21429964-
21430620 
GSTM3 @ Chr1 1 1 1 2 
Ψ:7045 chr20:37391075-
37391973 
ATG3 @ Chr3 1 2 1 1 
Ψ:7112 chr21:15051781-
15052541 
POLR2C @ Chr16 1 1 1 1 
Ψ:7176 chr21:45316169-
45316649 
Unknown   1 1 1 1 
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* Chromosome coordinates are based in the human march 2006 assembly (hg18; genome.ucsc.edu) 
# 
These loci were selected using the following filters: Processed ψs (according to the annotation in ψ.org); 
Minimum length of 400 bp; Unlinked to each other; not ribosomal RNA (according to the annotation in 
ψ.org); With human, orangutan and rhesus orthologs; No overlap with UCSC genes; No overlap with highly 
conserved regions (most conserved, UCSC); Average genome recombination rate; Processed ψs in single 
copy in human and chimpanzee genomes were preferred. (When this was not possible, one ψ per family 
was accepted provided that the members of the family had 90% identity or less among them.) 
Supplementary Table S2: Chimpanzee samples sequenced. 
  
 
 
Population Sample numbers 
 
Pan troglodytes troglodytes 
(15) 
Etrange Ewake  Kita Mac Maya Mokolo
 Nanga-Eboko Nikita Papaie Pauldina Pecos Silva
 Suzanne Lada Jules 
Pan troglodytes ellioti 
(31) 
Achidi  Akwaya-Jean Alex Bally Bankim Basho
  Bernadette Carlos Eve Gah
 George Jack  Jacob Julie Kopongo
 Louisa Margaret Mesange Nemo
 Nicolene Papa Paquita  TKC Taweh Tinto-
Mbu Tobi Bana Bergkamp Koto Damian 
 Banyo 
Pan troglodytes verus 
(22) 
 
 Pt100 Pt101 Pt102 Pt103 Pt104 Pt105 Pt106
  Pt107 Pt112 Pt115 Pt117 Pt120 Pt121
 Pt122 Pt124 Pt125 Pt126 Pt81 Pt87 Pt88
 Pt97 Pt98 
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Supplementary Table S3: Summary Statistics for all the WFDC genes. 
 
Gene Sub-species S π (10
-4
) Length Ɵw Tajima's D Fu & Li D* Fay and Wu’s H P(HKA) 
WFDC5 P. t. troglodytes 32 11.87 5536 8.077 -0.4202 -0.3432 -1.6644 0.3858 
WFDC12 P. t. troglodytes 16 3.026 1323 4.039 -0.6318 0.4407 -0.6437 0.1866 
PI3 P. t. troglodytes 25 7.748 3377 6.310 -0.3775 0.1365 1.5448 0.9625 
SEMG1 P. t. troglodytes 23 4.015 3305 5.806 -1.172 -0.8307 -1.2782 0.7463 
SEMG2 P. t. troglodytes 31 8.471 4324 7.825 -0.8778 0.2350 -2.4092 0.9241 
SLPI P. t. troglodytes 30 16.84 4709 7.573 0.5078 0.6260 2.5195 0.9095 
WFDC2 P. t. troglodytes 24 5.850 3984 6.058 -0.7272 0.3391 -3.6322 0.4648 
SPINT3 P. t. troglodytes 35 10.72 3727 8.835 -0.8613 -0.9377 14.278 0.0604 
WFDC6 P. t. troglodytes 19 1.269 2807 4.796 -2.073 -2.290 -1.7839 0.1907 
WFDC7 P. t. troglodytes 23 2.356 3233 5.806 -1.811 -2.218 5.2828 0.1362 
WFDC8 P. t. troglodytes 36 9.139 7179 9.087 -1.169 -1.054 0.5977 0.5583 
WFDC9/10A P. t. troglodytes 44 16.64 6863 11.11 -0.8419 -0.8662 2.0736 0.2643 
WFDC11 P. t. troglodytes 58 37.48 5037 14.64 -0.3621 -0.1044 9.0184 0.4493 
WFDC10B/13 P. t. troglodytes 41 13.99 7365 10.35 -0.9045 -0.8869 -5.0023 0.882 
SPINT4 P. t. troglodytes 14 2.296 3527 3.534 -0.7060 -0.1432 -1.9862 0.9805 
WFDC3 P. t. troglodytes 51 20.48 7572 12.87 -0.9501 -0.6436 -0.5163 0.4458 
WFDC5 P. t.ellioti 24 9.751 5536 5.110 0.8670 0.4099 -1.9799 0.1653 
WFDC12 P. t.ellioti 7 1.277 1323 1.491 0.8178 0.4173 -0.0063 0.9754 
PI3 P. t.ellioti 14 3.947 3377 2.981 0.9111 -0.4956 1.1021 0.3997 
SEMG1 P. t.ellioti 28 3.491 3305 5.962 -1.250 -0.5904 -0.9815 0.321 
SEMG2 P. t.ellioti 22 2.378 4324 4.685 -1.193 -0.4544 -0.1861 0.2107 
SLPI P. t.ellioti 30 5.464 4709 6.388 -0.8478 -1.875 4.6113 0.9302 
SPINT3 P. t.ellioti 14 3.866 3727 2.981 0.8654 0.5262 0.7953 0.2557 
WFDC2 P. t.ellioti 25 7.905 3984 5.323 0.2832 -0.1960 5.2226 0.5012 
WFDC6 P. t.ellioti 13 1.364 2807 2.768 -0.7455 -1.177 -1.6838 0.3477 
EPPIN P. t.ellioti 23 3.936 3233 4.898 -0.6386 -0.0079 12.0571 0.054 
WFDC8 P. t.ellioti 29 5.759 7179 6.175 -0.6888 -1.990 4.7842 0.3548 
WFDC9 10A P. t.ellioti 28 10.18 6863 5.962 0.3822 0.9311 3.1793 0.0392 
WFDC11 P. t.ellioti 42 15.62 5037 8.943 -0.1915 -0.1990 4.7848 0.2656 
WFDC10B P. t.ellioti 29 6.956 7365 6.175 -0.4046 -0.2142 0.055 0.2968 
SPINT4 P. t.ellioti 14 0.8043 3527 2.981 -1.498 -1.007 4.3977 0.8262 
WFDC3 P. t.ellioti 59 14.79 7572 12.56 -1.182 -0.8554 15.3739 0.7554 
WFDC5 P. t. verus 14 1.743 5536 3.218 -0.8086 0.6041 9.148 0.4733 
WFDC12 P. t. verus 7 1.396 1323 1.609 0.7787 -1.027 -0.8393 0.1127 
PI3 P. t. verus 7 1.979 3377 1.609 1.6256 0.4908 0.8076 0.6147 
SEMG1 P. t. verus 20 2.323 3305 4.598 -1.2464 -0.8163 -1.4884 0.0296 
SEMG2 P. t. verus 9 0.883 4324 2.069 -0.7344 -1.207 -0.5666 0.2473 
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SLPI P. t. verus 14 2.797 4709 3.218 -0.0454 1.071 0.8203 0.8173 
WFDC2 P. t. verus 3 0.212 3984 0.690 -0.4387 -0.3775 0.7653 0.3611 
SPINT3 P. t. verus 9 1.865 3727 2.069 0.5711 0.0750 3.3425 0.6688 
WFDC6 P. t. verus 9 0.629 2807 2.069 -1.1725 -0.5657 -1.0973 0.0616 
WFDC7 P. t. verus 7 1.523 3233 1.609 0.9748 -0.2682 -0.4207 0.2532 
WFDC8 P. t. verus 7 0.815 7179 1.609 -0.2537 0.4908 -1.1501 0.0954 
WFDC9/10A P. t. verus 22 3.333 6863 5.057 -1.002 -0.2720 3.2896 0.4979 
WFDC11 P. t. verus 25 7.986 5037 5.747 0.0283 -0.3329 2.408 0.0605 
WFDC10B/13 P. t. verus 14 3.356 7365 3.218 0.3020 1.071 0.4249 0.4759 
SPINT4 P. t. verus 6 1.062 3527 1.379 0.6795 -0.4940 -0.4989 0.856 
WFDC3 P. t. verus 32 17.27 7572 7.356 0.6888 0.3704 12.222 0.8309 
WFDC5 Pan troglodytes 45 7.7796 5536 8.25 -0.1739 -0.1817 1.4109 0.6746 
WFDC12 Pan troglodytes 24 2.4808 1323 4.39 -1.2459 -1.0808 0.7227 0.6637 
PI3 Pan troglodytes 32 4.3176 3377 5.85 -0.7764 -0.3782 6.5226 0.4454 
SEMG1 Pan troglodytes 45 3.9938 3305 8.2 -1.5677 0.3357 -1.0394 0.1462 
SEMG2 Pan troglodytes 47 3.5766 4324 8.57 -1.7859 -0.352 5.0682 0.8163 
SLPI Pan troglodytes 46 6.6832 4709 8.38 -0.6211 0.6394 7.6619 0.247 
WFDC2 Pan troglodytes 34 5.3535 3984 6.2 -0.4058 -0.2482 0.656 0.1038 
SPINT3 Pan troglodytes 44 5.2971 3727 8.04 -1.0425 -1.5881 36.879 0.0084 
WFDC6 Pan troglodytes 31 1.6333 2807 5.67 -2.1039 -2.8978 -1.5222 0.0131 
WFDC7 Pan troglodytes 38 3.165 3233 6.96 -1.648 -2.0926 16.8892 0.0175 
WFDC8 Pan troglodytes 56 4.8159 7179 10.2 -1.6397 -2.1769 6.131 0.1153 
WFDC9/10A Pan troglodytes 67 7.2409 6863 12.2 -1.2844 -1.8648 19.3656 0.3861 
WFDC11 Pan troglodytes 71 10.094 5037 13 -0.7082 -0.5289 25.782 0.0145 
WFDC10B/13 Pan troglodytes 59 6.8495 7365 10.8 -1.1309 -1.54 -4.1285 0.1052 
SPINT4 Pan troglodytes 30 2.2099 3527 5.5 -1.7644 -1.9467 16.0833 0.1734 
WFDC3 Pan troglodytes 93 10.64 7572 17 -1.1874 -1.0211 17.8464 0.0719 
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Supplementary Table S4: Nonsynonymous substitutions WFDC genes. 
a) Nonsynonymous chimpanzee variable positions 
 
 
SNP location Protein Frequency Expected Found Expected  Found  SIFT PolyPhen 
in chr20 (Pantro2)     Residue Residue Codon Codon     
42453065 WFDC5 0.06 R H CGC CAC Tolerated Benign 
42453208 WFDC5 0.04 V I GTC ATC Tolerated 
Possibly 
Damaging 
42453271 WFDC5 0.02 V M GTG ATG Tolerated 
Possibly 
Damaging 
42466176 WFDC12 0.04 W R TGG CGG Damaging Benign 
42466200 WFDC12 0.04 S P TCA CCA Damaging Benign 
42466206 WFDC12 0.04 D H GAT CAT Damaging 
Probably 
Damaging 
42466400 WFDC12 0.01 K N AAG AAT Tolerated 
Probably 
Damaging 
42466463 WFDC12 0.02 D E GAC GAA Tolerated 
Probably 
Damaging 
42466492 WFDC12 0.02 D N GAT AAT Tolerated Benign 
42466510 WFDC12 0.04 V I GTA ATA Tolerated Benign 
42519166 PI3 0.02 T M ACG ATG Tolerated Benign 
42520083 PI3 0.12 V I GTT ATT Tolerated 
Possibly 
Damaging 
42568115 SEMG2 0.02 G D GGT GAT 
Affect 
Protein 
Funcion 
Probably 
Damaging 
42568172 SEMG2 0.05 G V GGC GTC Tolerated 
Possibly 
Damaging 
42568204 SEMG2 0.02 H D CAT GAT Tolerated Benign 
42568441 SEMG2 0.02 A T GCT ACT Tolerated 
Possibly 
Damaging 
42568613 SEMG2 0.01 S N AGC AAC Tolerated 
Possibly 
Damaging 
42568780 SEMG2 0.01 H Y CAT TAT Tolerated 
Probably 
Damaging 
42568831 SEMG2 0.02 K E AAG GAG Tolerated 
Probably 
Damaging 
42568883 SEMG2 0.02 K M AAG ATG Tolerated 
Probably 
Damagin 
42568888 SEMG2 0.02 H Y CAT TAT Tolerated 
Probably 
Damaging 
42569052 SEMG2 0.01 E D GAG GAT Tolerated 
Probably 
Damaging 
42569213 SEMG2 0.07 I T ATT ACT Tolerated Benign 
42569468 SEMG2 0.02 R P CGA CCA Tolerated 
Probably 
Damaging 
42569698 SEMG2 0.02 H Y CAT TAT Tolerated Benign 
42826868 WFDC2 0.02 S L TCG TTG Tolerated 
Possibly 
Damaging 
42826905 WFDC2 0.04 S R AGC AGG Tolerated Benign 
42897365 WFDC6 0.01 C R TGT CGT Tolerated 
Probably 
Damaging 
42897376 WFDC6 0.02 R H CGT CAT Tolerated Benign 
42897403 WFDC6 0.03 E G GAA GGA Tolerated Benign 
42897449 WFDC6 0.01 E K GAA AAA Tolerated Benign 
42897457 WFDC6 0.07 V G GTG GGG Tolerated 
Probably 
Damaging 
42898710 WFDC6 0.01 I V ATC GTC Tolerated Benign 
42972808 WFDC9 0.03 I T ATT ACT Torerated 
Possibly 
Damaging 
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42992587 WFDC10A 0.09 T P ACT CCT 
Affect 
Protein 
Funcion Benign 
42992632 WFDC10A 0.01 Q K CAG AAG Torelated 
Possibly 
Damaging 
42993698 WFDC10A 0.01 C R TGT CGT 
Affect 
Protein 
Funcion 
Probably 
Damaging 
43044472 WFDC10B 0.01 C * TGT TGA 
  
43044552 WFDC10B 0.02 L V CTA GTA Torelated Benign 
43044585 WFDC10B 0.01 I V ATC GTC 
Affect 
Protein 
Funcion Benign 
43045539 WFDC10B 0.07 R C CGT TGT Tolerated 
Possibly 
Damaging 
43045602 WFDC10B 0.08 P T CCC ACC Tolerated Benign 
43071581 WFDC10B 0.02 R T AGG ACG 
Affect 
Protein 
Function 
Probably 
Damaging 
43142946 WFDC3 0.01 E K GAA AAA Tolerated Benign 
43142988 WFDC3 0.02 K E AAA GAA Tolerated Benign 
43143039 WFDC3 0.02 C S TGT AGT 
Affect 
Protein 
Function 
Probably 
Damaging 
43155352 WFDC3 0.44 S F TCT TTT Tolerated Benign 
43155425 WFDC3 0.45 T P ACT CCT Tolerated Benign 
43155466 WFDC3 0.20 P L CCT CTT Tolerated Benign 
43155467 WFDC3 0.03 P S CCT TCT 
Affect 
Protein 
Function Benign 
 
b) Non-synonymous chimpanzee specific fixed differences 
 
Protein Position Human Chimp Orang Macaque SIFT PolyPhen 
WFDC12 G27D C T C C Tolerated Benign 
SEMG2 A93V C T C C Tolerated Benign 
SEMG2 G101D G A G G Tolerated Benign 
SEMG2 K120E A G A A Tolerated Benign 
SEMG2 H136Y C T C C Tolerated Benign 
SEMG2 S232G A G A A Tolerated Benign 
SEMG2 H401R A G A A Tolerated Benign 
SEMG2 H461R A G A A Tolerated Benign 
SEMG2 T485S A T A A Affect Protein Function Benign 
SEMG2 G504D G A G G Tolerated Benign 
SLPI L13F G A G G Tolerated Benign 
WFDC6 P34S G A G G Tolerated Benign 
EPPIN K79E     Affect Protein Function  
WFDC8 L207P A G ? A Tolerated Benign 
WFDC8 D64E G T G A Tolerated Benign 
WFDC8 S30C G C G G Tolerated Benign 
WFDC9 F31L A G A T Tolerated Benign 
WFDC10B/13 L16S A G A A Tolerated Benign 
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Supplementary Table S5: 2.5 percentile resulting from 100000 coalescent simulations using ms, under three 
demographic models.  
 
 Constant Expansion 
model 
Wegmann et al. 2010 
WFDC6(P. t. 
troglodytes) 
-1.13 -1.33 -2.05 
WFDC6 (P. troglodytes) -1.586   
EPPIN(P. t. troglodytes) -1.00 -1.22 -2.03 
EPPIN(P. troglodytes) -1.589   
 
 
Supplementary Table S6: Parameter Estimates and Likelihood Scores under Different Branch models. 
 
 
  Parameters for Branches Likelihoods 
One ratio ω EPPIN-WFDC6= 0.4739 -1388.2014 
Two ratios ω EPPIN= 0.4738 -1387.6820 
  ω WFDC6 = 0.7782  
Three ratios ω EPPIN = 0.4739 -1387.5959 
 ω WFDC6others = 0.7091  
  ω WFDC6ancHomoPan = 1.1656  
Three ratios ω EPPIN = 0.4738 -1387.6534 
 ω WFDC6 others= 0.8119  
 ω WFDC6Pan = 0.5891  
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Supplementary Figures 
 
 
 
Supplementary Figure S1: Geographic distribution of P. troglodytes subspecies in Africa [adapted from Gonder et al. 
2011]. 
A) 
 
B) 
 
 
Supplementary Figure S2: A) Folded site frequency spectrum (SFS) in the control regions B) Distribution of nucleotide 
diversity for all the WFDC genes in the sequenced chimpanzee subspecies and the corresponding regions in the 1000 
genomes database. 
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Supplementary Figure S3: A) FST values in Y axis and heterozygozity in the X axis as calculated in ARLEQUIN. B) FST 
values for all the populations, plotted based on genomic position. 
 
 
Supplementary Figure S4: Principal component analysis (PCA) plots of markers. Eigenvalues were calculated in 
eigenstrat and plots were made using R package.  
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Supplementary Figure S5: A) Bar plot output from STRUCTURE; B) Likelihoods calculated from STRUCTURE 
outputs. 
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Supplementary Figure S6: LD plots as calculated in Haploview (r
2 
statistic). 
 
 
Supplementary Figure S7: Empirical comparisons generated from the 47 control regions. Tajima’s D and π were 
calculated for each regions using SLIDER and plotted using SPSS software. 2.5 and 97.5 percentiles are represented in 
dashed lines. 
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Supplementary Figure S8: Inferred EPPIN.network haplotypes. Each circle represents a unique haplotype, and its 
area is proportional to its frequency. Within each circle, P. t. verus, P. t. ellioti, and P. t. troglodytes are labeled in green, 
purple and orange, respectively. The mutations that differentiate each haplotype are shown along each branch.  
 
 
Supplementary Figure S9: Amino acid alignment of WFDC6 and EPPIN. Cysteines are marked in light green and 
disulfide bridges are marked in black lines. Black squares represent Stop Codons. 
Prepeptide
WAP domain
Kunitz domain
Chimpanzee M G L G L L P I L V P F I L L G D I Q E P G H A E G I L G K P C S K I K V E C E V E E I D Q C T K P R D C P E N M K C C L F S R G K K C L D F R
Human . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P . . . . . . . . . . . . . . . . . . . . . . . . . . . P . . . . . . . . . . .
Gorilla . R . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . P . . . . . . . . . . . . . R . . . . . . . . . . . . . . . . . . . . . . . . .
Orangutan . . . . . . . . . . . . . . . . N . . . . . . . . V . . . . . . P . . . . . . . . . . T . . . . . . . . . . . . . . R . . . . H . . . . . . L .
Gibbon . . . . . . . . . . . . . . . . . V . . . . . . . . . F . . . R P . . . . . . K . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . L .
Rhesus . . . . . . . . . . . . . . . . . . . . . . . . . . - - - - - . P . . . . . . . . . . . . H . . . H . . . . . . . . L . . . . C . . . . . . L .
Baboon . . . . . . . . . . . . . . . . . . . . . . . . . . - - - - - . P . . . . . . . . . . . . H . A . H . . . . . . . . R . . . . C . . . . . . L .
Chimpanzee . . S . . . S L . . L . V . . A N V . G . . L T D W L F P R R . P . . R E . . . F Q . R . V . . . D . Q . Q D . K . . . V . . C . . . . . . L K
Human . . S . . . S L . . L . V . . A N V . G . . L T D W L F P R R . P . . R E . . . F Q . R . V . . . D . Q . Q D . K . . . V . . C . . . . . . L K
Gorilla . . S . . . S L . . L . V . . V N V . G . . L T D W L F P R R . P . . R E . . . F Q . R . V . . . D . Q . Q D . K . . . V . . C . . . . . . L K
Orangutan . . S . . . N L . . L . V . . A N V . G . . L T D W L F P R R . P . . R E . . . F K . R . V . . . D . Q . Q D . K . . . V . . C . . . . . . L K
Gibbon . . S . . . S L . . L . . . . A N V . G . . L T D W L F P R R . P . . R E . . G F K . R . V . . . D . Q . Q D . K . . . V . . C . . . . . . L K
Rhesus . . S . . . S L . . L . . . . V N V . G . . L T D W L F P R R . P T . R E . . . F R . R . V . . R H . Q . . D . K . . . V . . C . . . . . . L K
Marmoset . . S . . . S L . . L . . . . V N V . G . . L T D W L F A R R . P R . . E . . A F K . R . V . . . D . Q . Q D . K . . . V . . C . . . . F . V K
Chimpanzee K I Y A V C H R R L A P A P P Y H T G G T I K K T K I C S E F I Y G G S Q G N N N N F Q T E A V C L V T C K K Y H - - - - - -
Human . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I . . . . . . . . . - - - - - -
Gorilla . . . . . . . . . . . . . . . . . A . . . . . . . . . . . . . . C D . . . . . . . . . . . . . I . . . . . . . . . - - - - - -
Orangutan . . . . . . . . . . . . . L . . . A . . . . . . . . . . . K . . . . . C K . . S . . . . . . . I . . . . . . . . . K - - - - -
Gibbon . . . . . . . . . . . . . L . . . A . . . . . . . . . . . K . . . . . C . . . . . . . . . . . I . V . . . . . . R - - - - - -
Rhesus . . . . . . . . . . . . . . . . . V . . . . . . L R S A P N S S M A V A R . T I T T S K L K L S A WS P A . N T I S Q P Y F I
Baboon . . . . . . . . . . . . . . . . . V . . . . . . L R S A P N S S M A V A R . T I T T S K L K L S A WS P A . N T V S Q P Y F I
Chimpanzee Q D V C K M P K E T G . C A Y F L R W W Y D . . N N T . . M . V . . . C . . . . . . . . S K . N . . N . . . N K R F P - - - -
Human Q D V C E M P K E T G . C A Y F L H W W Y D . . D N T . . M . V . . . C . . . . . . . . S K . N . . N . . . N K R F P - - - -
Gorilla Q D V C E M P K E T G . C A Y F L R W W Y D . . N N S . . M . V . . . C . . . . . . . . S K . N . . N . . R N K R F P - - - -
Orangutan Q D V C E M P K E T G . C A Y F L R W W Y D . . N N T . . M . V . . . C . . . . . . . . S K . N . . N . . . . K R F P - - - -
Gibbon Q D V C E M P K E T G . C A Y F L R W W Y D . . N N T . . M . V . . . C P . . . . . . . S K . N . . N . . . N K R F P - - - -
Rhesus Q D V C E M P N E T G . C A F F I R W W Y D . . N N T . . T . V . . . C . . . . . . . . S . . N . . N . . . N K R F P - - - -
Marmoset Q D V C E M P K E T G . C A F F R R W W Y D . . N D T . . I . . . . . C . . . . . . . . S K T N . . N . . . . K R F P - - - -
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Supplementary Figure S   10: Phylogenetic analysis of WFDC6 and EPPIN in primates, showing dN/dS ratios. The 
different branch models are represented as follows: ω0, one ratio model; ω1, two-ratio model; ω2 the three-ratio 
model 1; and ω3 the three-ratio model 2. 
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Appendix IV 
Supplementary Material Article 4 
Characterization of the Human WFDC8: Evolutionary history and 
differential allele expression 
(in preparation) 
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Supplementary Tables 
Supplementary Table S1: WFDC8 sequence references used for alignment and phylogeny. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* This sequence was obtained by the BLAT utility at http://genome.ucsc.edu/cgi-bin/hgBlat?command=start  
 
Supplementary Table S2: Samples genotypes.  
 
Sample DNA RNA RNA (post-
DNAase I) 
Genotype 
(ng/ul) (ng/ul) (ng/ul) rs2250860 
14416 78,83 506,37 38.46 G-A 
14454 150.6 387,01 33.27 G-A 
11667 51,72 454,48 34.85 G-A 
876 110,39 573,91 380.81 G-A 
7584 15,63 122,07 6.27 AA 
2637 51,24 162,35 13.08 AA 
17826 88,81 807,11 248.78 G-A 
22599 54,67 578,46 4.58 G-A 
19638 86,52 613,18 8.49 G-A 
11676 33,72 3,04  GG 
14873 71,69 497,65 55.17 GG 
123805 102.85 48,35 11.55 G-A 
22023 76.83 607,20 101.37 G-A 
 
 
 
 
 
 
WFDC8 NCBI reference 
Homo sapiens NM_130896.2 
Pan troglodytes XM_003316967.1 
Pan paniscus XM_003825972.1 
Gorilla gorilla N/A* 
Pongo abelii XM_002830356.2 
Macaca mulatta XM_001107439.2 
Saimiri boliviensis boliviensis XM_003936446.1 
Nomascus leucogenys XM_003253645.1 
Papio anubis XM_003904689.1 
Canis lupus familiaris XM_534437.2 
Mus musculus NM_001080550.2 
Rattus norvegicus XM_003749629.1 
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Supplementary Figures 
 
 
 
Supplementary Figure S1: Allele frequencies of rs7273669, extracted from the 1000 Genomes Project website.  
 
 
 
 
